id	sid	tid	token	lemma	pos
hls-1187	1	1	hrev_master	hrev_master	NOUN
hls-1187	2	1	[	[	X
hls-1187	2	2	healthcare	healthcare	NOUN
hls-1187	2	3	in	in	ADP
hls-1187	2	4	low	low	ADJ
hls-1187	2	5	-	-	PUNCT
hls-1187	2	6	resource	resource	NOUN
hls-1187	2	7	settings	setting	NOUN
hls-1187	2	8	2013	2013	NUM
hls-1187	2	9	;	;	PUNCT
hls-1187	2	10	1	1	NUM
hls-1187	2	11	:	:	PUNCT
hls-1187	2	12	e17	e17	NOUN
hls-1187	2	13	]	]	PUNCT
hls-1187	3	1	[	[	X
hls-1187	3	2	page	page	NOUN
hls-1187	3	3	57	57	NUM
hls-1187	3	4	]	]	PUNCT
hls-1187	3	5	sex	sex	NOUN
hls-1187	3	6	differences	difference	NOUN
hls-1187	3	7	in	in	ADP
hls-1187	3	8	long	long	ADJ
hls-1187	3	9	-	-	PUNCT
hls-1187	3	10	term	term	NOUN
hls-1187	3	11	outcomes	outcome	NOUN
hls-1187	3	12	of	of	ADP
hls-1187	3	13	patients	patient	NOUN
hls-1187	3	14	with	with	ADP
hls-1187	3	15	percutaneous	percutaneous	ADJ
hls-1187	3	16	coronary	coronary	ADJ
hls-1187	3	17	intervention	intervention	NOUN
hls-1187	3	18	:	:	PUNCT
hls-1187	3	19	the	the	DET
hls-1187	3	20	armenian	armenian	ADJ
hls-1187	3	21	experience	experience	NOUN
hls-1187	3	22	yeva	yeva	PROPN
hls-1187	3	23	sahakyan,1,2	sahakyan,1,2	PROPN
hls-1187	3	24	michael	michael	PROPN
hls-1187	3	25	e.	e.	PROPN
hls-1187	3	26	thompson,1,3	thompson,1,3	PROPN
hls-1187	3	27	lusine	lusine	NOUN
hls-1187	3	28	abrahamyan1,4	abrahamyan1,4	PROPN
hls-1187	3	29	1college	1college	NUM
hls-1187	3	30	of	of	ADP
hls-1187	3	31	health	health	NOUN
hls-1187	3	32	sciences	sciences	PROPN
hls-1187	3	33	,	,	PUNCT
hls-1187	3	34	american	american	PROPN
hls-1187	3	35	university	university	PROPN
hls-1187	3	36	of	of	ADP
hls-1187	3	37	armenia	armenia	PROPN
hls-1187	3	38	,	,	PUNCT
hls-1187	3	39	yerevan	yerevan	PROPN
hls-1187	3	40	;	;	PUNCT
hls-1187	3	41	2department	2department	NUM
hls-1187	3	42	of	of	ADP
hls-1187	3	43	therapy	therapy	NOUN
hls-1187	3	44	,	,	PUNCT
hls-1187	3	45	yerevan	yerevan	PROPN
hls-1187	3	46	state	state	PROPN
hls-1187	3	47	medical	medical	PROPN
hls-1187	3	48	university	university	PROPN
hls-1187	3	49	,	,	PUNCT
hls-1187	3	50	yerevan	yerevan	PROPN
hls-1187	3	51	,	,	PUNCT
hls-1187	3	52	armenia	armenia	PROPN
hls-1187	3	53	;	;	PUNCT
hls-1187	3	54	3department	3department	NUM
hls-1187	3	55	of	of	ADP
hls-1187	3	56	public	public	ADJ
hls-1187	3	57	health	health	NOUN
hls-1187	3	58	sciences	science	NOUN
hls-1187	3	59	,	,	PUNCT
hls-1187	3	60	the	the	DET
hls-1187	3	61	university	university	NOUN
hls-1187	3	62	of	of	ADP
hls-1187	3	63	north	north	PROPN
hls-1187	3	64	carolina	carolina	PROPN
hls-1187	3	65	at	at	ADP
hls-1187	3	66	charlotte	charlotte	PROPN
hls-1187	3	67	,	,	PUNCT
hls-1187	3	68	nc	nc	PROPN
hls-1187	3	69	,	,	PUNCT
hls-1187	3	70	usa	usa	PROPN
hls-1187	3	71	;	;	PUNCT
hls-1187	3	72	4toronto	4toronto	NUM
hls-1187	3	73	health	health	NOUN
hls-1187	3	74	economics	economic	NOUN
hls-1187	3	75	and	and	CCONJ
hls-1187	3	76	technology	technology	NOUN
hls-1187	3	77	assessment	assessment	NOUN
hls-1187	3	78	(	(	PUNCT
hls-1187	3	79	theta	theta	NOUN
hls-1187	3	80	)	)	PUNCT
hls-1187	3	81	collaborative	collaborative	NOUN
hls-1187	3	82	,	,	PUNCT
hls-1187	3	83	university	university	PROPN
hls-1187	3	84	of	of	ADP
hls-1187	3	85	toronto	toronto	PROPN
hls-1187	3	86	,	,	PUNCT
hls-1187	3	87	ontario	ontario	PROPN
hls-1187	3	88	,	,	PUNCT
hls-1187	3	89	canada	canada	PROPN
hls-1187	3	90	abstract	abstract	VERB
hls-1187	3	91	the	the	DET
hls-1187	3	92	present	present	ADJ
hls-1187	3	93	study	study	NOUN
hls-1187	3	94	aimed	aim	VERB
hls-1187	3	95	at	at	ADP
hls-1187	3	96	assessing	assess	VERB
hls-1187	3	97	sex	sex	NOUN
hls-1187	3	98	differences	difference	NOUN
hls-1187	3	99	in	in	ADP
hls-1187	3	100	perioperative	perioperative	ADJ
hls-1187	3	101	characteristics	characteristic	NOUN
hls-1187	3	102	and	and	CCONJ
hls-1187	3	103	3	3	NUM
hls-1187	3	104	-	-	PUNCT
hls-1187	3	105	year	year	NOUN
hls-1187	3	106	event	event	NOUN
hls-1187	3	107	-	-	PUNCT
hls-1187	3	108	free	free	ADJ
hls-1187	3	109	survival	survival	NOUN
hls-1187	3	110	from	from	ADP
hls-1187	3	111	major	major	ADJ
hls-1187	3	112	adverse	adverse	ADJ
hls-1187	3	113	cardiac	cardiac	ADJ
hls-1187	3	114	and	and	CCONJ
hls-1187	3	115	cerebrovascular	cerebrovascular	ADJ
hls-1187	3	116	events	event	NOUN
hls-1187	3	117	(	(	PUNCT
hls-1187	3	118	macce	macce	NOUN
hls-1187	3	119	)	)	PUNCT
hls-1187	3	120	in	in	ADP
hls-1187	3	121	patients	patient	NOUN
hls-1187	3	122	with	with	ADP
hls-1187	3	123	percutaneous	percutaneous	ADJ
hls-1187	3	124	coronary	coronary	ADJ
hls-1187	3	125	intervention	intervention	NOUN
hls-1187	3	126	(	(	PUNCT
hls-1187	3	127	pci	pci	ADJ
hls-1187	3	128	)	)	PUNCT
hls-1187	3	129	in	in	ADP
hls-1187	3	130	armenia	armenia	PROPN
hls-1187	3	131	.	.	PUNCT
hls-1187	4	1	the	the	DET
hls-1187	4	2	study	study	NOUN
hls-1187	4	3	utilized	utilize	VERB
hls-1187	4	4	an	an	DET
hls-1187	4	5	observational	observational	ADJ
hls-1187	4	6	,	,	PUNCT
hls-1187	4	7	retrospective	retrospective	ADJ
hls-1187	4	8	cohort	cohort	NOUN
hls-1187	4	9	design	design	NOUN
hls-1187	4	10	enrolling	enrolling	NOUN
hls-1187	4	11	patients	patient	NOUN
hls-1187	4	12	who	who	PRON
hls-1187	4	13	underwent	undergo	VERB
hls-1187	4	14	pci	pci	ADJ
hls-1187	4	15	from	from	ADP
hls-1187	4	16	2006	2006	NUM
hls-1187	4	17	to	to	ADP
hls-1187	4	18	2008	2008	NUM
hls-1187	4	19	at	at	ADP
hls-1187	4	20	a	a	DET
hls-1187	4	21	single	single	ADJ
hls-1187	4	22	center	center	NOUN
hls-1187	4	23	in	in	ADP
hls-1187	4	24	yerevan	yerevan	PROPN
hls-1187	4	25	,	,	PUNCT
hls-1187	4	26	armenia	armenia	PROPN
hls-1187	4	27	.	.	PUNCT
hls-1187	5	1	major	major	ADJ
hls-1187	5	2	adverse	adverse	ADJ
hls-1187	5	3	cardiac	cardiac	ADJ
hls-1187	5	4	and	and	CCONJ
hls-1187	5	5	cerebrovascular	cerebrovascular	ADJ
hls-1187	5	6	events	event	NOUN
hls-1187	5	7	included	include	VERB
hls-1187	5	8	all	all	DET
hls-1187	5	9	-	-	PUNCT
hls-1187	5	10	cause	cause	NOUN
hls-1187	5	11	mortality	mortality	NOUN
hls-1187	5	12	,	,	PUNCT
hls-1187	5	13	myocardial	myocardial	ADJ
hls-1187	5	14	infarction	infarction	NOUN
hls-1187	5	15	(	(	PUNCT
hls-1187	5	16	mi	mi	NOUN
hls-1187	5	17	)	)	PUNCT
hls-1187	5	18	,	,	PUNCT
hls-1187	5	19	repeat	repeat	NOUN
hls-1187	5	20	revascularization	revascularization	NOUN
hls-1187	5	21	,	,	PUNCT
hls-1187	5	22	or	or	CCONJ
hls-1187	5	23	stroke	stroke	NOUN
hls-1187	5	24	/	/	SYM
hls-1187	5	25	transient	transient	ADJ
hls-1187	5	26	ischemic	ischemic	ADJ
hls-1187	5	27	attack	attack	NOUN
hls-1187	5	28	.	.	PUNCT
hls-1187	6	1	among	among	ADP
hls-1187	6	2	485	485	NUM
hls-1187	6	3	participants	participant	NOUN
hls-1187	6	4	included	include	VERB
hls-1187	6	5	in	in	ADP
hls-1187	6	6	the	the	DET
hls-1187	6	7	analysis	analysis	NOUN
hls-1187	6	8	,	,	PUNCT
hls-1187	6	9	419	419	NUM
hls-1187	6	10	(	(	PUNCT
hls-1187	6	11	86	86	NUM
hls-1187	6	12	%	%	NOUN
hls-1187	6	13	)	)	PUNCT
hls-1187	6	14	were	be	AUX
hls-1187	6	15	men	man	NOUN
hls-1187	6	16	.	.	PUNCT
hls-1187	7	1	women	woman	NOUN
hls-1187	7	2	were	be	AUX
hls-1187	7	3	older	old	ADJ
hls-1187	7	4	,	,	PUNCT
hls-1187	7	5	more	more	ADV
hls-1187	7	6	hypertensive	hypertensive	ADJ
hls-1187	7	7	,	,	PUNCT
hls-1187	7	8	more	more	ADV
hls-1187	7	9	obese	obese	ADJ
hls-1187	7	10	,	,	PUNCT
hls-1187	7	11	and	and	CCONJ
hls-1187	7	12	had	have	VERB
hls-1187	7	13	significantly	significantly	ADV
hls-1187	7	14	higher	high	ADJ
hls-1187	7	15	rates	rate	NOUN
hls-1187	7	16	of	of	ADP
hls-1187	7	17	diabetes	diabetes	NOUN
hls-1187	7	18	.	.	PUNCT
hls-1187	8	1	at	at	ADP
hls-1187	8	2	the	the	DET
hls-1187	8	3	end	end	NOUN
hls-1187	8	4	of	of	ADP
hls-1187	8	5	follow	follow	NOUN
hls-1187	8	6	-	-	PUNCT
hls-1187	8	7	up	up	NOUN
hls-1187	8	8	,	,	PUNCT
hls-1187	8	9	the	the	DET
hls-1187	8	10	incidence	incidence	NOUN
hls-1187	8	11	of	of	ADP
hls-1187	8	12	macce	macce	NOUN
hls-1187	8	13	was	be	AUX
hls-1187	8	14	37	37	NUM
hls-1187	8	15	%	%	NOUN
hls-1187	8	16	for	for	ADP
hls-1187	8	17	men	man	NOUN
hls-1187	8	18	and	and	CCONJ
hls-1187	8	19	33	33	NUM
hls-1187	8	20	%	%	NOUN
hls-1187	8	21	for	for	ADP
hls-1187	8	22	women	woman	NOUN
hls-1187	8	23	(	(	PUNCT
hls-1187	8	24	p=0.9	p=0.9	ADV
hls-1187	8	25	)	)	PUNCT
hls-1187	8	26	.	.	PUNCT
hls-1187	9	1	based	base	VERB
hls-1187	9	2	on	on	ADP
hls-1187	9	3	the	the	DET
hls-1187	9	4	results	result	NOUN
hls-1187	9	5	from	from	ADP
hls-1187	9	6	the	the	DET
hls-1187	9	7	adjusted	adjust	VERB
hls-1187	9	8	cox	cox	PROPN
hls-1187	9	9	proportional	proportional	PROPN
hls-1187	9	10	hazards	hazard	NOUN
hls-1187	9	11	model	model	PROPN
hls-1187	9	12	,	,	PUNCT
hls-1187	9	13	the	the	DET
hls-1187	9	14	independent	independent	ADJ
hls-1187	9	15	predictors	predictor	NOUN
hls-1187	9	16	of	of	ADP
hls-1187	9	17	macce	macce	NOUN
hls-1187	9	18	included	include	VERB
hls-1187	9	19	acute	acute	PROPN
hls-1187	9	20	mi	mi	PROPN
hls-1187	10	1	[	[	X
hls-1187	10	2	hazard	hazard	NOUN
hls-1187	10	3	ratio	ratio	NOUN
hls-1187	10	4	(	(	PUNCT
hls-1187	10	5	hr)=1.43	hr)=1.43	PROPN
hls-1187	10	6	,	,	PUNCT
hls-1187	10	7	95	95	NUM
hls-1187	10	8	%	%	NOUN
hls-1187	10	9	confidence	confidence	NOUN
hls-1187	10	10	interval	interval	NOUN
hls-1187	10	11	(	(	PUNCT
hls-1187	10	12	ci	ci	NOUN
hls-1187	10	13	):	):	PUNCT
hls-1187	10	14	1.02	1.02	NUM
hls-1187	10	15	-	-	SYM
hls-1187	10	16	2.00	2.00	NUM
hls-1187	10	17	]	]	PUNCT
hls-1187	10	18	,	,	PUNCT
hls-1187	10	19	arrhythmia	arrhythmia	NOUN
hls-1187	10	20	(	(	PUNCT
hls-1187	10	21	hr=1.64	hr=1.64	PROPN
hls-1187	10	22	,	,	PUNCT
hls-1187	10	23	95	95	NUM
hls-1187	10	24	%	%	NOUN
hls-1187	10	25	ci	ci	NOUN
hls-1187	10	26	:	:	PUNCT
hls-1187	10	27	1.07	1.07	NUM
hls-1187	10	28	-	-	SYM
hls-1187	10	29	2.50	2.50	NUM
hls-1187	10	30	)	)	PUNCT
hls-1187	10	31	,	,	PUNCT
hls-1187	10	32	sex	sex	NOUN
hls-1187	10	33	(	(	PUNCT
hls-1187	10	34	hr=2.46	hr=2.46	NOUN
hls-1187	10	35	,	,	PUNCT
hls-1187	10	36	95	95	NUM
hls-1187	10	37	%	%	NOUN
hls-1187	10	38	ci	ci	NOUN
hls-1187	10	39	:	:	PUNCT
hls-1187	10	40	1.085.61	1.085.61	NUM
hls-1187	10	41	)	)	PUNCT
hls-1187	10	42	,	,	PUNCT
hls-1187	10	43	diabetes	diabetes	NOUN
hls-1187	10	44	(	(	PUNCT
hls-1187	10	45	hr=5.65	hr=5.65	NOUN
hls-1187	10	46	,	,	PUNCT
hls-1187	10	47	95	95	NUM
hls-1187	10	48	%	%	NOUN
hls-1187	10	49	ci	ci	NOUN
hls-1187	10	50	:	:	PUNCT
hls-1187	10	51	2.14	2.14	NUM
hls-1187	10	52	-	-	SYM
hls-1187	10	53	14.95	14.95	NUM
hls-1187	10	54	)	)	PUNCT
hls-1187	10	55	,	,	PUNCT
hls-1187	10	56	and	and	CCONJ
hls-1187	10	57	the	the	DET
hls-1187	10	58	interaction	interaction	NOUN
hls-1187	10	59	between	between	ADP
hls-1187	10	60	sex	sex	NOUN
hls-1187	10	61	and	and	CCONJ
hls-1187	10	62	diabetes	diabetes	NOUN
hls-1187	10	63	(	(	PUNCT
hls-1187	10	64	hr=0.16	hr=0.16	NOUN
hls-1187	10	65	;	;	PUNCT
hls-1187	10	66	95	95	NUM
hls-1187	10	67	%	%	NOUN
hls-1187	10	68	ci	ci	NOUN
hls-1187	10	69	:	:	PUNCT
hls-1187	10	70	0.05	0.05	NUM
hls-1187	10	71	-	-	SYM
hls-1187	10	72	0.47	0.47	NUM
hls-1187	10	73	)	)	PUNCT
hls-1187	10	74	.	.	PUNCT
hls-1187	11	1	among	among	ADP
hls-1187	11	2	diabetic	diabetic	ADJ
hls-1187	11	3	patients	patient	NOUN
hls-1187	11	4	,	,	PUNCT
hls-1187	11	5	men	man	NOUN
hls-1187	11	6	had	have	VERB
hls-1187	11	7	better	well	ADJ
hls-1187	11	8	event	event	NOUN
hls-1187	11	9	-	-	PUNCT
hls-1187	11	10	free	free	ADJ
hls-1187	11	11	survival	survival	NOUN
hls-1187	11	12	from	from	ADP
hls-1187	11	13	macce	macce	NOUN
hls-1187	11	14	(	(	PUNCT
hls-1187	11	15	hr=0.40	hr=0.40	NOUN
hls-1187	11	16	,	,	PUNCT
hls-1187	11	17	95	95	NUM
hls-1187	11	18	%	%	NOUN
hls-1187	11	19	ci	ci	NOUN
hls-1187	11	20	:	:	PUNCT
hls-1187	11	21	0.19	0.19	NUM
hls-1187	11	22	-	-	SYM
hls-1187	11	23	0.85	0.85	NUM
hls-1187	11	24	)	)	PUNCT
hls-1187	11	25	than	than	ADP
hls-1187	11	26	women	woman	NOUN
hls-1187	11	27	,	,	PUNCT
hls-1187	11	28	whereas	whereas	SCONJ
hls-1187	11	29	in	in	ADP
hls-1187	11	30	patients	patient	NOUN
hls-1187	11	31	without	without	ADP
hls-1187	11	32	diabetes	diabetes	NOUN
hls-1187	11	33	men	man	NOUN
hls-1187	11	34	had	have	VERB
hls-1187	11	35	worse	bad	ADJ
hls-1187	11	36	outcomes	outcome	NOUN
hls-1187	11	37	than	than	ADP
hls-1187	11	38	women	woman	NOUN
hls-1187	11	39	(	(	PUNCT
hls-1187	11	40	95	95	NUM
hls-1187	11	41	%	%	NOUN
hls-1187	11	42	ci	ci	NOUN
hls-1187	11	43	:	:	PUNCT
hls-1187	11	44	1.08	1.08	NUM
hls-1187	11	45	-	-	SYM
hls-1187	11	46	5.62	5.62	NUM
hls-1187	11	47	)	)	PUNCT
hls-1187	11	48	.	.	PUNCT
hls-1187	12	1	in	in	ADP
hls-1187	12	2	armenia	armenia	PROPN
hls-1187	12	3	,	,	PUNCT
hls-1187	12	4	the	the	DET
hls-1187	12	5	baseline	baseline	NOUN
hls-1187	12	6	profile	profile	NOUN
hls-1187	12	7	of	of	ADP
hls-1187	12	8	women	woman	NOUN
hls-1187	12	9	undergoing	undergo	VERB
hls-1187	12	10	pci	pci	PROPN
hls-1187	12	11	differed	differ	VERB
hls-1187	12	12	considerably	considerably	ADV
hls-1187	12	13	from	from	ADP
hls-1187	12	14	that	that	PRON
hls-1187	12	15	of	of	ADP
hls-1187	12	16	men	man	NOUN
hls-1187	12	17	.	.	PUNCT
hls-1187	13	1	in	in	ADP
hls-1187	13	2	patients	patient	NOUN
hls-1187	13	3	with	with	ADP
hls-1187	13	4	diabetes	diabetes	NOUN
hls-1187	13	5	,	,	PUNCT
hls-1187	13	6	women	woman	NOUN
hls-1187	13	7	had	have	VERB
hls-1187	13	8	worse	bad	ADJ
hls-1187	13	9	outcomes	outcome	NOUN
hls-1187	13	10	at	at	ADP
hls-1187	13	11	longterm	longterm	ADJ
hls-1187	13	12	follow	follow	NOUN
hls-1187	13	13	-	-	PUNCT
hls-1187	13	14	up	up	NOUN
hls-1187	13	15	,	,	PUNCT
hls-1187	13	16	while	while	SCONJ
hls-1187	13	17	the	the	DET
hls-1187	13	18	opposite	opposite	NOUN
hls-1187	13	19	was	be	AUX
hls-1187	13	20	noted	note	VERB
hls-1187	13	21	in	in	ADP
hls-1187	13	22	patients	patient	NOUN
hls-1187	13	23	without	without	ADP
hls-1187	13	24	diabetes	diabetes	NOUN
hls-1187	13	25	.	.	PUNCT
hls-1187	14	1	introduction	introduction	NOUN
hls-1187	14	2	coronary	coronary	ADJ
hls-1187	14	3	artery	artery	NOUN
hls-1187	14	4	disease	disease	NOUN
hls-1187	14	5	(	(	PUNCT
hls-1187	14	6	cad	cad	NOUN
hls-1187	14	7	)	)	PUNCT
hls-1187	14	8	is	be	AUX
hls-1187	14	9	the	the	DET
hls-1187	14	10	leading	lead	VERB
hls-1187	14	11	cause	cause	NOUN
hls-1187	14	12	of	of	ADP
hls-1187	14	13	morbidity	morbidity	NOUN
hls-1187	14	14	and	and	CCONJ
hls-1187	14	15	mortality	mortality	NOUN
hls-1187	14	16	among	among	ADP
hls-1187	14	17	both	both	DET
hls-1187	14	18	men	man	NOUN
hls-1187	14	19	and	and	CCONJ
hls-1187	14	20	women	woman	NOUN
hls-1187	14	21	worldwide.1	worldwide.1	ADP
hls-1187	14	22	although	although	SCONJ
hls-1187	14	23	historically	historically	ADV
hls-1187	14	24	considered	consider	VERB
hls-1187	14	25	a	a	DET
hls-1187	14	26	man	man	NOUN
hls-1187	14	27	’s	’s	PART
hls-1187	14	28	disease	disease	NOUN
hls-1187	14	29	because	because	SCONJ
hls-1187	14	30	of	of	ADP
hls-1187	14	31	its	its	PRON
hls-1187	14	32	earlier	early	ADJ
hls-1187	14	33	manifestation	manifestation	NOUN
hls-1187	14	34	in	in	ADP
hls-1187	14	35	a	a	DET
hls-1187	14	36	man	man	NOUN
hls-1187	14	37	’s	’s	PART
hls-1187	14	38	life	life	NOUN
hls-1187	14	39	,	,	PUNCT
hls-1187	14	40	recent	recent	ADJ
hls-1187	14	41	studies	study	NOUN
hls-1187	14	42	have	have	AUX
hls-1187	14	43	indicated	indicate	VERB
hls-1187	14	44	that	that	SCONJ
hls-1187	14	45	more	more	ADJ
hls-1187	14	46	females	female	NOUN
hls-1187	14	47	die	die	VERB
hls-1187	14	48	from	from	ADP
hls-1187	14	49	cad	cad	PROPN
hls-1187	14	50	than	than	ADP
hls-1187	14	51	males.2,3	males.2,3	PROPN
hls-1187	14	52	nonetheless	nonetheless	ADV
hls-1187	14	53	,	,	PUNCT
hls-1187	14	54	women	woman	NOUN
hls-1187	14	55	are	be	AUX
hls-1187	14	56	referred	refer	VERB
hls-1187	14	57	less	less	ADV
hls-1187	14	58	frequently	frequently	ADV
hls-1187	14	59	for	for	ADP
hls-1187	14	60	invasive	invasive	ADJ
hls-1187	14	61	interventions	intervention	NOUN
hls-1187	14	62	such	such	ADJ
hls-1187	14	63	as	as	ADP
hls-1187	14	64	percutaneous	percutaneous	ADJ
hls-1187	14	65	coronary	coronary	ADJ
hls-1187	14	66	intervention	intervention	NOUN
hls-1187	14	67	(	(	PUNCT
hls-1187	14	68	pci	pci	PROPN
hls-1187	14	69	)	)	PUNCT
hls-1187	14	70	,	,	PUNCT
hls-1187	14	71	comprising	comprise	VERB
hls-1187	14	72	only	only	ADV
hls-1187	14	73	one	one	NUM
hls-1187	14	74	-	-	PUNCT
hls-1187	14	75	third	third	NOUN
hls-1187	14	76	of	of	ADP
hls-1187	14	77	all	all	DET
hls-1187	14	78	pcis	pcis	NOUN
hls-1187	14	79	performed	perform	VERB
hls-1187	14	80	in	in	ADP
hls-1187	14	81	the	the	DET
hls-1187	14	82	us.4	us.4	NOUN
hls-1187	14	83	such	such	DET
hls-1187	14	84	a	a	DET
hls-1187	14	85	discrepancy	discrepancy	NOUN
hls-1187	14	86	may	may	AUX
hls-1187	14	87	be	be	AUX
hls-1187	14	88	explained	explain	VERB
hls-1187	14	89	by	by	ADP
hls-1187	14	90	the	the	DET
hls-1187	14	91	belief	belief	NOUN
hls-1187	14	92	that	that	SCONJ
hls-1187	14	93	women	woman	NOUN
hls-1187	14	94	do	do	AUX
hls-1187	14	95	not	not	PART
hls-1187	14	96	benefit	benefit	VERB
hls-1187	14	97	from	from	ADP
hls-1187	14	98	invasive	invasive	ADJ
hls-1187	14	99	strategies	strategy	NOUN
hls-1187	14	100	as	as	ADV
hls-1187	14	101	much	much	ADV
hls-1187	14	102	as	as	SCONJ
hls-1187	14	103	men	man	NOUN
hls-1187	14	104	do.2	do.2	PROPN
hls-1187	14	105	studies	study	NOUN
hls-1187	14	106	have	have	AUX
hls-1187	14	107	documented	document	VERB
hls-1187	14	108	that	that	SCONJ
hls-1187	14	109	women	woman	NOUN
hls-1187	14	110	have	have	VERB
hls-1187	14	111	worse	bad	ADJ
hls-1187	14	112	clinical	clinical	ADJ
hls-1187	14	113	outcomes	outcome	NOUN
hls-1187	14	114	such	such	ADJ
hls-1187	14	115	as	as	ADP
hls-1187	14	116	myocardial	myocardial	ADJ
hls-1187	14	117	infarction	infarction	NOUN
hls-1187	14	118	(	(	PUNCT
hls-1187	14	119	mi	mi	NOUN
hls-1187	14	120	)	)	PUNCT
hls-1187	14	121	,	,	PUNCT
hls-1187	14	122	stroke	stroke	NOUN
hls-1187	14	123	,	,	PUNCT
hls-1187	14	124	and	and	CCONJ
hls-1187	14	125	vascular	vascular	ADJ
hls-1187	14	126	complication	complication	NOUN
hls-1187	14	127	after	after	ADP
hls-1187	14	128	pci	pci	ADJ
hls-1187	14	129	than	than	SCONJ
hls-1187	14	130	men.2,5	men.2,5	PROPN
hls-1187	14	131	poor	poor	ADJ
hls-1187	14	132	outcomes	outcome	NOUN
hls-1187	14	133	can	can	AUX
hls-1187	14	134	be	be	AUX
hls-1187	14	135	attributed	attribute	VERB
hls-1187	14	136	to	to	ADP
hls-1187	14	137	a	a	DET
hls-1187	14	138	higher	high	ADJ
hls-1187	14	139	prevalence	prevalence	NOUN
hls-1187	14	140	of	of	ADP
hls-1187	14	141	risk	risk	NOUN
hls-1187	14	142	factors	factor	NOUN
hls-1187	14	143	and	and	CCONJ
hls-1187	14	144	comorbidities	comorbiditie	NOUN
hls-1187	14	145	such	such	ADJ
hls-1187	14	146	as	as	ADP
hls-1187	14	147	older	old	ADJ
hls-1187	14	148	age	age	NOUN
hls-1187	14	149	,	,	PUNCT
hls-1187	14	150	obesity	obesity	NOUN
hls-1187	14	151	,	,	PUNCT
hls-1187	14	152	hypertension	hypertension	NOUN
hls-1187	14	153	,	,	PUNCT
hls-1187	14	154	diabetes	diabetes	NOUN
hls-1187	14	155	mellitus	mellitus	NOUN
hls-1187	14	156	,	,	PUNCT
hls-1187	14	157	and	and	CCONJ
hls-1187	14	158	congestive	congestive	ADJ
hls-1187	14	159	heart	heart	NOUN
hls-1187	14	160	failure	failure	NOUN
hls-1187	14	161	in	in	ADP
hls-1187	14	162	women	woman	NOUN
hls-1187	14	163	than	than	ADP
hls-1187	14	164	in	in	ADP
hls-1187	14	165	men	man	NOUN
hls-1187	14	166	at	at	ADP
hls-1187	14	167	the	the	DET
hls-1187	14	168	time	time	NOUN
hls-1187	14	169	of	of	ADP
hls-1187	14	170	the	the	DET
hls-1187	14	171	intervention.2,5,6	intervention.2,5,6	NOUN
hls-1187	14	172	after	after	ADP
hls-1187	14	173	adjustment	adjustment	NOUN
hls-1187	14	174	for	for	ADP
hls-1187	14	175	these	these	DET
hls-1187	14	176	factors	factor	NOUN
hls-1187	14	177	,	,	PUNCT
hls-1187	14	178	several	several	ADJ
hls-1187	14	179	studies	study	NOUN
hls-1187	14	180	reported	report	VERB
hls-1187	14	181	a	a	DET
hls-1187	14	182	persistent	persistent	ADJ
hls-1187	14	183	survival	survival	NOUN
hls-1187	14	184	disadvantage	disadvantage	NOUN
hls-1187	14	185	for	for	ADP
hls-1187	14	186	women.2,4	women.2,4	PROPN
hls-1187	14	187	several	several	ADJ
hls-1187	14	188	other	other	ADJ
hls-1187	14	189	studies	study	NOUN
hls-1187	14	190	,	,	PUNCT
hls-1187	14	191	however	however	ADV
hls-1187	14	192	,	,	PUNCT
hls-1187	14	193	reported	report	VERB
hls-1187	14	194	that	that	SCONJ
hls-1187	14	195	the	the	DET
hls-1187	14	196	sex	sex	NOUN
hls-1187	14	197	differences	difference	NOUN
hls-1187	14	198	disappeared	disappear	VERB
hls-1187	14	199	after	after	ADP
hls-1187	14	200	adjustments5	adjustments5	NOUN
hls-1187	14	201	-	-	SYM
hls-1187	14	202	9	9	NUM
hls-1187	14	203	or	or	CCONJ
hls-1187	14	204	that	that	SCONJ
hls-1187	14	205	women	woman	NOUN
hls-1187	14	206	had	have	VERB
hls-1187	14	207	better	well	ADJ
hls-1187	14	208	outcomes.10	outcomes.10	NOUN
hls-1187	14	209	-	-	PUNCT
hls-1187	14	210	12	12	NUM
hls-1187	14	211	armenia	armenia	NOUN
hls-1187	14	212	,	,	PUNCT
hls-1187	14	213	located	locate	VERB
hls-1187	14	214	in	in	ADP
hls-1187	14	215	the	the	DET
hls-1187	14	216	caucasus	caucasus	NOUN
hls-1187	14	217	,	,	PUNCT
hls-1187	14	218	has	have	AUX
hls-1187	14	219	a	a	DET
hls-1187	14	220	population	population	NOUN
hls-1187	14	221	of	of	ADP
hls-1187	14	222	approximately	approximately	ADV
hls-1187	14	223	3	3	NUM
hls-1187	14	224	million	million	NUM
hls-1187	14	225	people.13	people.13	NOUN
hls-1187	14	226	the	the	DET
hls-1187	14	227	burden	burden	NOUN
hls-1187	14	228	of	of	ADP
hls-1187	14	229	cad	cad	PROPN
hls-1187	14	230	in	in	ADP
hls-1187	14	231	armenia	armenia	PROPN
hls-1187	14	232	is	be	AUX
hls-1187	14	233	significant	significant	ADJ
hls-1187	14	234	.	.	PUNCT
hls-1187	15	1	according	accord	VERB
hls-1187	15	2	to	to	ADP
hls-1187	15	3	armenia	armenia	PROPN
hls-1187	15	4	’s	’s	PART
hls-1187	15	5	ministry	ministry	PROPN
hls-1187	15	6	of	of	ADP
hls-1187	15	7	health	health	PROPN
hls-1187	15	8	,	,	PUNCT
hls-1187	15	9	in	in	ADP
hls-1187	15	10	2009	2009	NUM
hls-1187	15	11	cad	cad	NOUN
hls-1187	15	12	morbidity	morbidity	NOUN
hls-1187	15	13	was	be	AUX
hls-1187	15	14	1967/100,000	1967/100,000	NUM
hls-1187	15	15	and	and	CCONJ
hls-1187	15	16	mortality	mortality	NOUN
hls-1187	15	17	was	be	AUX
hls-1187	15	18	247/100,000	247/100,000	NUM
hls-1187	15	19	population.14	population.14	NOUN
hls-1187	15	20	given	give	VERB
hls-1187	15	21	the	the	DET
hls-1187	15	22	conflicting	conflict	VERB
hls-1187	15	23	evidence	evidence	NOUN
hls-1187	15	24	on	on	ADP
hls-1187	15	25	gender	gender	NOUN
hls-1187	15	26	differences	difference	NOUN
hls-1187	15	27	and	and	CCONJ
hls-1187	15	28	the	the	DET
hls-1187	15	29	paucity	paucity	NOUN
hls-1187	15	30	of	of	ADP
hls-1187	15	31	information	information	NOUN
hls-1187	15	32	on	on	ADP
hls-1187	15	33	cad	cad	PROPN
hls-1187	15	34	in	in	ADP
hls-1187	15	35	armenia	armenia	PROPN
hls-1187	15	36	,	,	PUNCT
hls-1187	15	37	this	this	DET
hls-1187	15	38	study	study	NOUN
hls-1187	15	39	assessed	assess	VERB
hls-1187	15	40	sex	sex	NOUN
hls-1187	15	41	differences	difference	NOUN
hls-1187	15	42	in	in	ADP
hls-1187	15	43	the	the	DET
hls-1187	15	44	long	long	ADJ
hls-1187	15	45	-	-	PUNCT
hls-1187	15	46	term	term	NOUN
hls-1187	15	47	clinical	clinical	ADJ
hls-1187	15	48	outcomes	outcome	NOUN
hls-1187	15	49	of	of	ADP
hls-1187	15	50	pci	pci	ADJ
hls-1187	15	51	patients	patient	NOUN
hls-1187	15	52	in	in	ADP
hls-1187	15	53	armenia	armenia	PROPN
hls-1187	15	54	treated	treat	VERB
hls-1187	15	55	at	at	ADP
hls-1187	15	56	the	the	DET
hls-1187	15	57	nork	nork	PROPN
hls-1187	15	58	marash	marash	PROPN
hls-1187	15	59	medical	medical	ADJ
hls-1187	15	60	center	center	NOUN
hls-1187	15	61	(	(	PUNCT
hls-1187	15	62	nmmc	nmmc	PROPN
hls-1187	15	63	)	)	PUNCT
hls-1187	15	64	in	in	ADP
hls-1187	15	65	yerevan	yerevan	PROPN
hls-1187	15	66	.	.	PUNCT
hls-1187	16	1	the	the	DET
hls-1187	16	2	nork	nork	PROPN
hls-1187	16	3	marash	marash	PROPN
hls-1187	16	4	medical	medical	ADJ
hls-1187	16	5	center	center	NOUN
hls-1187	16	6	is	be	AUX
hls-1187	16	7	the	the	DET
hls-1187	16	8	largest	large	ADJ
hls-1187	16	9	tertiary	tertiary	ADJ
hls-1187	16	10	cardiac	cardiac	ADJ
hls-1187	16	11	surgery	surgery	NOUN
hls-1187	16	12	center	center	NOUN
hls-1187	16	13	in	in	ADP
hls-1187	16	14	armenia	armenia	PROPN
hls-1187	16	15	and	and	CCONJ
hls-1187	16	16	boasts	boast	VERB
hls-1187	16	17	outcomes	outcome	NOUN
hls-1187	16	18	comparable	comparable	ADJ
hls-1187	16	19	to	to	ADP
hls-1187	16	20	those	those	PRON
hls-1187	16	21	observed	observe	VERB
hls-1187	16	22	in	in	ADP
hls-1187	16	23	other	other	ADJ
hls-1187	16	24	international	international	ADJ
hls-1187	16	25	cardiac	cardiac	ADJ
hls-1187	16	26	centers.15	centers.15	NOUN
hls-1187	16	27	in	in	ADP
hls-1187	16	28	this	this	DET
hls-1187	16	29	study	study	NOUN
hls-1187	16	30	we	we	PRON
hls-1187	16	31	evaluated	evaluate	VERB
hls-1187	16	32	sex	sex	NOUN
hls-1187	16	33	differences	difference	NOUN
hls-1187	16	34	in	in	ADP
hls-1187	16	35	average	average	ADJ
hls-1187	16	36	patient	patient	NOUN
hls-1187	16	37	-	-	PUNCT
hls-1187	16	38	reported	report	VERB
hls-1187	16	39	3	3	NUM
hls-1187	16	40	-	-	PUNCT
hls-1187	16	41	year	year	NOUN
hls-1187	16	42	event	event	NOUN
hls-1187	16	43	-	-	PUNCT
hls-1187	16	44	free	free	ADJ
hls-1187	16	45	survival	survival	NOUN
hls-1187	16	46	from	from	ADP
hls-1187	16	47	the	the	DET
hls-1187	16	48	composite	composite	ADJ
hls-1187	16	49	major	major	ADJ
hls-1187	16	50	adverse	adverse	ADJ
hls-1187	16	51	cardiac	cardiac	ADJ
hls-1187	16	52	and	and	CCONJ
hls-1187	16	53	cerebrovascular	cerebrovascular	ADJ
hls-1187	16	54	events	event	NOUN
hls-1187	16	55	(	(	PUNCT
hls-1187	16	56	macce	macce	NOUN
hls-1187	16	57	)	)	PUNCT
hls-1187	16	58	in	in	ADP
hls-1187	16	59	patients	patient	NOUN
hls-1187	16	60	with	with	ADP
hls-1187	16	61	cad	cad	PROPN
hls-1187	16	62	who	who	PRON
hls-1187	16	63	had	have	AUX
hls-1187	16	64	pci	pci	VERB
hls-1187	16	65	at	at	ADP
hls-1187	16	66	nmmc	nmmc	NOUN
hls-1187	16	67	.	.	PUNCT
hls-1187	17	1	materials	material	NOUN
hls-1187	17	2	and	and	CCONJ
hls-1187	17	3	methods	method	NOUN
hls-1187	17	4	the	the	DET
hls-1187	17	5	study	study	NOUN
hls-1187	17	6	utilized	utilize	VERB
hls-1187	17	7	an	an	DET
hls-1187	17	8	observational	observational	ADJ
hls-1187	17	9	,	,	PUNCT
hls-1187	17	10	retrospective	retrospective	ADJ
hls-1187	17	11	cohort	cohort	NOUN
hls-1187	17	12	design	design	NOUN
hls-1187	17	13	.	.	PUNCT
hls-1187	18	1	the	the	DET
hls-1187	18	2	sample	sample	NOUN
hls-1187	18	3	included	include	VERB
hls-1187	18	4	all	all	DET
hls-1187	18	5	patients	patient	NOUN
hls-1187	18	6	with	with	ADP
hls-1187	18	7	cad	cad	PROPN
hls-1187	18	8	who	who	PRON
hls-1187	18	9	had	have	AUX
hls-1187	18	10	undergone	undergo	VERB
hls-1187	18	11	pci	pci	NOUN
hls-1187	18	12	at	at	ADP
hls-1187	18	13	nmmc	nmmc	NOUN
hls-1187	18	14	from	from	ADP
hls-1187	18	15	1	1	NUM
hls-1187	18	16	january	january	NOUN
hls-1187	18	17	2006	2006	NUM
hls-1187	18	18	to	to	ADP
hls-1187	18	19	31	31	NUM
hls-1187	18	20	december	december	PROPN
hls-1187	18	21	2008	2008	NUM
hls-1187	18	22	.	.	PUNCT
hls-1187	19	1	patients	patient	NOUN
hls-1187	19	2	with	with	ADP
hls-1187	19	3	missing	miss	VERB
hls-1187	19	4	contact	contact	NOUN
hls-1187	19	5	information	information	NOUN
hls-1187	19	6	,	,	PUNCT
hls-1187	19	7	missing	miss	VERB
hls-1187	19	8	medical	medical	ADJ
hls-1187	19	9	records	record	NOUN
hls-1187	19	10	,	,	PUNCT
hls-1187	19	11	residing	reside	VERB
hls-1187	19	12	outside	outside	ADV
hls-1187	19	13	of	of	ADP
hls-1187	19	14	armenia	armenia	PROPN
hls-1187	19	15	at	at	ADP
hls-1187	19	16	the	the	DET
hls-1187	19	17	time	time	NOUN
hls-1187	19	18	of	of	ADP
hls-1187	19	19	the	the	DET
hls-1187	19	20	study	study	NOUN
hls-1187	19	21	,	,	PUNCT
hls-1187	19	22	or	or	CCONJ
hls-1187	19	23	who	who	PRON
hls-1187	19	24	did	do	AUX
hls-1187	19	25	not	not	PART
hls-1187	19	26	speak	speak	VERB
hls-1187	19	27	armenian	armenian	PROPN
hls-1187	19	28	were	be	AUX
hls-1187	19	29	excluded	exclude	VERB
hls-1187	19	30	.	.	PUNCT
hls-1187	20	1	patient	patient	ADJ
hls-1187	20	2	contact	contact	NOUN
hls-1187	20	3	information	information	NOUN
hls-1187	20	4	was	be	AUX
hls-1187	20	5	abstracted	abstract	VERB
hls-1187	20	6	from	from	ADP
hls-1187	20	7	the	the	DET
hls-1187	20	8	nmmc	nmmc	PROPN
hls-1187	20	9	pci	pci	PROPN
hls-1187	20	10	dataset	dataset	PROPN
hls-1187	20	11	.	.	PUNCT
hls-1187	21	1	telephone	telephone	NOUN
hls-1187	21	2	surveys	survey	NOUN
hls-1187	21	3	were	be	AUX
hls-1187	21	4	conducted	conduct	VERB
hls-1187	21	5	from	from	ADP
hls-1187	21	6	february	february	PROPN
hls-1187	21	7	to	to	ADP
hls-1187	21	8	april	april	PROPN
hls-1187	21	9	2011	2011	NUM
hls-1187	21	10	to	to	PART
hls-1187	21	11	evaluate	evaluate	VERB
hls-1187	21	12	patients	patient	NOUN
hls-1187	21	13	’	'	PUNCT
hls-1187	21	14	long	long	ADJ
hls-1187	21	15	-	-	PUNCT
hls-1187	21	16	term	term	NOUN
hls-1187	21	17	outcomes	outcome	NOUN
hls-1187	21	18	and	and	CCONJ
hls-1187	21	19	to	to	PART
hls-1187	21	20	obtain	obtain	VERB
hls-1187	21	21	consent	consent	NOUN
hls-1187	21	22	to	to	PART
hls-1187	21	23	review	review	VERB
hls-1187	21	24	patients	patient	NOUN
hls-1187	21	25	’	'	PUNCT
hls-1187	21	26	medical	medical	ADJ
hls-1187	21	27	records	record	NOUN
hls-1187	21	28	for	for	ADP
hls-1187	21	29	perioperative	perioperative	ADJ
hls-1187	21	30	information	information	NOUN
hls-1187	21	31	.	.	PUNCT
hls-1187	22	1	the	the	DET
hls-1187	22	2	study	study	NOUN
hls-1187	22	3	protocol	protocol	NOUN
hls-1187	22	4	was	be	AUX
hls-1187	22	5	approved	approve	VERB
hls-1187	22	6	by	by	ADP
hls-1187	22	7	the	the	DET
hls-1187	22	8	institutional	institutional	PROPN
hls-1187	22	9	review	review	PROPN
hls-1187	22	10	board	board	NOUN
hls-1187	22	11	at	at	ADP
hls-1187	22	12	the	the	DET
hls-1187	22	13	american	american	PROPN
hls-1187	22	14	university	university	PROPN
hls-1187	22	15	of	of	ADP
hls-1187	22	16	armenia	armenia	PROPN
hls-1187	22	17	and	and	CCONJ
hls-1187	22	18	by	by	ADP
hls-1187	22	19	the	the	DET
hls-1187	22	20	nmmc	nmmc	PROPN
hls-1187	22	21	administrative	administrative	PROPN
hls-1187	22	22	board	board	PROPN
hls-1187	22	23	.	.	PUNCT
hls-1187	23	1	the	the	DET
hls-1187	23	2	main	main	ADJ
hls-1187	23	3	outcome	outcome	NOUN
hls-1187	23	4	of	of	ADP
hls-1187	23	5	interest	interest	NOUN
hls-1187	23	6	was	be	AUX
hls-1187	23	7	the	the	DET
hls-1187	23	8	3	3	NUM
hls-1187	23	9	-	-	PUNCT
hls-1187	23	10	year	year	NOUN
hls-1187	23	11	average	average	ADJ
hls-1187	23	12	survival	survival	NOUN
hls-1187	23	13	rate	rate	NOUN
hls-1187	23	14	from	from	ADP
hls-1187	23	15	the	the	DET
hls-1187	23	16	composite	composite	ADJ
hls-1187	23	17	macce	macce	NOUN
hls-1187	23	18	that	that	PRON
hls-1187	23	19	included	include	VERB
hls-1187	23	20	all	all	DET
hls-1187	23	21	-	-	PUNCT
hls-1187	23	22	cause	cause	NOUN
hls-1187	23	23	mortality	mortality	NOUN
hls-1187	23	24	,	,	PUNCT
hls-1187	23	25	mi	mi	PROPN
hls-1187	23	26	,	,	PUNCT
hls-1187	23	27	repeat	repeat	NOUN
hls-1187	23	28	revascularization	revascularization	NOUN
hls-1187	23	29	,	,	PUNCT
hls-1187	23	30	or	or	CCONJ
hls-1187	23	31	stroke	stroke	NOUN
hls-1187	23	32	/	/	SYM
hls-1187	23	33	transient	transient	ADJ
hls-1187	23	34	ischemic	ischemic	ADJ
hls-1187	23	35	attack	attack	NOUN
hls-1187	23	36	(	(	PUNCT
hls-1187	23	37	tia	tia	PROPN
hls-1187	23	38	)	)	PUNCT
hls-1187	23	39	established	establish	VERB
hls-1187	23	40	by	by	ADP
hls-1187	23	41	patient	patient	ADJ
hls-1187	23	42	self	self	NOUN
hls-1187	23	43	-	-	PUNCT
hls-1187	23	44	reports	report	NOUN
hls-1187	23	45	.	.	PUNCT
hls-1187	24	1	all	all	DET
hls-1187	24	2	patient	patient	NOUN
hls-1187	24	3	-	-	PUNCT
hls-1187	24	4	reported	report	VERB
hls-1187	24	5	repeat	repeat	NOUN
hls-1187	24	6	hospitalizations	hospitalization	NOUN
hls-1187	24	7	to	to	ADP
hls-1187	24	8	nmmc	nmmc	PROPN
hls-1187	24	9	were	be	AUX
hls-1187	24	10	verified	verify	VERB
hls-1187	24	11	using	use	VERB
hls-1187	24	12	the	the	DET
hls-1187	24	13	nmmc	nmmc	PROPN
hls-1187	24	14	database	database	NOUN
hls-1187	24	15	.	.	PUNCT
hls-1187	25	1	we	we	PRON
hls-1187	25	2	also	also	ADV
hls-1187	25	3	assessed	assess	VERB
hls-1187	25	4	patients	patient	NOUN
hls-1187	25	5	’	’	PART
hls-1187	25	6	hospital	hospital	NOUN
hls-1187	25	7	length	length	NOUN
hls-1187	25	8	of	of	ADP
hls-1187	25	9	stay	stay	NOUN
hls-1187	25	10	,	,	PUNCT
hls-1187	25	11	prescription	prescription	NOUN
hls-1187	25	12	of	of	ADP
hls-1187	25	13	discharge	discharge	NOUN
hls-1187	25	14	medications	medication	NOUN
hls-1187	25	15	,	,	PUNCT
hls-1187	25	16	and	and	CCONJ
hls-1187	25	17	in	in	ADP
hls-1187	25	18	-	-	PUNCT
hls-1187	25	19	hospital	hospital	NOUN
hls-1187	25	20	and	and	CCONJ
hls-1187	25	21	early	early	ADJ
hls-1187	25	22	operative	operative	ADJ
hls-1187	25	23	complications	complication	NOUN
hls-1187	25	24	and	and	CCONJ
hls-1187	25	25	mortality	mortality	NOUN
hls-1187	25	26	.	.	PUNCT
hls-1187	26	1	a	a	DET
hls-1187	26	2	repeat	repeat	NOUN
hls-1187	26	3	revascularization	revascularization	NOUN
hls-1187	26	4	was	be	AUX
hls-1187	26	5	defined	define	VERB
hls-1187	26	6	as	as	ADP
hls-1187	26	7	a	a	DET
hls-1187	26	8	repeat	repeat	NOUN
hls-1187	26	9	surgical	surgical	ADJ
hls-1187	26	10	(	(	PUNCT
hls-1187	26	11	coronary	coronary	ADJ
hls-1187	26	12	artery	artery	NOUN
hls-1187	26	13	bypass	bypass	NOUN
hls-1187	26	14	grafting	grafting	NOUN
hls-1187	26	15	)	)	PUNCT
hls-1187	26	16	or	or	CCONJ
hls-1187	26	17	percutaneous	percutaneous	ADJ
hls-1187	26	18	coronary	coronary	ADJ
hls-1187	26	19	intervention	intervention	NOUN
hls-1187	26	20	(	(	PUNCT
hls-1187	26	21	target	target	NOUN
hls-1187	26	22	or	or	CCONJ
hls-1187	26	23	new	new	ADJ
hls-1187	26	24	vessel	vessel	NOUN
hls-1187	26	25	)	)	PUNCT
hls-1187	26	26	.	.	PUNCT
hls-1187	27	1	operative	operative	ADJ
hls-1187	27	2	complications	complication	NOUN
hls-1187	27	3	were	be	AUX
hls-1187	27	4	defined	define	VERB
hls-1187	27	5	as	as	ADP
hls-1187	27	6	all	all	DET
hls-1187	27	7	major	major	ADJ
hls-1187	27	8	events	event	NOUN
hls-1187	27	9	occurring	occur	VERB
hls-1187	27	10	within	within	ADP
hls-1187	27	11	30	30	NUM
hls-1187	27	12	days	day	NOUN
hls-1187	27	13	after	after	ADP
hls-1187	27	14	the	the	DET
hls-1187	27	15	pci	pci	PROPN
hls-1187	27	16	.	.	PUNCT
hls-1187	28	1	healthcare	healthcare	PROPN
hls-1187	28	2	in	in	ADP
hls-1187	28	3	low	low	ADJ
hls-1187	28	4	-	-	PUNCT
hls-1187	28	5	resource	resource	NOUN
hls-1187	28	6	settings	setting	NOUN
hls-1187	28	7	2013	2013	NUM
hls-1187	28	8	;	;	PUNCT
hls-1187	28	9	volume	volume	NOUN
hls-1187	28	10	1	1	NUM
hls-1187	28	11	:	:	PUNCT
hls-1187	28	12	e17	e17	NOUN
hls-1187	28	13	correspondence	correspondence	NOUN
hls-1187	28	14	:	:	PUNCT
hls-1187	28	15	lusine	lusine	PROPN
hls-1187	28	16	abrahamyan	abrahamyan	PROPN
hls-1187	28	17	,	,	PUNCT
hls-1187	28	18	toronto	toronto	PROPN
hls-1187	28	19	health	health	NOUN
hls-1187	28	20	economics	economic	NOUN
hls-1187	28	21	and	and	CCONJ
hls-1187	28	22	technology	technology	NOUN
hls-1187	28	23	assessment	assessment	NOUN
hls-1187	28	24	(	(	PUNCT
hls-1187	28	25	theta	theta	NOUN
hls-1187	28	26	)	)	PUNCT
hls-1187	28	27	collaborative	collaborative	NOUN
hls-1187	28	28	,	,	PUNCT
hls-1187	28	29	university	university	PROPN
hls-1187	28	30	of	of	ADP
hls-1187	28	31	toronto	toronto	PROPN
hls-1187	28	32	,	,	PUNCT
hls-1187	28	33	144	144	NUM
hls-1187	28	34	college	college	PROPN
hls-1187	28	35	street	street	NOUN
hls-1187	28	36	,	,	PUNCT
hls-1187	28	37	on	on	ADP
hls-1187	28	38	m5s	m5s	NUM
hls-1187	28	39	2s2	2s2	NUM
hls-1187	28	40	toronto	toronto	PROPN
hls-1187	28	41	,	,	PUNCT
hls-1187	28	42	ontario	ontario	PROPN
hls-1187	28	43	,	,	PUNCT
hls-1187	28	44	canada	canada	PROPN
hls-1187	28	45	.	.	PUNCT
hls-1187	29	1	tel	tel	PROPN
hls-1187	29	2	.	.	PUNCT
hls-1187	30	1	+1.416.946.3718	+1.416.946.3718	NUM
hls-1187	30	2	fax	fax	PROPN
hls-1187	30	3	:	:	PUNCT
hls-1187	30	4	+1.416.946.3719	+1.416.946.3719	NUM
hls-1187	30	5	.	.	PUNCT
hls-1187	31	1	e	e	X
hls-1187	31	2	-	-	NOUN
hls-1187	31	3	mail	mail	NOUN
hls-1187	31	4	:	:	PUNCT
hls-1187	31	5	lusine.abrahamyan@utoronto.ca	lusine.abrahamyan@utoronto.ca	NOUN
hls-1187	31	6	key	key	ADJ
hls-1187	31	7	words	word	NOUN
hls-1187	31	8	:	:	PUNCT
hls-1187	31	9	percutaneous	percutaneous	ADJ
hls-1187	31	10	coronary	coronary	ADJ
hls-1187	31	11	intervention	intervention	NOUN
hls-1187	31	12	,	,	PUNCT
hls-1187	31	13	diabetes	diabetes	NOUN
hls-1187	31	14	,	,	PUNCT
hls-1187	31	15	long	long	ADJ
hls-1187	31	16	-	-	PUNCT
hls-1187	31	17	term	term	NOUN
hls-1187	31	18	outcomes	outcome	NOUN
hls-1187	31	19	,	,	PUNCT
hls-1187	31	20	armenia	armenia	PROPN
hls-1187	31	21	.	.	PUNCT
hls-1187	32	1	contributions	contribution	NOUN
hls-1187	32	2	:	:	PUNCT
hls-1187	32	3	ys	ys	NOUN
hls-1187	32	4	developed	develop	VERB
hls-1187	32	5	the	the	DET
hls-1187	32	6	project	project	NOUN
hls-1187	32	7	proposal	proposal	NOUN
hls-1187	32	8	,	,	PUNCT
hls-1187	32	9	acquired	acquire	VERB
hls-1187	32	10	data	datum	NOUN
hls-1187	32	11	,	,	PUNCT
hls-1187	32	12	performed	perform	VERB
hls-1187	32	13	data	datum	NOUN
hls-1187	32	14	analysis	analysis	NOUN
hls-1187	32	15	and	and	CCONJ
hls-1187	32	16	wrote	write	VERB
hls-1187	32	17	the	the	DET
hls-1187	32	18	draft	draft	NOUN
hls-1187	32	19	paper	paper	NOUN
hls-1187	32	20	;	;	PUNCT
hls-1187	32	21	la	la	PRON
hls-1187	32	22	and	and	CCONJ
hls-1187	32	23	met	meet	VERB
hls-1187	32	24	provided	provide	VERB
hls-1187	32	25	guidance	guidance	NOUN
hls-1187	32	26	to	to	ADP
hls-1187	32	27	project	project	NOUN
hls-1187	32	28	proposal	proposal	NOUN
hls-1187	32	29	,	,	PUNCT
hls-1187	32	30	data	data	VERB
hls-1187	32	31	analysis	analysis	NOUN
hls-1187	32	32	and	and	CCONJ
hls-1187	32	33	interpretation	interpretation	NOUN
hls-1187	32	34	,	,	PUNCT
hls-1187	32	35	and	and	CCONJ
hls-1187	32	36	critically	critically	ADV
hls-1187	32	37	revised	revise	VERB
hls-1187	32	38	the	the	DET
hls-1187	32	39	manuscript	manuscript	NOUN
hls-1187	32	40	.	.	PUNCT
hls-1187	33	1	conflict	conflict	NOUN
hls-1187	33	2	of	of	ADP
hls-1187	33	3	interests	interest	NOUN
hls-1187	33	4	:	:	PUNCT
hls-1187	33	5	the	the	DET
hls-1187	33	6	authors	author	NOUN
hls-1187	33	7	declare	declare	VERB
hls-1187	33	8	no	no	DET
hls-1187	33	9	potential	potential	ADJ
hls-1187	33	10	conflict	conflict	NOUN
hls-1187	33	11	of	of	ADP
hls-1187	33	12	interests	interest	NOUN
hls-1187	33	13	.	.	PUNCT
hls-1187	34	1	funding	funding	NOUN
hls-1187	34	2	:	:	PUNCT
hls-1187	34	3	this	this	DET
hls-1187	34	4	study	study	NOUN
hls-1187	34	5	was	be	AUX
hls-1187	34	6	made	make	VERB
hls-1187	34	7	possible	possible	ADJ
hls-1187	34	8	by	by	ADP
hls-1187	34	9	the	the	DET
hls-1187	34	10	internal	internal	ADJ
hls-1187	34	11	student	student	NOUN
hls-1187	34	12	support	support	NOUN
hls-1187	34	13	funds	fund	NOUN
hls-1187	34	14	provided	provide	VERB
hls-1187	34	15	by	by	ADP
hls-1187	34	16	the	the	DET
hls-1187	34	17	college	college	PROPN
hls-1187	34	18	of	of	ADP
hls-1187	34	19	health	health	PROPN
hls-1187	34	20	sciences	sciences	PROPN
hls-1187	34	21	and	and	CCONJ
hls-1187	34	22	the	the	DET
hls-1187	34	23	center	center	NOUN
hls-1187	34	24	for	for	ADP
hls-1187	34	25	health	health	NOUN
hls-1187	34	26	services	service	NOUN
hls-1187	34	27	research	research	NOUN
hls-1187	34	28	and	and	CCONJ
hls-1187	34	29	development	development	NOUN
hls-1187	34	30	of	of	ADP
hls-1187	34	31	the	the	DET
hls-1187	34	32	american	american	PROPN
hls-1187	34	33	university	university	PROPN
hls-1187	34	34	of	of	ADP
hls-1187	34	35	armenia	armenia	PROPN
hls-1187	34	36	.	.	PUNCT
hls-1187	35	1	received	receive	VERB
hls-1187	35	2	for	for	ADP
hls-1187	35	3	publication	publication	NOUN
hls-1187	35	4	:	:	PUNCT
hls-1187	35	5	15	15	NUM
hls-1187	35	6	february	february	NOUN
hls-1187	35	7	2013	2013	NUM
hls-1187	35	8	.	.	PUNCT
hls-1187	36	1	revision	revision	NOUN
hls-1187	36	2	received	receive	VERB
hls-1187	36	3	:	:	PUNCT
hls-1187	36	4	14	14	NUM
hls-1187	36	5	april	april	PROPN
hls-1187	36	6	2013	2013	NUM
hls-1187	36	7	.	.	PUNCT
hls-1187	37	1	accepted	accept	VERB
hls-1187	37	2	for	for	ADP
hls-1187	37	3	publication	publication	NOUN
hls-1187	37	4	:	:	PUNCT
hls-1187	37	5	15	15	NUM
hls-1187	37	6	april	april	PROPN
hls-1187	37	7	2013	2013	NUM
hls-1187	37	8	.	.	PUNCT
hls-1187	38	1	this	this	DET
hls-1187	38	2	work	work	NOUN
hls-1187	38	3	is	be	AUX
hls-1187	38	4	licensed	license	VERB
hls-1187	38	5	under	under	ADP
hls-1187	38	6	a	a	DET
hls-1187	38	7	creative	creative	ADJ
hls-1187	38	8	commons	common	NOUN
hls-1187	38	9	attribution	attribution	NOUN
hls-1187	38	10	3.0	3.0	NUM
hls-1187	38	11	license	license	NOUN
hls-1187	38	12	(	(	PUNCT
hls-1187	38	13	by	by	ADP
hls-1187	38	14	-	-	PUNCT
hls-1187	38	15	nc	nc	PROPN
hls-1187	38	16	3.0	3.0	NUM
hls-1187	38	17	)	)	PUNCT
hls-1187	38	18	.	.	PUNCT
hls-1187	39	1	©	©	PROPN
hls-1187	39	2	copyright	copyright	PROPN
hls-1187	39	3	y.	y.	PROPN
hls-1187	39	4	sahakyan	sahakyan	PROPN
hls-1187	39	5	et	et	PROPN
hls-1187	39	6	al	al	PROPN
hls-1187	39	7	.	.	PROPN
hls-1187	39	8	,	,	PUNCT
hls-1187	39	9	2013	2013	NUM
hls-1187	39	10	licensee	licensee	NOUN
hls-1187	39	11	pagepress	pagepress	NOUN
hls-1187	39	12	,	,	PUNCT
hls-1187	39	13	italy	italy	PROPN
hls-1187	39	14	healthcare	healthcare	PROPN
hls-1187	39	15	in	in	ADP
hls-1187	39	16	low	low	ADJ
hls-1187	39	17	-	-	PUNCT
hls-1187	39	18	resource	resource	NOUN
hls-1187	39	19	settings	setting	NOUN
hls-1187	39	20	2013	2013	NUM
hls-1187	39	21	;	;	PUNCT
hls-1187	39	22	1	1	NUM
hls-1187	39	23	:	:	PUNCT
hls-1187	39	24	e17	e17	PROPN
hls-1187	39	25	doi:10.4081	doi:10.4081	PROPN
hls-1187	39	26	/	/	SYM
hls-1187	39	27	hls.2013.e17	hls.2013.e17	PROPN
hls-1187	39	28	non	non	PROPN
hls-1187	39	29	co	co	PROPN
hls-1187	39	30	mmerc	mmerc	PROPN
hls-1187	39	31	ial	ial	PROPN
hls-1187	39	32	us	us	PROPN
hls-1187	39	33	e	e	NOUN
hls-1187	39	34	o	o	NOUN
hls-1187	40	1	nly	nly	ADV
hls-1187	40	2	[	[	X
hls-1187	40	3	page	page	NOUN
hls-1187	40	4	58	58	NUM
hls-1187	40	5	]	]	PUNCT
hls-1187	41	1	[	[	X
hls-1187	41	2	healthcare	healthcare	NOUN
hls-1187	41	3	in	in	ADP
hls-1187	41	4	low	low	ADJ
hls-1187	41	5	-	-	PUNCT
hls-1187	41	6	resource	resource	NOUN
hls-1187	41	7	settings	setting	NOUN
hls-1187	41	8	2013	2013	NUM
hls-1187	41	9	;	;	PUNCT
hls-1187	41	10	1	1	NUM
hls-1187	41	11	:	:	PUNCT
hls-1187	41	12	e17	e17	NOUN
hls-1187	41	13	]	]	PUNCT
hls-1187	41	14	statistical	statistical	ADJ
hls-1187	41	15	analysis	analysis	NOUN
hls-1187	41	16	continuous	continuous	ADJ
hls-1187	41	17	variables	variable	NOUN
hls-1187	41	18	are	be	AUX
hls-1187	41	19	presented	present	VERB
hls-1187	41	20	as	as	ADP
hls-1187	41	21	means	mean	NOUN
hls-1187	41	22	and	and	CCONJ
hls-1187	41	23	standard	standard	ADJ
hls-1187	41	24	deviations	deviation	NOUN
hls-1187	41	25	and	and	CCONJ
hls-1187	41	26	compared	compare	VERB
hls-1187	41	27	between	between	ADP
hls-1187	41	28	groups	group	NOUN
hls-1187	41	29	using	use	VERB
hls-1187	41	30	student	student	NOUN
hls-1187	41	31	’s	’s	PART
hls-1187	41	32	t	t	PROPN
hls-1187	41	33	-	-	PUNCT
hls-1187	41	34	test	test	NOUN
hls-1187	41	35	;	;	PUNCT
hls-1187	41	36	categorical	categorical	ADJ
hls-1187	41	37	variables	variable	NOUN
hls-1187	41	38	are	be	AUX
hls-1187	41	39	presented	present	VERB
hls-1187	41	40	as	as	ADP
hls-1187	41	41	counts	count	NOUN
hls-1187	41	42	and	and	CCONJ
hls-1187	41	43	percentages	percentage	NOUN
hls-1187	41	44	and	and	CCONJ
hls-1187	41	45	compared	compare	VERB
hls-1187	41	46	using	use	VERB
hls-1187	41	47	a	a	DET
hls-1187	41	48	chi	chi	ADJ
hls-1187	41	49	-	-	PUNCT
hls-1187	41	50	square	square	ADJ
hls-1187	41	51	test	test	NOUN
hls-1187	41	52	or	or	CCONJ
hls-1187	41	53	fisher	fisher	PROPN
hls-1187	41	54	’s	’s	PART
hls-1187	41	55	exact	exact	ADJ
hls-1187	41	56	test	test	NOUN
hls-1187	41	57	.	.	PUNCT
hls-1187	42	1	the	the	DET
hls-1187	42	2	event	event	NOUN
hls-1187	42	3	-	-	PUNCT
hls-1187	42	4	free	free	ADJ
hls-1187	42	5	survival	survival	NOUN
hls-1187	42	6	rate	rate	NOUN
hls-1187	42	7	from	from	ADP
hls-1187	42	8	macce	macce	NOUN
hls-1187	42	9	was	be	AUX
hls-1187	42	10	estimated	estimate	VERB
hls-1187	42	11	by	by	ADP
hls-1187	42	12	the	the	DET
hls-1187	42	13	kaplan	kaplan	PROPN
hls-1187	42	14	-	-	PUNCT
hls-1187	42	15	meier	meier	PROPN
hls-1187	42	16	product	product	NOUN
hls-1187	42	17	-	-	PUNCT
hls-1187	42	18	limit	limit	NOUN
hls-1187	42	19	method	method	NOUN
hls-1187	42	20	.	.	PUNCT
hls-1187	43	1	cox	cox	PROPN
hls-1187	43	2	proportional	proportional	ADJ
hls-1187	43	3	hazard	hazard	NOUN
hls-1187	43	4	models	model	NOUN
hls-1187	43	5	were	be	AUX
hls-1187	43	6	used	use	VERB
hls-1187	43	7	to	to	PART
hls-1187	43	8	estimate	estimate	VERB
hls-1187	43	9	unadjusted	unadjuste	VERB
hls-1187	43	10	and	and	CCONJ
hls-1187	43	11	adjusted	adjust	VERB
hls-1187	43	12	hazard	hazard	NOUN
hls-1187	43	13	ratios	ratio	NOUN
hls-1187	43	14	(	(	PUNCT
hls-1187	43	15	hr	hr	NOUN
hls-1187	43	16	)	)	PUNCT
hls-1187	43	17	of	of	ADP
hls-1187	43	18	macce	macce	NOUN
hls-1187	43	19	at	at	ADP
hls-1187	43	20	the	the	DET
hls-1187	43	21	end	end	NOUN
hls-1187	43	22	of	of	ADP
hls-1187	43	23	follow	follow	NOUN
hls-1187	43	24	-	-	PUNCT
hls-1187	43	25	up	up	NOUN
hls-1187	43	26	.	.	PUNCT
hls-1187	44	1	backward	backward	ADJ
hls-1187	44	2	stepwise	stepwise	PROPN
hls-1187	44	3	elimination	elimination	NOUN
hls-1187	44	4	was	be	AUX
hls-1187	44	5	used	use	VERB
hls-1187	44	6	for	for	ADP
hls-1187	44	7	the	the	DET
hls-1187	44	8	multivariable	multivariable	ADJ
hls-1187	44	9	cox	cox	PROPN
hls-1187	44	10	proportional	proportional	PROPN
hls-1187	44	11	hazards	hazard	NOUN
hls-1187	44	12	model	model	NOUN
hls-1187	44	13	.	.	PUNCT
hls-1187	45	1	all	all	DET
hls-1187	45	2	variables	variable	NOUN
hls-1187	45	3	found	find	VERB
hls-1187	45	4	significant	significant	ADJ
hls-1187	45	5	in	in	ADP
hls-1187	45	6	univariate	univariate	ADJ
hls-1187	45	7	analyses	analysis	NOUN
hls-1187	45	8	(	(	PUNCT
hls-1187	45	9	p<0.05	p<0.05	NOUN
hls-1187	45	10	)	)	PUNCT
hls-1187	45	11	and	and	CCONJ
hls-1187	45	12	those	those	PRON
hls-1187	45	13	found	find	VERB
hls-1187	45	14	predictive	predictive	ADJ
hls-1187	45	15	from	from	ADP
hls-1187	45	16	past	past	ADJ
hls-1187	45	17	studies	study	NOUN
hls-1187	45	18	were	be	AUX
hls-1187	45	19	entered	enter	VERB
hls-1187	45	20	together	together	ADV
hls-1187	45	21	into	into	ADP
hls-1187	45	22	the	the	DET
hls-1187	45	23	model	model	NOUN
hls-1187	45	24	at	at	ADP
hls-1187	45	25	once	once	ADV
hls-1187	45	26	and	and	CCONJ
hls-1187	45	27	eliminated	eliminate	VERB
hls-1187	45	28	using	use	VERB
hls-1187	45	29	the	the	DET
hls-1187	45	30	likelihood	likelihood	NOUN
hls-1187	45	31	ratio	ratio	NOUN
hls-1187	45	32	test	test	NOUN
hls-1187	45	33	.	.	PUNCT
hls-1187	46	1	the	the	DET
hls-1187	46	2	final	final	ADJ
hls-1187	46	3	model	model	NOUN
hls-1187	46	4	was	be	AUX
hls-1187	46	5	checked	check	VERB
hls-1187	46	6	for	for	ADP
hls-1187	46	7	effect	effect	NOUN
hls-1187	46	8	modifiers	modifier	NOUN
hls-1187	46	9	and	and	CCONJ
hls-1187	46	10	for	for	ADP
hls-1187	46	11	conformity	conformity	NOUN
hls-1187	46	12	with	with	ADP
hls-1187	46	13	the	the	DET
hls-1187	46	14	proportionality	proportionality	NOUN
hls-1187	46	15	assumption	assumption	NOUN
hls-1187	46	16	.	.	PUNCT
hls-1187	47	1	all	all	DET
hls-1187	47	2	statistical	statistical	ADJ
hls-1187	47	3	analyses	analysis	NOUN
hls-1187	47	4	were	be	AUX
hls-1187	47	5	performed	perform	VERB
hls-1187	47	6	using	use	VERB
hls-1187	47	7	the	the	DET
hls-1187	47	8	stata10	stata10	NOUN
hls-1187	47	9	software	software	NOUN
hls-1187	47	10	package	package	NOUN
hls-1187	47	11	(	(	PUNCT
hls-1187	47	12	stata	stata	VERB
hls-1187	47	13	statistical	statistical	ADJ
hls-1187	47	14	software	software	NOUN
hls-1187	47	15	,	,	PUNCT
hls-1187	47	16	college	college	NOUN
hls-1187	47	17	station	station	NOUN
hls-1187	47	18	,	,	PUNCT
hls-1187	47	19	tx	tx	PROPN
hls-1187	47	20	,	,	PUNCT
hls-1187	47	21	usa	usa	PROPN
hls-1187	47	22	)	)	PUNCT
hls-1187	47	23	.	.	PUNCT
hls-1187	48	1	results	result	VERB
hls-1187	48	2	overall	overall	ADV
hls-1187	48	3	,	,	PUNCT
hls-1187	48	4	894	894	NUM
hls-1187	48	5	patients	patient	NOUN
hls-1187	48	6	underwent	undergo	VERB
hls-1187	48	7	pci	pci	ADJ
hls-1187	48	8	from	from	ADP
hls-1187	48	9	2006	2006	NUM
hls-1187	48	10	to	to	ADP
hls-1187	48	11	2008	2008	NUM
hls-1187	48	12	at	at	ADP
hls-1187	48	13	nmmc	nmmc	NOUN
hls-1187	48	14	.	.	PUNCT
hls-1187	49	1	of	of	ADP
hls-1187	49	2	these	these	PRON
hls-1187	49	3	,	,	PUNCT
hls-1187	49	4	839	839	NUM
hls-1187	49	5	were	be	AUX
hls-1187	49	6	residents	resident	NOUN
hls-1187	49	7	of	of	ADP
hls-1187	49	8	armenia	armenia	PROPN
hls-1187	49	9	.	.	PUNCT
hls-1187	50	1	we	we	PRON
hls-1187	50	2	could	could	AUX
hls-1187	50	3	not	not	PART
hls-1187	50	4	reach	reach	VERB
hls-1187	50	5	315	315	NUM
hls-1187	50	6	patients	patient	NOUN
hls-1187	50	7	for	for	ADP
hls-1187	50	8	various	various	ADJ
hls-1187	50	9	reasons	reason	NOUN
hls-1187	50	10	(	(	PUNCT
hls-1187	50	11	i.e.	i.e.	X
hls-1187	50	12	phone	phone	NOUN
hls-1187	50	13	number	number	NOUN
hls-1187	50	14	not	not	PART
hls-1187	50	15	provided	provide	VERB
hls-1187	50	16	,	,	PUNCT
hls-1187	50	17	wrong	wrong	ADJ
hls-1187	50	18	number	number	NOUN
hls-1187	50	19	/	/	SYM
hls-1187	50	20	number	number	NOUN
hls-1187	50	21	changed	change	VERB
hls-1187	50	22	,	,	PUNCT
hls-1187	50	23	patient	patient	NOUN
hls-1187	50	24	was	be	AUX
hls-1187	50	25	out	out	ADP
hls-1187	50	26	of	of	ADP
hls-1187	50	27	the	the	DET
hls-1187	50	28	country	country	NOUN
hls-1187	50	29	at	at	ADP
hls-1187	50	30	the	the	DET
hls-1187	50	31	time	time	NOUN
hls-1187	50	32	of	of	ADP
hls-1187	50	33	contact	contact	NOUN
hls-1187	50	34	,	,	PUNCT
hls-1187	50	35	no	no	DET
hls-1187	50	36	response	response	NOUN
hls-1187	50	37	to	to	PART
hls-1187	50	38	call	call	VERB
hls-1187	50	39	)	)	PUNCT
hls-1187	50	40	.	.	PUNCT
hls-1187	51	1	in	in	ADP
hls-1187	51	2	total	total	ADJ
hls-1187	51	3	,	,	PUNCT
hls-1187	51	4	524	524	NUM
hls-1187	51	5	patients	patient	NOUN
hls-1187	51	6	were	be	AUX
hls-1187	51	7	contacted	contact	VERB
hls-1187	51	8	for	for	ADP
hls-1187	51	9	the	the	DET
hls-1187	51	10	phone	phone	NOUN
hls-1187	51	11	interview	interview	NOUN
hls-1187	51	12	.	.	PUNCT
hls-1187	52	1	of	of	ADP
hls-1187	52	2	these	these	PRON
hls-1187	52	3	,	,	PUNCT
hls-1187	52	4	23	23	NUM
hls-1187	52	5	refused	refuse	VERB
hls-1187	52	6	to	to	PART
hls-1187	52	7	participate	participate	VERB
hls-1187	52	8	,	,	PUNCT
hls-1187	52	9	3	3	NUM
hls-1187	52	10	were	be	AUX
hls-1187	52	11	found	find	VERB
hls-1187	52	12	to	to	PART
hls-1187	52	13	be	be	AUX
hls-1187	52	14	ineligible	ineligible	ADJ
hls-1187	52	15	,	,	PUNCT
hls-1187	52	16	and	and	CCONJ
hls-1187	52	17	,	,	PUNCT
hls-1187	52	18	after	after	ADP
hls-1187	52	19	the	the	DET
hls-1187	52	20	interviews	interview	NOUN
hls-1187	52	21	,	,	PUNCT
hls-1187	52	22	medical	medical	ADJ
hls-1187	52	23	records	record	NOUN
hls-1187	52	24	were	be	AUX
hls-1187	52	25	not	not	PART
hls-1187	52	26	available	available	ADJ
hls-1187	52	27	for	for	ADP
hls-1187	52	28	13	13	NUM
hls-1187	52	29	patients	patient	NOUN
hls-1187	52	30	.	.	PUNCT
hls-1187	53	1	if	if	SCONJ
hls-1187	53	2	the	the	DET
hls-1187	53	3	patient	patient	NOUN
hls-1187	53	4	was	be	AUX
hls-1187	53	5	reported	report	VERB
hls-1187	53	6	as	as	ADP
hls-1187	53	7	dead	dead	ADJ
hls-1187	53	8	(	(	PUNCT
hls-1187	53	9	n=38	n=38	NOUN
hls-1187	53	10	)	)	PUNCT
hls-1187	53	11	at	at	ADP
hls-1187	53	12	the	the	DET
hls-1187	53	13	time	time	NOUN
hls-1187	53	14	of	of	ADP
hls-1187	53	15	the	the	DET
hls-1187	53	16	interview	interview	NOUN
hls-1187	53	17	,	,	PUNCT
hls-1187	53	18	information	information	NOUN
hls-1187	53	19	about	about	ADP
hls-1187	53	20	the	the	DET
hls-1187	53	21	macce	macce	NOUN
hls-1187	53	22	and	and	CCONJ
hls-1187	53	23	consent	consent	NOUN
hls-1187	53	24	to	to	PART
hls-1187	53	25	access	access	VERB
hls-1187	53	26	the	the	DET
hls-1187	53	27	medical	medical	ADJ
hls-1187	53	28	records	record	NOUN
hls-1187	53	29	was	be	AUX
hls-1187	53	30	obtained	obtain	VERB
hls-1187	53	31	from	from	ADP
hls-1187	53	32	an	an	DET
hls-1187	53	33	immediate	immediate	ADJ
hls-1187	53	34	family	family	NOUN
hls-1187	53	35	member	member	NOUN
hls-1187	53	36	.	.	PUNCT
hls-1187	54	1	the	the	DET
hls-1187	54	2	final	final	ADJ
hls-1187	54	3	total	total	NOUN
hls-1187	54	4	sample	sample	NOUN
hls-1187	54	5	included	include	VERB
hls-1187	54	6	485	485	NUM
hls-1187	54	7	patients	patient	NOUN
hls-1187	54	8	.	.	PUNCT
hls-1187	55	1	patient	patient	ADJ
hls-1187	55	2	baseline	baseline	NOUN
hls-1187	55	3	and	and	CCONJ
hls-1187	55	4	procedural	procedural	ADJ
hls-1187	55	5	characteristics	characteristic	NOUN
hls-1187	55	6	the	the	DET
hls-1187	55	7	study	study	NOUN
hls-1187	55	8	sample	sample	NOUN
hls-1187	55	9	(	(	PUNCT
hls-1187	55	10	n=485	n=485	NOUN
hls-1187	55	11	)	)	PUNCT
hls-1187	55	12	included	include	VERB
hls-1187	55	13	419	419	NUM
hls-1187	55	14	(	(	PUNCT
hls-1187	55	15	86	86	NUM
hls-1187	55	16	%	%	NOUN
hls-1187	55	17	)	)	PUNCT
hls-1187	55	18	men	man	NOUN
hls-1187	55	19	and	and	CCONJ
hls-1187	55	20	66	66	NUM
hls-1187	55	21	women	woman	NOUN
hls-1187	55	22	.	.	PUNCT
hls-1187	56	1	patients	patient	NOUN
hls-1187	56	2	’	'	PUNCT
hls-1187	56	3	baseline	baseline	PROPN
hls-1187	56	4	characteristics	characteristic	NOUN
hls-1187	56	5	stratified	stratify	VERB
hls-1187	56	6	by	by	ADP
hls-1187	56	7	sex	sex	NOUN
hls-1187	56	8	are	be	AUX
hls-1187	56	9	presented	present	VERB
hls-1187	56	10	in	in	ADP
hls-1187	56	11	table	table	NOUN
hls-1187	56	12	1	1	NUM
hls-1187	56	13	.	.	PUNCT
hls-1187	57	1	women	woman	NOUN
hls-1187	57	2	were	be	AUX
hls-1187	57	3	on	on	ADP
hls-1187	57	4	average	average	ADJ
hls-1187	57	5	5	5	NUM
hls-1187	57	6	years	year	NOUN
hls-1187	57	7	older	old	ADJ
hls-1187	57	8	than	than	ADP
hls-1187	57	9	men	man	NOUN
hls-1187	57	10	and	and	CCONJ
hls-1187	57	11	had	have	VERB
hls-1187	57	12	a	a	DET
hls-1187	57	13	higher	high	ADJ
hls-1187	57	14	prevalence	prevalence	NOUN
hls-1187	57	15	of	of	ADP
hls-1187	57	16	hypertension	hypertension	NOUN
hls-1187	57	17	,	,	PUNCT
hls-1187	57	18	obesity	obesity	NOUN
hls-1187	57	19	,	,	PUNCT
hls-1187	57	20	and	and	CCONJ
hls-1187	57	21	diabetes	diabetes	NOUN
hls-1187	57	22	and	and	CCONJ
hls-1187	57	23	more	more	ADV
hls-1187	57	24	often	often	ADV
hls-1187	57	25	presented	present	VERB
hls-1187	57	26	with	with	ADP
hls-1187	57	27	stable	stable	ADJ
hls-1187	57	28	angina	angina	NOUN
hls-1187	57	29	.	.	PUNCT
hls-1187	58	1	a	a	DET
hls-1187	58	2	significantly	significantly	ADV
hls-1187	58	3	higher	high	ADJ
hls-1187	58	4	proportion	proportion	NOUN
hls-1187	58	5	of	of	ADP
hls-1187	58	6	men	man	NOUN
hls-1187	58	7	smoked	smoke	VERB
hls-1187	58	8	and	and	CCONJ
hls-1187	58	9	at	at	ADP
hls-1187	58	10	admission	admission	NOUN
hls-1187	58	11	presented	present	VERB
hls-1187	58	12	with	with	ADP
hls-1187	58	13	acute	acute	PROPN
hls-1187	58	14	mi	mi	PROPN
hls-1187	58	15	more	more	ADV
hls-1187	58	16	frequently	frequently	ADV
hls-1187	58	17	than	than	ADP
hls-1187	58	18	women	woman	NOUN
hls-1187	58	19	.	.	PUNCT
hls-1187	59	1	no	no	DET
hls-1187	59	2	differences	difference	NOUN
hls-1187	59	3	were	be	AUX
hls-1187	59	4	observed	observe	VERB
hls-1187	59	5	in	in	ADP
hls-1187	59	6	the	the	DET
hls-1187	59	7	number	number	NOUN
hls-1187	59	8	of	of	ADP
hls-1187	59	9	diseased	diseased	ADJ
hls-1187	59	10	vessels	vessel	NOUN
hls-1187	59	11	and	and	CCONJ
hls-1187	59	12	the	the	DET
hls-1187	59	13	number	number	NOUN
hls-1187	59	14	and	and	CCONJ
hls-1187	59	15	types	type	NOUN
hls-1187	59	16	of	of	ADP
hls-1187	59	17	stents	stent	NOUN
hls-1187	59	18	implanted	implant	VERB
hls-1187	59	19	(	(	PUNCT
hls-1187	59	20	table	table	NOUN
hls-1187	59	21	1	1	NUM
hls-1187	59	22	)	)	PUNCT
hls-1187	59	23	.	.	PUNCT
hls-1187	60	1	in	in	ADP
hls-1187	60	2	men	man	NOUN
hls-1187	60	3	and	and	CCONJ
hls-1187	60	4	women	woman	NOUN
hls-1187	60	5	,	,	PUNCT
hls-1187	60	6	the	the	DET
hls-1187	60	7	most	most	ADV
hls-1187	60	8	frequently	frequently	ADV
hls-1187	60	9	stented	stente	VERB
hls-1187	60	10	vessel	vessel	NOUN
hls-1187	60	11	was	be	AUX
hls-1187	60	12	the	the	DET
hls-1187	60	13	left	left	ADJ
hls-1187	60	14	anterior	anterior	NOUN
hls-1187	60	15	descending	descend	VERB
hls-1187	60	16	(	(	PUNCT
hls-1187	60	17	lad	lad	NOUN
hls-1187	60	18	)	)	PUNCT
hls-1187	60	19	artery	artery	NOUN
hls-1187	60	20	.	.	PUNCT
hls-1187	61	1	no	no	DET
hls-1187	61	2	statistically	statistically	ADV
hls-1187	61	3	significant	significant	ADJ
hls-1187	61	4	differences	difference	NOUN
hls-1187	61	5	were	be	AUX
hls-1187	61	6	seen	see	VERB
hls-1187	61	7	between	between	ADP
hls-1187	61	8	women	woman	NOUN
hls-1187	61	9	and	and	CCONJ
hls-1187	61	10	men	man	NOUN
hls-1187	61	11	in	in	ADP
hls-1187	61	12	discharge	discharge	NOUN
hls-1187	61	13	medication	medication	NOUN
hls-1187	61	14	,	,	PUNCT
hls-1187	61	15	except	except	SCONJ
hls-1187	61	16	for	for	ADP
hls-1187	61	17	a	a	DET
hls-1187	61	18	higher	high	ADJ
hls-1187	61	19	rate	rate	NOUN
hls-1187	61	20	of	of	ADP
hls-1187	61	21	angiotensinconverting	angiotensinconverte	VERB
hls-1187	61	22	enzyme	enzyme	NOUN
hls-1187	61	23	inhibitors	inhibitor	NOUN
hls-1187	61	24	(	(	PUNCT
hls-1187	61	25	acei)/	acei)/	X
hls-1187	61	26	angiotensin	angiotensin	NOUN
hls-1187	61	27	receptor	receptor	NOUN
hls-1187	61	28	blockers	blocker	NOUN
hls-1187	61	29	(	(	PUNCT
hls-1187	61	30	arb	arb	NOUN
hls-1187	61	31	)	)	PUNCT
hls-1187	61	32	prescribed	prescribe	VERB
hls-1187	61	33	to	to	ADP
hls-1187	61	34	women	woman	NOUN
hls-1187	61	35	.	.	PUNCT
hls-1187	62	1	acute	acute	ADJ
hls-1187	62	2	in	in	ADP
hls-1187	62	3	-	-	PUNCT
hls-1187	62	4	hospital	hospital	NOUN
hls-1187	62	5	and	and	CCONJ
hls-1187	62	6	30	30	NUM
hls-1187	62	7	-	-	PUNCT
hls-1187	62	8	day	day	NOUN
hls-1187	62	9	operative	operative	ADJ
hls-1187	62	10	outcomes	outcome	NOUN
hls-1187	62	11	thirty	thirty	NUM
hls-1187	62	12	-	-	PUNCT
hls-1187	62	13	day	day	NOUN
hls-1187	62	14	operative	operative	ADJ
hls-1187	62	15	complications	complication	NOUN
hls-1187	62	16	were	be	AUX
hls-1187	62	17	observed	observe	VERB
hls-1187	62	18	in	in	ADP
hls-1187	62	19	3	3	NUM
hls-1187	62	20	women	woman	NOUN
hls-1187	62	21	(	(	PUNCT
hls-1187	62	22	4.5	4.5	NUM
hls-1187	62	23	%	%	NOUN
hls-1187	62	24	)	)	PUNCT
hls-1187	62	25	and	and	CCONJ
hls-1187	62	26	in	in	ADP
hls-1187	62	27	23	23	NUM
hls-1187	62	28	men	man	NOUN
hls-1187	62	29	(	(	PUNCT
hls-1187	62	30	5.5	5.5	NUM
hls-1187	62	31	%	%	NOUN
hls-1187	62	32	,	,	PUNCT
hls-1187	62	33	p=0.7	p=0.7	NOUN
hls-1187	62	34	)	)	PUNCT
hls-1187	62	35	.	.	PUNCT
hls-1187	63	1	overall	overall	ADV
hls-1187	63	2	,	,	PUNCT
hls-1187	63	3	the	the	DET
hls-1187	63	4	following	follow	VERB
hls-1187	63	5	complications	complication	NOUN
hls-1187	63	6	were	be	AUX
hls-1187	63	7	observed	observe	VERB
hls-1187	63	8	:	:	PUNCT
hls-1187	63	9	ventricular	ventricular	VERB
hls-1187	63	10	tachycardia/	tachycardia/	NUM
hls-1187	63	11	ventricular	ventricular	ADJ
hls-1187	63	12	fibrillation	fibrillation	NOUN
hls-1187	63	13	(	(	PUNCT
hls-1187	63	14	n=4	n=4	NOUN
hls-1187	63	15	)	)	PUNCT
hls-1187	63	16	;	;	PUNCT
hls-1187	63	17	complete	complete	VERB
hls-1187	63	18	atrioventricular	atrioventricular	ADJ
hls-1187	63	19	block	block	NOUN
hls-1187	63	20	(	(	PUNCT
hls-1187	63	21	n=2	n=2	ADV
hls-1187	63	22	)	)	PUNCT
hls-1187	63	23	;	;	PUNCT
hls-1187	63	24	hematoma	hematoma	NOUN
hls-1187	63	25	at	at	ADP
hls-1187	63	26	the	the	DET
hls-1187	63	27	intervention	intervention	NOUN
hls-1187	63	28	site	site	NOUN
hls-1187	63	29	(	(	PUNCT
hls-1187	63	30	n=1	n=1	PROPN
hls-1187	63	31	)	)	PUNCT
hls-1187	63	32	;	;	PUNCT
hls-1187	63	33	coronary	coronary	ADJ
hls-1187	63	34	artery	artery	NOUN
hls-1187	63	35	dissection	dissection	NOUN
hls-1187	63	36	(	(	PUNCT
hls-1187	63	37	n=1	n=1	PROPN
hls-1187	63	38	)	)	PUNCT
hls-1187	63	39	;	;	PUNCT
hls-1187	63	40	reperfusion	reperfusion	NOUN
hls-1187	63	41	syndrome	syndrome	NOUN
hls-1187	63	42	(	(	PUNCT
hls-1187	63	43	n=1	n=1	PROPN
hls-1187	63	44	)	)	PUNCT
hls-1187	63	45	;	;	PUNCT
hls-1187	63	46	stent	stent	NOUN
hls-1187	63	47	thrombosis	thrombosis	NOUN
hls-1187	63	48	(	(	PUNCT
hls-1187	63	49	n=2	n=2	X
hls-1187	63	50	)	)	PUNCT
hls-1187	63	51	;	;	PUNCT
hls-1187	63	52	tia	tia	PROPN
hls-1187	63	53	(	(	PUNCT
hls-1187	63	54	n=1	n=1	PROPN
hls-1187	63	55	)	)	PUNCT
hls-1187	63	56	;	;	PUNCT
hls-1187	63	57	acute	acute	ADJ
hls-1187	63	58	renal	renal	ADJ
hls-1187	63	59	failure	failure	NOUN
hls-1187	63	60	(	(	PUNCT
hls-1187	63	61	n=1	n=1	PROPN
hls-1187	63	62	)	)	PUNCT
hls-1187	63	63	;	;	PUNCT
hls-1187	63	64	acute	acute	ADJ
hls-1187	63	65	heart	heart	NOUN
hls-1187	63	66	failure	failure	NOUN
hls-1187	63	67	(	(	PUNCT
hls-1187	63	68	n=1	n=1	PROPN
hls-1187	63	69	)	)	PUNCT
hls-1187	63	70	;	;	PUNCT
hls-1187	63	71	lad	lad	NUM
hls-1187	63	72	occlusion	occlusion	NOUN
hls-1187	63	73	during	during	ADP
hls-1187	63	74	coronary	coronary	ADJ
hls-1187	63	75	angiography	angiography	NOUN
hls-1187	63	76	(	(	PUNCT
hls-1187	63	77	n=1	n=1	PROPN
hls-1187	63	78	)	)	PUNCT
hls-1187	63	79	;	;	PUNCT
hls-1187	63	80	recurrent	recurrent	NOUN
hls-1187	63	81	mi	mi	PROPN
hls-1187	63	82	(	(	PUNCT
hls-1187	63	83	n=2	n=2	ADV
hls-1187	63	84	)	)	PUNCT
hls-1187	63	85	;	;	PUNCT
hls-1187	63	86	and	and	CCONJ
hls-1187	63	87	repeat	repeat	NOUN
hls-1187	63	88	revascularization	revascularization	NOUN
hls-1187	63	89	(	(	PUNCT
hls-1187	63	90	n=4	n=4	NOUN
hls-1187	63	91	)	)	PUNCT
hls-1187	63	92	.	.	PUNCT
hls-1187	64	1	in	in	ADP
hls-1187	64	2	-	-	PUNCT
hls-1187	64	3	hospital	hospital	NOUN
hls-1187	64	4	deaths	death	NOUN
hls-1187	64	5	occurred	occur	VERB
hls-1187	64	6	in	in	ADP
hls-1187	64	7	2	2	NUM
hls-1187	64	8	men	man	NOUN
hls-1187	64	9	.	.	PUNCT
hls-1187	65	1	death	death	NOUN
hls-1187	65	2	within	within	ADP
hls-1187	65	3	30	30	NUM
hls-1187	65	4	days	day	NOUN
hls-1187	65	5	after	after	SCONJ
hls-1187	65	6	pci	pci	PROPN
hls-1187	65	7	occurred	occur	VERB
hls-1187	65	8	in	in	ADP
hls-1187	65	9	1	1	NUM
hls-1187	65	10	woman	woman	NOUN
hls-1187	65	11	and	and	CCONJ
hls-1187	65	12	3	3	NUM
hls-1187	65	13	men	man	NOUN
hls-1187	65	14	.	.	PUNCT
hls-1187	66	1	the	the	DET
hls-1187	66	2	hospital	hospital	NOUN
hls-1187	66	3	length	length	NOUN
hls-1187	66	4	of	of	ADP
hls-1187	66	5	stay	stay	NOUN
hls-1187	66	6	did	do	AUX
hls-1187	66	7	not	not	PART
hls-1187	66	8	differ	differ	VERB
hls-1187	66	9	between	between	ADP
hls-1187	66	10	sexes	sex	NOUN
hls-1187	66	11	and	and	CCONJ
hls-1187	66	12	was	be	AUX
hls-1187	66	13	on	on	ADP
hls-1187	66	14	average	average	ADJ
hls-1187	66	15	4.5±3.6	4.5±3.6	NUM
hls-1187	66	16	days	day	NOUN
hls-1187	66	17	for	for	ADP
hls-1187	66	18	the	the	DET
hls-1187	66	19	total	total	ADJ
hls-1187	66	20	sample	sample	NOUN
hls-1187	66	21	.	.	PUNCT
hls-1187	67	1	article	article	NOUN
hls-1187	67	2	table	table	NOUN
hls-1187	67	3	1	1	NUM
hls-1187	67	4	.	.	PUNCT
hls-1187	67	5	baseline	baseline	PROPN
hls-1187	67	6	patients	patient	NOUN
hls-1187	67	7	’	'	PUNCT
hls-1187	67	8	characteristics	characteristic	NOUN
hls-1187	67	9	.	.	PUNCT
hls-1187	68	1	patients	patient	NOUN
hls-1187	68	2	’	'	PUNCT
hls-1187	68	3	characteristics	characteristic	NOUN
hls-1187	68	4	°	°	ADP
hls-1187	68	5	men	man	NOUN
hls-1187	68	6	(	(	PUNCT
hls-1187	68	7	n=419	n=419	X
hls-1187	68	8	)	)	PUNCT
hls-1187	68	9	women	woman	NOUN
hls-1187	68	10	(	(	PUNCT
hls-1187	68	11	n=66	n=66	NOUN
hls-1187	68	12	)	)	PUNCT
hls-1187	68	13	p	p	NOUN
hls-1187	68	14	risk	risk	NOUN
hls-1187	68	15	factors	factor	NOUN
hls-1187	68	16	and	and	CCONJ
hls-1187	68	17	comorbidities	comorbiditie	NOUN
hls-1187	68	18	age	age	NOUN
hls-1187	68	19	(	(	PUNCT
hls-1187	68	20	years	year	NOUN
hls-1187	68	21	,	,	PUNCT
hls-1187	68	22	mean±sd	mean±sd	PROPN
hls-1187	68	23	)	)	PUNCT
hls-1187	68	24	54.7±9.5	54.7±9.5	NUM
hls-1187	68	25	59.9±8.6	59.9±8.6	NUM
hls-1187	68	26	<	<	NOUN
hls-1187	68	27	0.01	0.01	NUM
hls-1187	68	28	family	family	NOUN
hls-1187	68	29	history	history	NOUN
hls-1187	68	30	of	of	ADP
hls-1187	68	31	cad	cad	PROPN
hls-1187	68	32	(	(	PUNCT
hls-1187	68	33	%	%	INTJ
hls-1187	68	34	)	)	PUNCT
hls-1187	68	35	210	210	NUM
hls-1187	68	36	(	(	PUNCT
hls-1187	68	37	53.4	53.4	NUM
hls-1187	68	38	)	)	PUNCT
hls-1187	68	39	41	41	NUM
hls-1187	68	40	(	(	PUNCT
hls-1187	68	41	65.1	65.1	NUM
hls-1187	68	42	)	)	PUNCT
hls-1187	68	43	0.09	0.09	NUM
hls-1187	68	44	current	current	ADJ
hls-1187	68	45	smoker	smoker	NOUN
hls-1187	68	46	(	(	PUNCT
hls-1187	68	47	%	%	INTJ
hls-1187	68	48	)	)	PUNCT
hls-1187	68	49	258	258	NUM
hls-1187	68	50	(	(	PUNCT
hls-1187	68	51	63.9	63.9	NUM
hls-1187	68	52	)	)	SYM
hls-1187	68	53	4	4	NUM
hls-1187	68	54	(	(	PUNCT
hls-1187	68	55	6.2	6.2	NUM
hls-1187	68	56	)	)	PUNCT
hls-1187	68	57	<	<	X
hls-1187	68	58	0.01	0.01	NUM
hls-1187	68	59	diabetes	diabetes	NOUN
hls-1187	68	60	(	(	PUNCT
hls-1187	68	61	%	%	INTJ
hls-1187	68	62	)	)	PUNCT
hls-1187	68	63	58	58	NUM
hls-1187	68	64	(	(	PUNCT
hls-1187	68	65	13.9	13.9	NUM
hls-1187	68	66	)	)	PUNCT
hls-1187	68	67	24	24	NUM
hls-1187	68	68	(	(	PUNCT
hls-1187	68	69	36.3	36.3	NUM
hls-1187	68	70	)	)	PUNCT
hls-1187	68	71	<	<	X
hls-1187	68	72	0.01	0.01	NUM
hls-1187	68	73	hypertension	hypertension	NOUN
hls-1187	68	74	(	(	PUNCT
hls-1187	68	75	%	%	INTJ
hls-1187	68	76	)	)	PUNCT
hls-1187	68	77	292	292	NUM
hls-1187	68	78	(	(	PUNCT
hls-1187	68	79	69.6	69.6	NUM
hls-1187	68	80	)	)	SYM
hls-1187	68	81	57	57	NUM
hls-1187	68	82	(	(	PUNCT
hls-1187	68	83	86.4	86.4	NUM
hls-1187	68	84	)	)	PUNCT
hls-1187	68	85	<	<	X
hls-1187	68	86	0.01	0.01	NUM
hls-1187	68	87	bmi	bmi	NOUN
hls-1187	68	88	(	(	PUNCT
hls-1187	68	89	kg	kg	NOUN
hls-1187	68	90	/	/	SYM
hls-1187	68	91	m2	m2	PROPN
hls-1187	68	92	,	,	PUNCT
hls-1187	68	93	mean±sd	mean±sd	PROPN
hls-1187	68	94	)	)	PUNCT
hls-1187	68	95	28.6±4.1	28.6±4.1	NUM
hls-1187	68	96	30.4±5.3	30.4±5.3	NUM
hls-1187	68	97	<	<	X
hls-1187	68	98	0.01	0.01	NUM
hls-1187	68	99	stroke	stroke	NOUN
hls-1187	68	100	/	/	SYM
hls-1187	68	101	tia	tia	PROPN
hls-1187	68	102	(	(	PUNCT
hls-1187	68	103	%	%	INTJ
hls-1187	68	104	)	)	PUNCT
hls-1187	68	105	33	33	NUM
hls-1187	68	106	(	(	PUNCT
hls-1187	68	107	7.9	7.9	NUM
hls-1187	68	108	)	)	PUNCT
hls-1187	68	109	8	8	NUM
hls-1187	68	110	(	(	PUNCT
hls-1187	68	111	12.1	12.1	NUM
hls-1187	68	112	)	)	PUNCT
hls-1187	68	113	0.26	0.26	NUM
hls-1187	68	114	renal	renal	ADJ
hls-1187	68	115	failure	failure	NOUN
hls-1187	68	116	(	(	PUNCT
hls-1187	68	117	%	%	INTJ
hls-1187	68	118	)	)	PUNCT
hls-1187	68	119	3	3	NUM
hls-1187	68	120	(	(	PUNCT
hls-1187	68	121	0.7	0.7	NUM
hls-1187	68	122	)	)	PUNCT
hls-1187	68	123	0	0	NUM
hls-1187	69	1	(	(	PUNCT
hls-1187	69	2	0.0	0.0	NUM
hls-1187	69	3	)	)	PUNCT
hls-1187	69	4	0.49	0.49	NUM
hls-1187	69	5	cardiac	cardiac	ADJ
hls-1187	69	6	status	status	NOUN
hls-1187	69	7	(	(	PUNCT
hls-1187	69	8	%	%	INTJ
hls-1187	69	9	)	)	PUNCT
hls-1187	69	10	acute	acute	NOUN
hls-1187	69	11	mi	mi	PROPN
hls-1187	69	12	148	148	NUM
hls-1187	69	13	(	(	PUNCT
hls-1187	69	14	35.3	35.3	NUM
hls-1187	69	15	)	)	PUNCT
hls-1187	69	16	16	16	NUM
hls-1187	69	17	(	(	PUNCT
hls-1187	69	18	24.2	24.2	NUM
hls-1187	69	19	)	)	PUNCT
hls-1187	69	20	0.08	0.08	NUM
hls-1187	69	21	prior	prior	ADJ
hls-1187	69	22	mi	mi	PROPN
hls-1187	69	23	155	155	NUM
hls-1187	69	24	(	(	PUNCT
hls-1187	69	25	37.2	37.2	NUM
hls-1187	69	26	)	)	SYM
hls-1187	69	27	19	19	NUM
hls-1187	69	28	(	(	PUNCT
hls-1187	69	29	28.7	28.7	NUM
hls-1187	69	30	)	)	PUNCT
hls-1187	69	31	0.19	0.19	NUM
hls-1187	69	32	unstable	unstable	ADJ
hls-1187	69	33	angina	angina	NOUN
hls-1187	69	34	183	183	NUM
hls-1187	69	35	(	(	PUNCT
hls-1187	69	36	43.7	43.7	NUM
hls-1187	69	37	)	)	PUNCT
hls-1187	69	38	32	32	NUM
hls-1187	69	39	(	(	PUNCT
hls-1187	69	40	48.5	48.5	NUM
hls-1187	69	41	)	)	PUNCT
hls-1187	69	42	0.46	0.46	NUM
hls-1187	69	43	stable	stable	ADJ
hls-1187	69	44	angina	angina	NOUN
hls-1187	69	45	56	56	NUM
hls-1187	69	46	(	(	PUNCT
hls-1187	69	47	13.4	13.4	NUM
hls-1187	69	48	)	)	PUNCT
hls-1187	69	49	17	17	NUM
hls-1187	69	50	(	(	PUNCT
hls-1187	69	51	25.7	25.7	NUM
hls-1187	69	52	)	)	PUNCT
hls-1187	69	53	0.01	0.01	NUM
hls-1187	69	54	previous	previous	ADJ
hls-1187	69	55	pci	pci	ADJ
hls-1187	69	56	10	10	NUM
hls-1187	69	57	(	(	PUNCT
hls-1187	69	58	2.4	2.4	NUM
hls-1187	69	59	)	)	PUNCT
hls-1187	69	60	0	0	NUM
hls-1187	70	1	(	(	PUNCT
hls-1187	70	2	0.0	0.0	NUM
hls-1187	70	3	)	)	PUNCT
hls-1187	70	4	0.20	0.20	NUM
hls-1187	70	5	previous	previous	ADJ
hls-1187	70	6	cabg	cabg	ADJ
hls-1187	70	7	24	24	NUM
hls-1187	70	8	(	(	PUNCT
hls-1187	70	9	5.7	5.7	NUM
hls-1187	70	10	)	)	PUNCT
hls-1187	70	11	2	2	NUM
hls-1187	70	12	(	(	PUNCT
hls-1187	70	13	3.0	3.0	NUM
hls-1187	70	14	)	)	PUNCT
hls-1187	70	15	0.36	0.36	NUM
hls-1187	70	16	arrhythmia	arrhythmia	NOUN
hls-1187	70	17	59	59	NUM
hls-1187	70	18	(	(	PUNCT
hls-1187	70	19	14.2	14.2	NUM
hls-1187	70	20	)	)	PUNCT
hls-1187	70	21	11	11	NUM
hls-1187	70	22	(	(	PUNCT
hls-1187	70	23	16.7	16.7	NUM
hls-1187	70	24	)	)	PUNCT
hls-1187	70	25	0.59	0.59	NUM
hls-1187	70	26	angiographic	angiographic	ADJ
hls-1187	70	27	profile	profile	NOUN
hls-1187	70	28	ef	ef	X
hls-1187	70	29	(	(	PUNCT
hls-1187	70	30	%	%	INTJ
hls-1187	70	31	,	,	PUNCT
hls-1187	70	32	mean±sd	mean±sd	PROPN
hls-1187	70	33	)	)	PUNCT
hls-1187	70	34	45.1±7.1	45.1±7.1	NUM
hls-1187	70	35	47.2±6.9	47.2±6.9	NUM
hls-1187	70	36	0.03	0.03	NUM
hls-1187	70	37	number	number	NOUN
hls-1187	70	38	of	of	ADP
hls-1187	70	39	diseased	diseased	ADJ
hls-1187	70	40	vessels	vessel	NOUN
hls-1187	70	41	(	(	PUNCT
hls-1187	70	42	%	%	INTJ
hls-1187	70	43	)	)	PUNCT
hls-1187	70	44	single	single	ADJ
hls-1187	70	45	vessel	vessel	NOUN
hls-1187	70	46	123	123	NUM
hls-1187	70	47	(	(	PUNCT
hls-1187	70	48	30.2	30.2	NUM
hls-1187	70	49	)	)	SYM
hls-1187	70	50	20	20	NUM
hls-1187	70	51	(	(	PUNCT
hls-1187	70	52	31.8	31.8	NUM
hls-1187	70	53	)	)	PUNCT
hls-1187	70	54	0.40	0.40	NUM
hls-1187	70	55	double	double	ADJ
hls-1187	70	56	vessel	vessel	NOUN
hls-1187	70	57	161	161	NUM
hls-1187	70	58	(	(	PUNCT
hls-1187	70	59	39.6	39.6	NUM
hls-1187	70	60	)	)	PUNCT
hls-1187	70	61	20	20	NUM
hls-1187	70	62	(	(	PUNCT
hls-1187	70	63	31.8	31.8	NUM
hls-1187	70	64	)	)	PUNCT
hls-1187	70	65	triple	triple	ADJ
hls-1187	70	66	vessel	vessel	NOUN
hls-1187	70	67	123	123	NUM
hls-1187	70	68	(	(	PUNCT
hls-1187	70	69	30.2	30.2	NUM
hls-1187	70	70	)	)	PUNCT
hls-1187	70	71	23	23	NUM
hls-1187	70	72	(	(	PUNCT
hls-1187	70	73	36.5	36.5	NUM
hls-1187	70	74	)	)	PUNCT
hls-1187	70	75	number	number	NOUN
hls-1187	70	76	of	of	ADP
hls-1187	70	77	stents	stent	NOUN
hls-1187	70	78	implanted	implant	VERB
hls-1187	70	79	(	(	PUNCT
hls-1187	70	80	%	%	NOUN
hls-1187	70	81	)	)	PUNCT
hls-1187	70	82	one	one	NUM
hls-1187	70	83	303	303	NUM
hls-1187	70	84	(	(	PUNCT
hls-1187	70	85	72.3	72.3	NUM
hls-1187	70	86	)	)	PUNCT
hls-1187	70	87	41	41	NUM
hls-1187	70	88	(	(	PUNCT
hls-1187	70	89	62.1	62.1	NUM
hls-1187	70	90	)	)	PUNCT
hls-1187	70	91	0.21	0.21	NUM
hls-1187	70	92	two	two	NUM
hls-1187	70	93	101	101	NUM
hls-1187	70	94	(	(	PUNCT
hls-1187	70	95	24.1	24.1	NUM
hls-1187	70	96	)	)	SYM
hls-1187	70	97	21	21	NUM
hls-1187	70	98	(	(	PUNCT
hls-1187	70	99	31.8	31.8	NUM
hls-1187	70	100	)	)	PUNCT
hls-1187	70	101	three	three	NUM
hls-1187	70	102	15	15	NUM
hls-1187	70	103	(	(	PUNCT
hls-1187	70	104	3.6	3.6	NUM
hls-1187	70	105	)	)	PUNCT
hls-1187	70	106	4	4	NUM
hls-1187	70	107	(	(	PUNCT
hls-1187	70	108	6.1	6.1	NUM
hls-1187	70	109	)	)	PUNCT
hls-1187	70	110	type	type	NOUN
hls-1187	70	111	of	of	ADP
hls-1187	70	112	stented	stente	VERB
hls-1187	70	113	vessel	vessel	NOUN
hls-1187	70	114	(	(	PUNCT
hls-1187	70	115	%	%	INTJ
hls-1187	70	116	)	)	PUNCT
hls-1187	70	117	lcx	lcx	NOUN
hls-1187	70	118	130	130	NUM
hls-1187	70	119	(	(	PUNCT
hls-1187	70	120	31.2	31.2	NUM
hls-1187	70	121	)	)	PUNCT
hls-1187	70	122	19	19	NUM
hls-1187	70	123	(	(	PUNCT
hls-1187	70	124	28.8	28.8	NUM
hls-1187	70	125	)	)	PUNCT
hls-1187	70	126	0.45	0.45	NUM
hls-1187	70	127	lad	lad	NOUN
hls-1187	70	128	221	221	NUM
hls-1187	70	129	(	(	PUNCT
hls-1187	70	130	53.0	53.0	NUM
hls-1187	70	131	)	)	PUNCT
hls-1187	70	132	45	45	NUM
hls-1187	70	133	(	(	PUNCT
hls-1187	70	134	68.0	68.0	NUM
hls-1187	70	135	)	)	PUNCT
hls-1187	70	136	0.02	0.02	NUM
hls-1187	70	137	rca	rca	NOUN
hls-1187	70	138	125	125	NUM
hls-1187	70	139	(	(	PUNCT
hls-1187	70	140	29.9	29.9	NUM
hls-1187	70	141	)	)	SYM
hls-1187	70	142	18	18	NUM
hls-1187	70	143	(	(	PUNCT
hls-1187	70	144	27.3	27.3	NUM
hls-1187	70	145	)	)	PUNCT
hls-1187	70	146	0.65	0.65	NUM
hls-1187	70	147	stent	stent	NOUN
hls-1187	70	148	type	type	NOUN
hls-1187	70	149	(	(	PUNCT
hls-1187	70	150	%	%	INTJ
hls-1187	70	151	)	)	PUNCT
hls-1187	70	152	des	des	X
hls-1187	70	153	339	339	NUM
hls-1187	70	154	(	(	PUNCT
hls-1187	70	155	81.9	81.9	NUM
hls-1187	70	156	)	)	PUNCT
hls-1187	70	157	58	58	NUM
hls-1187	70	158	(	(	PUNCT
hls-1187	70	159	87.9	87.9	NUM
hls-1187	70	160	)	)	PUNCT
hls-1187	70	161	0.48	0.48	NUM
hls-1187	70	162	bms	bms	PROPN
hls-1187	70	163	67	67	NUM
hls-1187	70	164	(	(	PUNCT
hls-1187	70	165	16.2	16.2	NUM
hls-1187	70	166	)	)	PUNCT
hls-1187	70	167	7	7	NUM
hls-1187	70	168	(	(	PUNCT
hls-1187	70	169	10.6	10.6	NUM
hls-1187	70	170	)	)	PUNCT
hls-1187	70	171	both	both	PRON
hls-1187	70	172	8	8	NUM
hls-1187	70	173	(	(	PUNCT
hls-1187	70	174	1.9	1.9	NUM
hls-1187	70	175	)	)	PUNCT
hls-1187	70	176	1	1	NUM
hls-1187	70	177	(	(	PUNCT
hls-1187	70	178	1.5	1.5	NUM
hls-1187	70	179	)	)	PUNCT
hls-1187	70	180	discharge	discharge	NOUN
hls-1187	70	181	medications	medication	NOUN
hls-1187	70	182	(	(	PUNCT
hls-1187	70	183	%	%	INTJ
hls-1187	70	184	)	)	PUNCT
hls-1187	70	185	aspirin	aspirin	NOUN
hls-1187	70	186	384	384	NUM
hls-1187	70	187	(	(	PUNCT
hls-1187	70	188	97.5	97.5	NUM
hls-1187	70	189	)	)	PUNCT
hls-1187	70	190	63	63	NUM
hls-1187	70	191	(	(	PUNCT
hls-1187	70	192	100.0	100.0	NUM
hls-1187	70	193	)	)	PUNCT
hls-1187	70	194	0.20	0.20	NUM
hls-1187	70	195	tienopiridine	tienopiridine	NOUN
hls-1187	70	196	derivatives	derivative	NOUN
hls-1187	70	197	382	382	NUM
hls-1187	70	198	(	(	PUNCT
hls-1187	70	199	96.9	96.9	NUM
hls-1187	70	200	)	)	PUNCT
hls-1187	70	201	62	62	NUM
hls-1187	70	202	(	(	PUNCT
hls-1187	70	203	98.4	98.4	NUM
hls-1187	70	204	)	)	PUNCT
hls-1187	70	205	0.50	0.50	NUM
hls-1187	70	206	beta	beta	ADJ
hls-1187	70	207	blockers	blocker	NOUN
hls-1187	70	208	330	330	NUM
hls-1187	70	209	(	(	PUNCT
hls-1187	70	210	83.7	83.7	NUM
hls-1187	70	211	)	)	PUNCT
hls-1187	70	212	56	56	NUM
hls-1187	70	213	(	(	PUNCT
hls-1187	70	214	88.9	88.9	NUM
hls-1187	70	215	)	)	PUNCT
hls-1187	70	216	0.30	0.30	NUM
hls-1187	70	217	acei	acei	NOUN
hls-1187	70	218	/	/	SYM
hls-1187	70	219	arb	arb	PROPN
hls-1187	70	220	259	259	NUM
hls-1187	70	221	(	(	PUNCT
hls-1187	70	222	65.7	65.7	NUM
hls-1187	70	223	)	)	PUNCT
hls-1187	70	224	50	50	NUM
hls-1187	70	225	(	(	PUNCT
hls-1187	70	226	79.3	79.3	NUM
hls-1187	70	227	)	)	PUNCT
hls-1187	70	228	0.03	0.03	NUM
hls-1187	70	229	statins	statin	NOUN
hls-1187	70	230	340	340	NUM
hls-1187	70	231	(	(	PUNCT
hls-1187	70	232	86.0	86.0	NUM
hls-1187	70	233	)	)	PUNCT
hls-1187	70	234	52	52	NUM
hls-1187	70	235	(	(	PUNCT
hls-1187	70	236	82.0	82.0	NUM
hls-1187	70	237	)	)	PUNCT
hls-1187	70	238	0.40	0.40	NUM
hls-1187	70	239	cad	cad	NOUN
hls-1187	70	240	,	,	PUNCT
hls-1187	70	241	coronary	coronary	ADJ
hls-1187	70	242	artery	artery	NOUN
hls-1187	70	243	disease	disease	NOUN
hls-1187	70	244	;	;	PUNCT
hls-1187	70	245	bmi	bmi	PROPN
hls-1187	70	246	,	,	PUNCT
hls-1187	70	247	body	body	NOUN
hls-1187	70	248	mass	mass	PROPN
hls-1187	70	249	index	index	NOUN
hls-1187	70	250	;	;	PUNCT
hls-1187	70	251	tia	tia	PROPN
hls-1187	70	252	,	,	PUNCT
hls-1187	70	253	transient	transient	VERB
hls-1187	70	254	ischemic	ischemic	ADJ
hls-1187	70	255	attack	attack	NOUN
hls-1187	70	256	;	;	PUNCT
hls-1187	70	257	mi	mi	PROPN
hls-1187	70	258	,	,	PUNCT
hls-1187	70	259	myocardial	myocardial	ADJ
hls-1187	70	260	infarction	infarction	NOUN
hls-1187	70	261	;	;	PUNCT
hls-1187	70	262	pci	pci	ADJ
hls-1187	70	263	,	,	PUNCT
hls-1187	70	264	percutaneous	percutaneous	ADJ
hls-1187	70	265	coronary	coronary	ADJ
hls-1187	70	266	intervention	intervention	NOUN
hls-1187	70	267	;	;	PUNCT
hls-1187	70	268	cabg	cabg	VERB
hls-1187	70	269	,	,	PUNCT
hls-1187	70	270	coronary	coronary	ADJ
hls-1187	70	271	artery	artery	NOUN
hls-1187	70	272	bypass	bypass	NOUN
hls-1187	70	273	graft	graft	NOUN
hls-1187	70	274	;	;	PUNCT
hls-1187	70	275	ef	ef	PROPN
hls-1187	70	276	,	,	PUNCT
hls-1187	70	277	ejection	ejection	NOUN
hls-1187	70	278	fraction	fraction	NOUN
hls-1187	70	279	;	;	PUNCT
hls-1187	70	280	lcx	lcx	PROPN
hls-1187	70	281	,	,	PUNCT
hls-1187	70	282	left	leave	VERB
hls-1187	70	283	circumflex	circumflex	NOUN
hls-1187	70	284	;	;	PUNCT
hls-1187	70	285	lad	lad	ADJ
hls-1187	70	286	,	,	PUNCT
hls-1187	70	287	left	leave	VERB
hls-1187	70	288	anterior	anterior	ADJ
hls-1187	70	289	descending	descending	NOUN
hls-1187	70	290	;	;	PUNCT
hls-1187	70	291	rca	rca	NOUN
hls-1187	70	292	,	,	PUNCT
hls-1187	70	293	right	right	ADJ
hls-1187	70	294	coronary	coronary	ADJ
hls-1187	70	295	artery	artery	NOUN
hls-1187	70	296	;	;	PUNCT
hls-1187	70	297	des	des	X
hls-1187	70	298	,	,	PUNCT
hls-1187	70	299	drug	drug	NOUN
hls-1187	70	300	eluting	eluting	NOUN
hls-1187	70	301	stent	stent	NOUN
hls-1187	70	302	;	;	PUNCT
hls-1187	70	303	bms	bms	PROPN
hls-1187	70	304	,	,	PUNCT
hls-1187	70	305	bare	bare	ADJ
hls-1187	70	306	metal	metal	NOUN
hls-1187	70	307	stent	stent	NOUN
hls-1187	70	308	;	;	PUNCT
hls-1187	70	309	acei	acei	PROPN
hls-1187	70	310	/	/	SYM
hls-1187	70	311	arb	arb	PROPN
hls-1187	70	312	,	,	PUNCT
hls-1187	70	313	angiotensin	angiotensin	NOUN
hls-1187	70	314	converting	convert	VERB
hls-1187	70	315	enzyme	enzyme	NOUN
hls-1187	70	316	inhibitors	inhibitor	NOUN
hls-1187	70	317	/	/	SYM
hls-1187	70	318	angiotensin	angiotensin	NOUN
hls-1187	70	319	receptor	receptor	NOUN
hls-1187	70	320	blockers	blocker	NOUN
hls-1187	70	321	.	.	PUNCT
hls-1187	71	1	°	°	ADP
hls-1187	71	2	results	result	NOUN
hls-1187	71	3	are	be	AUX
hls-1187	71	4	presented	present	VERB
hls-1187	71	5	as	as	ADP
hls-1187	71	6	frequencies	frequency	NOUN
hls-1187	71	7	and	and	CCONJ
hls-1187	71	8	percentages	percentage	NOUN
hls-1187	71	9	,	,	PUNCT
hls-1187	71	10	unless	unless	SCONJ
hls-1187	71	11	specified	specify	VERB
hls-1187	71	12	otherwise	otherwise	ADV
hls-1187	71	13	.	.	PUNCT
hls-1187	72	1	all	all	DET
hls-1187	72	2	percentages	percentage	NOUN
hls-1187	72	3	were	be	AUX
hls-1187	72	4	calculated	calculate	VERB
hls-1187	72	5	after	after	ADP
hls-1187	72	6	excluding	exclude	VERB
hls-1187	72	7	missing	miss	VERB
hls-1187	72	8	values	value	NOUN
hls-1187	72	9	.	.	PUNCT
hls-1187	73	1	non	non	PROPN
hls-1187	73	2	co	co	PROPN
hls-1187	73	3	mmerc	mmerc	PROPN
hls-1187	73	4	ial	ial	PROPN
hls-1187	73	5	us	us	PROPN
hls-1187	74	1	e	e	NOUN
hls-1187	74	2	o	o	NOUN
hls-1187	74	3	nly	nly	ADV
hls-1187	74	4	[	[	X
hls-1187	74	5	healthcare	healthcare	NOUN
hls-1187	74	6	in	in	ADP
hls-1187	74	7	low	low	ADJ
hls-1187	74	8	-	-	PUNCT
hls-1187	74	9	resource	resource	NOUN
hls-1187	74	10	settings	setting	NOUN
hls-1187	74	11	2013	2013	NUM
hls-1187	74	12	;	;	PUNCT
hls-1187	74	13	1	1	NUM
hls-1187	74	14	:	:	PUNCT
hls-1187	74	15	e17	e17	NOUN
hls-1187	74	16	]	]	PUNCT
hls-1187	75	1	[	[	X
hls-1187	75	2	page	page	NOUN
hls-1187	75	3	59	59	NUM
hls-1187	75	4	]	]	PUNCT
hls-1187	75	5	event	event	NOUN
hls-1187	75	6	-	-	PUNCT
hls-1187	75	7	free	free	ADJ
hls-1187	75	8	survival	survival	NOUN
hls-1187	75	9	rates	rate	NOUN
hls-1187	75	10	at	at	ADP
hls-1187	75	11	long	long	ADJ
hls-1187	75	12	-	-	PUNCT
hls-1187	75	13	term	term	NOUN
hls-1187	75	14	follow	follow	NOUN
hls-1187	75	15	-	-	PUNCT
hls-1187	75	16	up	up	NOUN
hls-1187	75	17	the	the	DET
hls-1187	75	18	median	median	ADJ
hls-1187	75	19	follow	follow	NOUN
hls-1187	75	20	-	-	PUNCT
hls-1187	75	21	up	up	NOUN
hls-1187	75	22	of	of	ADP
hls-1187	75	23	the	the	DET
hls-1187	75	24	total	total	ADJ
hls-1187	75	25	sample	sample	NOUN
hls-1187	75	26	was	be	AUX
hls-1187	75	27	1148	1148	NUM
hls-1187	75	28	days	day	NOUN
hls-1187	75	29	,	,	PUNCT
hls-1187	75	30	ranging	range	VERB
hls-1187	75	31	from	from	ADP
hls-1187	75	32	3	3	NUM
hls-1187	75	33	to	to	ADP
hls-1187	75	34	1917	1917	NUM
hls-1187	75	35	.	.	PUNCT
hls-1187	76	1	the	the	DET
hls-1187	76	2	mean	mean	ADJ
hls-1187	76	3	follow	follow	NOUN
hls-1187	76	4	-	-	PUNCT
hls-1187	76	5	up	up	NOUN
hls-1187	76	6	was	be	AUX
hls-1187	76	7	1267±321	1267±321	NUM
hls-1187	76	8	days	day	NOUN
hls-1187	76	9	for	for	ADP
hls-1187	76	10	women	woman	NOUN
hls-1187	76	11	and	and	CCONJ
hls-1187	76	12	1232±321	1232±321	NUM
hls-1187	76	13	days	day	NOUN
hls-1187	76	14	for	for	ADP
hls-1187	76	15	men	man	NOUN
hls-1187	76	16	(	(	PUNCT
hls-1187	76	17	p=0.4	p=0.4	NOUN
hls-1187	76	18	)	)	PUNCT
hls-1187	76	19	.	.	PUNCT
hls-1187	77	1	during	during	ADP
hls-1187	77	2	the	the	DET
hls-1187	77	3	follow	follow	NOUN
hls-1187	77	4	-	-	PUNCT
hls-1187	77	5	up	up	NOUN
hls-1187	77	6	period	period	NOUN
hls-1187	77	7	,	,	PUNCT
hls-1187	77	8	the	the	DET
hls-1187	77	9	total	total	ADJ
hls-1187	77	10	number	number	NOUN
hls-1187	77	11	of	of	ADP
hls-1187	77	12	macce	macce	NOUN
hls-1187	77	13	(	(	PUNCT
hls-1187	77	14	n=180	n=180	NOUN
hls-1187	77	15	)	)	PUNCT
hls-1187	77	16	did	do	AUX
hls-1187	77	17	not	not	PART
hls-1187	77	18	significantly	significantly	ADV
hls-1187	77	19	differ	differ	VERB
hls-1187	77	20	between	between	ADP
hls-1187	77	21	men	man	NOUN
hls-1187	77	22	and	and	CCONJ
hls-1187	77	23	women	woman	NOUN
hls-1187	77	24	(	(	PUNCT
hls-1187	77	25	37.0	37.0	NUM
hls-1187	77	26	vs	vs	ADP
hls-1187	77	27	33.3	33.3	NUM
hls-1187	77	28	%	%	NOUN
hls-1187	77	29	,	,	PUNCT
hls-1187	77	30	p=0.9	p=0.9	PROPN
hls-1187	77	31	)	)	PUNCT
hls-1187	77	32	(	(	PUNCT
hls-1187	77	33	table	table	NOUN
hls-1187	77	34	2	2	NUM
hls-1187	77	35	)	)	PUNCT
hls-1187	77	36	.	.	PUNCT
hls-1187	78	1	the	the	DET
hls-1187	78	2	most	most	ADV
hls-1187	78	3	frequently	frequently	ADV
hls-1187	78	4	observed	observe	VERB
hls-1187	78	5	macce	macce	NOUN
hls-1187	78	6	in	in	ADP
hls-1187	78	7	both	both	DET
hls-1187	78	8	groups	group	NOUN
hls-1187	78	9	was	be	AUX
hls-1187	78	10	repeat	repeat	NOUN
hls-1187	78	11	revascularization	revascularization	NOUN
hls-1187	78	12	.	.	PUNCT
hls-1187	79	1	the	the	DET
hls-1187	79	2	event	event	NOUN
hls-1187	79	3	-	-	PUNCT
hls-1187	79	4	free	free	ADJ
hls-1187	79	5	survival	survival	NOUN
hls-1187	79	6	from	from	ADP
hls-1187	79	7	macce	macce	NOUN
hls-1187	79	8	at	at	ADP
hls-1187	79	9	the	the	DET
hls-1187	79	10	median	median	ADJ
hls-1187	79	11	follow	follow	NOUN
hls-1187	79	12	-	-	PUNCT
hls-1187	79	13	up	up	NOUN
hls-1187	79	14	was	be	AUX
hls-1187	79	15	0.79	0.79	NUM
hls-1187	79	16	(	(	PUNCT
hls-1187	79	17	95	95	NUM
hls-1187	79	18	%	%	NOUN
hls-1187	79	19	ci	ci	NOUN
hls-1187	79	20	:	:	PUNCT
hls-1187	79	21	0.66	0.66	NUM
hls-1187	79	22	-	-	SYM
hls-1187	79	23	0.87	0.87	NUM
hls-1187	79	24	)	)	PUNCT
hls-1187	79	25	for	for	ADP
hls-1187	79	26	women	woman	NOUN
hls-1187	79	27	and	and	CCONJ
hls-1187	79	28	0.74	0.74	NUM
hls-1187	79	29	(	(	PUNCT
hls-1187	79	30	95	95	NUM
hls-1187	79	31	%	%	NOUN
hls-1187	79	32	ci	ci	NOUN
hls-1187	79	33	:	:	PUNCT
hls-1187	79	34	0.69	0.69	NUM
hls-1187	79	35	-	-	PUNCT
hls-1187	79	36	0.78	0.78	NUM
hls-1187	79	37	)	)	PUNCT
hls-1187	79	38	for	for	ADP
hls-1187	79	39	men	man	NOUN
hls-1187	79	40	(	(	PUNCT
hls-1187	79	41	p>0.05	p>0.05	PROPN
hls-1187	79	42	)	)	PUNCT
hls-1187	79	43	.	.	PUNCT
hls-1187	80	1	the	the	DET
hls-1187	80	2	unadjusted	unadjusted	ADJ
hls-1187	80	3	predictors	predictor	NOUN
hls-1187	80	4	of	of	ADP
hls-1187	80	5	long	long	ADJ
hls-1187	80	6	-	-	PUNCT
hls-1187	80	7	term	term	NOUN
hls-1187	80	8	survival	survival	NOUN
hls-1187	80	9	(	(	PUNCT
hls-1187	80	10	macce	macce	NOUN
hls-1187	80	11	)	)	PUNCT
hls-1187	80	12	were	be	AUX
hls-1187	80	13	identified	identify	VERB
hls-1187	80	14	using	use	VERB
hls-1187	80	15	univariate	univariate	ADJ
hls-1187	80	16	cox	cox	PROPN
hls-1187	80	17	proportional	proportional	ADJ
hls-1187	80	18	hazard	hazard	NOUN
hls-1187	80	19	models	model	NOUN
hls-1187	80	20	.	.	PUNCT
hls-1187	81	1	significant	significant	ADJ
hls-1187	81	2	predictors	predictor	NOUN
hls-1187	81	3	(	(	PUNCT
hls-1187	81	4	p<0.05	p<0.05	NOUN
hls-1187	81	5	)	)	PUNCT
hls-1187	81	6	of	of	ADP
hls-1187	81	7	event	event	NOUN
hls-1187	81	8	-	-	PUNCT
hls-1187	81	9	free	free	ADJ
hls-1187	81	10	survival	survival	NOUN
hls-1187	81	11	were	be	AUX
hls-1187	81	12	acute	acute	ADJ
hls-1187	81	13	mi	mi	PROPN
hls-1187	81	14	at	at	ADP
hls-1187	81	15	admission	admission	NOUN
hls-1187	81	16	,	,	PUNCT
hls-1187	81	17	arrhythmia	arrhythmia	NOUN
hls-1187	81	18	,	,	PUNCT
hls-1187	81	19	left	leave	VERB
hls-1187	81	20	ventricular	ventricular	ADJ
hls-1187	81	21	ejection	ejection	NOUN
hls-1187	81	22	fraction	fraction	NOUN
hls-1187	81	23	,	,	PUNCT
hls-1187	81	24	number	number	NOUN
hls-1187	81	25	of	of	ADP
hls-1187	81	26	diseased	diseased	ADJ
hls-1187	81	27	vessels	vessel	NOUN
hls-1187	81	28	,	,	PUNCT
hls-1187	81	29	and	and	CCONJ
hls-1187	81	30	stent	stent	NOUN
hls-1187	81	31	type	type	NOUN
hls-1187	81	32	.	.	PUNCT
hls-1187	82	1	the	the	DET
hls-1187	82	2	final	final	ADJ
hls-1187	82	3	,	,	PUNCT
hls-1187	82	4	multivariable	multivariable	ADJ
hls-1187	82	5	model	model	NOUN
hls-1187	82	6	included	include	VERB
hls-1187	82	7	sex	sex	NOUN
hls-1187	82	8	(	(	PUNCT
hls-1187	82	9	hr=2.46	hr=2.46	NOUN
hls-1187	82	10	,	,	PUNCT
hls-1187	82	11	95	95	NUM
hls-1187	82	12	%	%	NOUN
hls-1187	82	13	ci	ci	NOUN
hls-1187	82	14	:	:	PUNCT
hls-1187	82	15	1.08	1.08	NUM
hls-1187	82	16	-	-	SYM
hls-1187	82	17	5.61	5.61	NUM
hls-1187	82	18	)	)	PUNCT
hls-1187	82	19	,	,	PUNCT
hls-1187	82	20	diabetes	diabetes	NOUN
hls-1187	82	21	(	(	PUNCT
hls-1187	82	22	hr=5.65	hr=5.65	NOUN
hls-1187	82	23	,	,	PUNCT
hls-1187	82	24	95	95	NUM
hls-1187	82	25	%	%	NOUN
hls-1187	82	26	ci	ci	NOUN
hls-1187	82	27	:	:	PUNCT
hls-1187	82	28	2.14	2.14	NUM
hls-1187	82	29	-	-	SYM
hls-1187	82	30	14.95	14.95	NUM
hls-1187	82	31	)	)	PUNCT
hls-1187	82	32	,	,	PUNCT
hls-1187	82	33	arrhythmia	arrhythmia	NOUN
hls-1187	82	34	(	(	PUNCT
hls-1187	82	35	hr=1.64	hr=1.64	PROPN
hls-1187	82	36	,	,	PUNCT
hls-1187	82	37	95	95	NUM
hls-1187	82	38	%	%	NOUN
hls-1187	82	39	ci	ci	NOUN
hls-1187	82	40	:	:	PUNCT
hls-1187	82	41	1.07	1.07	NUM
hls-1187	82	42	-	-	SYM
hls-1187	82	43	2.50	2.50	NUM
hls-1187	82	44	)	)	PUNCT
hls-1187	82	45	,	,	PUNCT
hls-1187	82	46	acute	acute	PROPN
hls-1187	82	47	mi	mi	PROPN
hls-1187	82	48	at	at	ADP
hls-1187	82	49	admission	admission	NOUN
hls-1187	82	50	(	(	PUNCT
hls-1187	82	51	hr=1.43	hr=1.43	NOUN
hls-1187	82	52	,	,	PUNCT
hls-1187	82	53	95	95	NUM
hls-1187	82	54	%	%	NOUN
hls-1187	82	55	ci	ci	NOUN
hls-1187	82	56	:	:	PUNCT
hls-1187	82	57	1.02	1.02	NUM
hls-1187	82	58	-	-	SYM
hls-1187	82	59	2.00	2.00	NUM
hls-1187	82	60	)	)	PUNCT
hls-1187	82	61	,	,	PUNCT
hls-1187	82	62	and	and	CCONJ
hls-1187	82	63	the	the	DET
hls-1187	82	64	interaction	interaction	NOUN
hls-1187	82	65	between	between	ADP
hls-1187	82	66	sex	sex	NOUN
hls-1187	82	67	and	and	CCONJ
hls-1187	82	68	diabetes	diabetes	NOUN
hls-1187	82	69	(	(	PUNCT
hls-1187	82	70	hr=0.16	hr=0.16	NOUN
hls-1187	82	71	;	;	PUNCT
hls-1187	82	72	95	95	NUM
hls-1187	82	73	%	%	NOUN
hls-1187	82	74	ci	ci	NOUN
hls-1187	82	75	:	:	PUNCT
hls-1187	82	76	0.05	0.05	NUM
hls-1187	82	77	-	-	SYM
hls-1187	82	78	0.47	0.47	NUM
hls-1187	82	79	)	)	PUNCT
hls-1187	82	80	(	(	PUNCT
hls-1187	82	81	table	table	NOUN
hls-1187	82	82	3	3	NUM
hls-1187	82	83	)	)	PUNCT
hls-1187	82	84	.	.	PUNCT
hls-1187	83	1	in	in	ADP
hls-1187	83	2	patients	patient	NOUN
hls-1187	83	3	without	without	ADP
hls-1187	83	4	diabetes	diabetes	NOUN
hls-1187	83	5	,	,	PUNCT
hls-1187	83	6	after	after	ADP
hls-1187	83	7	adjusting	adjust	VERB
hls-1187	83	8	for	for	ADP
hls-1187	83	9	arrhythmia	arrhythmia	NOUN
hls-1187	83	10	and	and	CCONJ
hls-1187	83	11	acute	acute	PROPN
hls-1187	83	12	mi	mi	PROPN
hls-1187	83	13	at	at	ADP
hls-1187	83	14	admission	admission	NOUN
hls-1187	83	15	,	,	PUNCT
hls-1187	83	16	men	man	NOUN
hls-1187	83	17	had	have	VERB
hls-1187	83	18	worse	bad	ADJ
hls-1187	83	19	event	event	NOUN
hls-1187	83	20	-	-	PUNCT
hls-1187	83	21	free	free	ADJ
hls-1187	83	22	survival	survival	NOUN
hls-1187	83	23	from	from	ADP
hls-1187	83	24	macce	macce	NOUN
hls-1187	83	25	(	(	PUNCT
hls-1187	83	26	hr=2.46	hr=2.46	NOUN
hls-1187	83	27	,	,	PUNCT
hls-1187	83	28	95	95	NUM
hls-1187	83	29	%	%	NOUN
hls-1187	83	30	ci	ci	NOUN
hls-1187	83	31	:	:	PUNCT
hls-1187	83	32	1.08	1.08	NUM
hls-1187	83	33	-	-	SYM
hls-1187	83	34	5.62	5.62	NUM
hls-1187	83	35	)	)	PUNCT
hls-1187	83	36	than	than	ADP
hls-1187	83	37	women	woman	NOUN
hls-1187	83	38	(	(	PUNCT
hls-1187	83	39	table	table	NOUN
hls-1187	83	40	4	4	NUM
hls-1187	83	41	,	,	PUNCT
hls-1187	83	42	figure	figure	NOUN
hls-1187	83	43	1a	1a	NOUN
hls-1187	83	44	)	)	PUNCT
hls-1187	83	45	.	.	PUNCT
hls-1187	84	1	after	after	ADP
hls-1187	84	2	adjusting	adjust	VERB
hls-1187	84	3	for	for	ADP
hls-1187	84	4	arrhythmia	arrhythmia	NOUN
hls-1187	84	5	and	and	CCONJ
hls-1187	84	6	acute	acute	PROPN
hls-1187	84	7	mi	mi	PROPN
hls-1187	84	8	at	at	ADP
hls-1187	84	9	admission	admission	NOUN
hls-1187	84	10	,	,	PUNCT
hls-1187	84	11	in	in	ADP
hls-1187	84	12	patients	patient	NOUN
hls-1187	84	13	with	with	ADP
hls-1187	84	14	diabetes	diabetes	NOUN
hls-1187	84	15	,	,	PUNCT
hls-1187	84	16	men	man	NOUN
hls-1187	84	17	had	have	VERB
hls-1187	84	18	better	well	ADJ
hls-1187	84	19	eventfree	eventfree	ADJ
hls-1187	84	20	survival	survival	NOUN
hls-1187	84	21	from	from	ADP
hls-1187	84	22	macce	macce	NOUN
hls-1187	84	23	(	(	PUNCT
hls-1187	84	24	hr=0.40	hr=0.40	NOUN
hls-1187	84	25	,	,	PUNCT
hls-1187	84	26	95	95	NUM
hls-1187	84	27	%	%	NOUN
hls-1187	84	28	ci	ci	NOUN
hls-1187	84	29	:	:	PUNCT
hls-1187	84	30	0.19	0.19	NUM
hls-1187	84	31	-	-	SYM
hls-1187	84	32	0.85	0.85	NUM
hls-1187	84	33	)	)	PUNCT
hls-1187	84	34	than	than	ADP
hls-1187	84	35	women	woman	NOUN
hls-1187	84	36	(	(	PUNCT
hls-1187	84	37	table	table	NOUN
hls-1187	84	38	4	4	NUM
hls-1187	84	39	,	,	PUNCT
hls-1187	84	40	figure	figure	NOUN
hls-1187	84	41	1b	1b	NUM
hls-1187	84	42	)	)	PUNCT
hls-1187	84	43	.	.	PUNCT
hls-1187	85	1	discussion	discussion	NOUN
hls-1187	85	2	this	this	DET
hls-1187	85	3	observational	observational	ADJ
hls-1187	85	4	study	study	NOUN
hls-1187	85	5	sought	seek	VERB
hls-1187	85	6	to	to	PART
hls-1187	85	7	evaluate	evaluate	VERB
hls-1187	85	8	sex	sex	NOUN
hls-1187	85	9	differences	difference	NOUN
hls-1187	85	10	in	in	ADP
hls-1187	85	11	3	3	NUM
hls-1187	85	12	-	-	PUNCT
hls-1187	85	13	year	year	NOUN
hls-1187	85	14	event	event	NOUN
hls-1187	85	15	-	-	PUNCT
hls-1187	85	16	free	free	ADJ
hls-1187	85	17	survival	survival	NOUN
hls-1187	85	18	from	from	ADP
hls-1187	85	19	macce	macce	NOUN
hls-1187	85	20	in	in	ADP
hls-1187	85	21	patients	patient	NOUN
hls-1187	85	22	with	with	ADP
hls-1187	85	23	cad	cad	PROPN
hls-1187	85	24	who	who	PRON
hls-1187	85	25	had	have	AUX
hls-1187	85	26	pci	pci	VERB
hls-1187	85	27	in	in	ADP
hls-1187	85	28	a	a	DET
hls-1187	85	29	single	single	ADJ
hls-1187	85	30	center	center	NOUN
hls-1187	85	31	in	in	ADP
hls-1187	85	32	armenia	armenia	PROPN
hls-1187	85	33	.	.	PUNCT
hls-1187	86	1	we	we	PRON
hls-1187	86	2	observed	observe	VERB
hls-1187	86	3	significant	significant	ADJ
hls-1187	86	4	differences	difference	NOUN
hls-1187	86	5	in	in	ADP
hls-1187	86	6	several	several	ADJ
hls-1187	86	7	baseline	baseline	ADJ
hls-1187	86	8	factors	factor	NOUN
hls-1187	86	9	between	between	ADP
hls-1187	86	10	men	man	NOUN
hls-1187	86	11	and	and	CCONJ
hls-1187	86	12	women	woman	NOUN
hls-1187	86	13	.	.	PUNCT
hls-1187	87	1	for	for	ADP
hls-1187	87	2	example	example	NOUN
hls-1187	87	3	,	,	PUNCT
hls-1187	87	4	women	woman	NOUN
hls-1187	87	5	on	on	ADP
hls-1187	87	6	average	average	ADJ
hls-1187	87	7	were	be	AUX
hls-1187	87	8	older	old	ADJ
hls-1187	87	9	than	than	ADP
hls-1187	87	10	men	man	NOUN
hls-1187	87	11	,	,	PUNCT
hls-1187	87	12	more	more	ADV
hls-1187	87	13	hypertensive	hypertensive	ADJ
hls-1187	87	14	,	,	PUNCT
hls-1187	87	15	more	more	ADV
hls-1187	87	16	obese	obese	ADJ
hls-1187	87	17	,	,	PUNCT
hls-1187	87	18	and	and	CCONJ
hls-1187	87	19	had	have	VERB
hls-1187	87	20	a	a	DET
hls-1187	87	21	significantly	significantly	ADV
hls-1187	87	22	higher	high	ADJ
hls-1187	87	23	rate	rate	NOUN
hls-1187	87	24	of	of	ADP
hls-1187	87	25	diabetes	diabetes	NOUN
hls-1187	87	26	.	.	PUNCT
hls-1187	88	1	in	in	ADP
hls-1187	88	2	contrast	contrast	NOUN
hls-1187	88	3	,	,	PUNCT
hls-1187	88	4	men	man	NOUN
hls-1187	88	5	were	be	AUX
hls-1187	88	6	more	more	ADV
hls-1187	88	7	likely	likely	ADJ
hls-1187	88	8	to	to	PART
hls-1187	88	9	be	be	AUX
hls-1187	88	10	smokers	smoker	NOUN
hls-1187	88	11	.	.	PUNCT
hls-1187	89	1	similar	similar	ADJ
hls-1187	89	2	differences	difference	NOUN
hls-1187	89	3	were	be	AUX
hls-1187	89	4	observed	observe	VERB
hls-1187	89	5	in	in	ADP
hls-1187	89	6	several	several	ADJ
hls-1187	89	7	past	past	ADJ
hls-1187	89	8	studies.2,5,11,16,17	studies.2,5,11,16,17	NOUN
hls-1187	89	9	for	for	ADP
hls-1187	89	10	example	example	NOUN
hls-1187	89	11	,	,	PUNCT
hls-1187	89	12	a	a	DET
hls-1187	89	13	recent	recent	ADJ
hls-1187	89	14	observational	observational	ADJ
hls-1187	89	15	study	study	NOUN
hls-1187	89	16	conducted	conduct	VERB
hls-1187	89	17	by	by	ADP
hls-1187	89	18	duvernoy	duvernoy	NOUN
hls-1187	89	19	et	et	PROPN
hls-1187	89	20	al	al	PROPN
hls-1187	89	21	.	.	PROPN
hls-1187	89	22	found	find	VERB
hls-1187	89	23	that	that	SCONJ
hls-1187	89	24	women	woman	NOUN
hls-1187	89	25	were	be	AUX
hls-1187	89	26	more	more	ADV
hls-1187	89	27	obese	obese	ADJ
hls-1187	89	28	(	(	PUNCT
hls-1187	89	29	47.9	47.9	NUM
hls-1187	89	30	vs	vs	ADP
hls-1187	89	31	43.1	43.1	NUM
hls-1187	89	32	%	%	NOUN
hls-1187	89	33	)	)	PUNCT
hls-1187	89	34	and	and	CCONJ
hls-1187	89	35	more	more	ADV
hls-1187	89	36	often	often	ADV
hls-1187	89	37	had	have	AUX
hls-1187	89	38	diabetes	diabetes	NOUN
hls-1187	89	39	mellitus	mellitus	NOUN
hls-1187	89	40	(	(	PUNCT
hls-1187	89	41	38.5	38.5	NUM
hls-1187	89	42	vs	vs	ADP
hls-1187	89	43	29.2	29.2	NUM
hls-1187	89	44	%	%	NOUN
hls-1187	89	45	)	)	PUNCT
hls-1187	89	46	and	and	CCONJ
hls-1187	89	47	hypertension	hypertension	NOUN
hls-1187	89	48	(	(	PUNCT
hls-1187	89	49	82.5	82.5	NUM
hls-1187	89	50	vs	vs	ADP
hls-1187	89	51	71.0	71.0	NUM
hls-1187	89	52	%	%	NOUN
hls-1187	89	53	)	)	PUNCT
hls-1187	89	54	,	,	PUNCT
hls-1187	89	55	and	and	CCONJ
hls-1187	89	56	that	that	SCONJ
hls-1187	89	57	men	man	NOUN
hls-1187	89	58	were	be	AUX
hls-1187	89	59	more	more	ADV
hls-1187	89	60	likely	likely	ADJ
hls-1187	89	61	to	to	PART
hls-1187	89	62	smoke	smoke	VERB
hls-1187	89	63	(	(	PUNCT
hls-1187	89	64	27.3	27.3	NUM
hls-1187	89	65	vs	vs	ADP
hls-1187	89	66	21.7%).2	21.7%).2	NUM
hls-1187	89	67	in	in	ADP
hls-1187	89	68	the	the	DET
hls-1187	89	69	current	current	ADJ
hls-1187	89	70	analysis	analysis	NOUN
hls-1187	89	71	,	,	PUNCT
hls-1187	89	72	the	the	DET
hls-1187	89	73	unadjusted	unadjusted	ADJ
hls-1187	89	74	event	event	NOUN
hls-1187	89	75	-	-	PUNCT
hls-1187	89	76	free	free	ADJ
hls-1187	89	77	survival	survival	NOUN
hls-1187	89	78	at	at	ADP
hls-1187	89	79	the	the	DET
hls-1187	89	80	end	end	NOUN
hls-1187	89	81	of	of	ADP
hls-1187	89	82	follow	follow	NOUN
hls-1187	89	83	-	-	PUNCT
hls-1187	89	84	up	up	NOUN
hls-1187	89	85	was	be	AUX
hls-1187	89	86	article	article	NOUN
hls-1187	89	87	table	table	NOUN
hls-1187	89	88	2	2	NUM
hls-1187	89	89	.	.	PUNCT
hls-1187	89	90	distribution	distribution	NOUN
hls-1187	89	91	of	of	ADP
hls-1187	89	92	major	major	ADJ
hls-1187	89	93	adverse	adverse	ADJ
hls-1187	89	94	cardiac	cardiac	ADJ
hls-1187	89	95	and	and	CCONJ
hls-1187	89	96	cerebrovascular	cerebrovascular	ADJ
hls-1187	89	97	events	event	NOUN
hls-1187	89	98	between	between	ADP
hls-1187	89	99	sexes	sex	NOUN
hls-1187	89	100	.	.	PUNCT
hls-1187	90	1	events	event	NOUN
hls-1187	90	2	,	,	PUNCT
hls-1187	90	3	n	n	CCONJ
hls-1187	90	4	(	(	PUNCT
hls-1187	90	5	%	%	INTJ
hls-1187	90	6	)	)	PUNCT
hls-1187	90	7	total	total	ADJ
hls-1187	90	8	sample	sample	NOUN
hls-1187	90	9	men	man	NOUN
hls-1187	90	10	women	woman	NOUN
hls-1187	90	11	p	p	X
hls-1187	90	12	(	(	PUNCT
hls-1187	90	13	n=485	n=485	PROPN
hls-1187	90	14	)	)	PUNCT
hls-1187	90	15	(	(	PUNCT
hls-1187	90	16	n=419	n=419	X
hls-1187	90	17	)	)	PUNCT
hls-1187	90	18	(	(	PUNCT
hls-1187	90	19	n=66	n=66	PROPN
hls-1187	90	20	)	)	PUNCT
hls-1187	90	21	mi	mi	PROPN
hls-1187	90	22	31	31	NUM
hls-1187	90	23	(	(	PUNCT
hls-1187	90	24	6.4	6.4	NUM
hls-1187	90	25	)	)	PUNCT
hls-1187	90	26	26	26	NUM
hls-1187	90	27	(	(	PUNCT
hls-1187	90	28	6.2	6.2	NUM
hls-1187	90	29	)	)	PUNCT
hls-1187	90	30	5	5	NUM
hls-1187	90	31	(	(	PUNCT
hls-1187	90	32	7.6	7.6	NUM
hls-1187	90	33	)	)	PUNCT
hls-1187	90	34	0.8	0.8	NUM
hls-1187	90	35	rr	rr	NOUN
hls-1187	90	36	102	102	NUM
hls-1187	90	37	(	(	PUNCT
hls-1187	90	38	21.0	21.0	NUM
hls-1187	90	39	)	)	PUNCT
hls-1187	90	40	92	92	NUM
hls-1187	90	41	(	(	PUNCT
hls-1187	90	42	22.0	22.0	NUM
hls-1187	90	43	)	)	PUNCT
hls-1187	90	44	10	10	NUM
hls-1187	90	45	(	(	PUNCT
hls-1187	90	46	15.2	15.2	NUM
hls-1187	90	47	)	)	PUNCT
hls-1187	90	48	0.3	0.3	NUM
hls-1187	90	49	pci	pci	ADJ
hls-1187	90	50	71	71	NUM
hls-1187	90	51	(	(	PUNCT
hls-1187	90	52	14.6	14.6	NUM
hls-1187	90	53	)	)	PUNCT
hls-1187	90	54	64	64	NUM
hls-1187	90	55	(	(	PUNCT
hls-1187	90	56	15.3	15.3	NUM
hls-1187	90	57	)	)	PUNCT
hls-1187	90	58	7	7	NUM
hls-1187	90	59	(	(	PUNCT
hls-1187	90	60	10.6	10.6	NUM
hls-1187	90	61	)	)	PUNCT
hls-1187	90	62	cabg	cabg	VERB
hls-1187	90	63	32	32	NUM
hls-1187	90	64	(	(	PUNCT
hls-1187	90	65	6.6	6.6	NUM
hls-1187	90	66	)	)	PUNCT
hls-1187	90	67	29	29	NUM
hls-1187	90	68	(	(	PUNCT
hls-1187	90	69	6.9	6.9	NUM
hls-1187	90	70	)	)	PUNCT
hls-1187	90	71	3	3	NUM
hls-1187	90	72	(	(	PUNCT
hls-1187	90	73	4.5	4.5	NUM
hls-1187	90	74	)	)	PUNCT
hls-1187	90	75	death	death	NOUN
hls-1187	90	76	38	38	NUM
hls-1187	90	77	(	(	PUNCT
hls-1187	90	78	7.8	7.8	NUM
hls-1187	90	79	)	)	PUNCT
hls-1187	90	80	31	31	NUM
hls-1187	90	81	(	(	PUNCT
hls-1187	90	82	7.4	7.4	NUM
hls-1187	90	83	)	)	PUNCT
hls-1187	90	84	7	7	NUM
hls-1187	90	85	(	(	PUNCT
hls-1187	90	86	10.6	10.6	NUM
hls-1187	90	87	)	)	PUNCT
hls-1187	90	88	0.4	0.4	NUM
hls-1187	90	89	stroke	stroke	PROPN
hls-1187	90	90	/	/	SYM
hls-1187	90	91	tia	tia	PROPN
hls-1187	90	92	9	9	NUM
hls-1187	90	93	(	(	PUNCT
hls-1187	90	94	1.9	1.9	NUM
hls-1187	90	95	)	)	PUNCT
hls-1187	90	96	9	9	NUM
hls-1187	90	97	(	(	PUNCT
hls-1187	90	98	2.2	2.2	NUM
hls-1187	90	99	)	)	PUNCT
hls-1187	90	100	0	0	NUM
hls-1187	91	1	(	(	PUNCT
hls-1187	91	2	0.0	0.0	NUM
hls-1187	91	3	)	)	PUNCT
hls-1187	91	4	0.4	0.4	NUM
hls-1187	91	5	total	total	ADJ
hls-1187	91	6	macce	macce	NOUN
hls-1187	91	7	180	180	NUM
hls-1187	91	8	(	(	PUNCT
hls-1187	91	9	37.1	37.1	NUM
hls-1187	91	10	)	)	PUNCT
hls-1187	91	11	158	158	NUM
hls-1187	91	12	(	(	PUNCT
hls-1187	91	13	37.7	37.7	NUM
hls-1187	91	14	)	)	SYM
hls-1187	91	15	22	22	NUM
hls-1187	91	16	(	(	PUNCT
hls-1187	91	17	33.3	33.3	NUM
hls-1187	91	18	)	)	PUNCT
hls-1187	91	19	0.9	0.9	NUM
hls-1187	91	20	mi	mi	PROPN
hls-1187	91	21	,	,	PUNCT
hls-1187	91	22	myocardial	myocardial	ADJ
hls-1187	91	23	infarction	infarction	NOUN
hls-1187	91	24	;	;	PUNCT
hls-1187	91	25	rr	rr	NOUN
hls-1187	91	26	,	,	PUNCT
hls-1187	91	27	repeat	repeat	NOUN
hls-1187	91	28	revascularization	revascularization	NOUN
hls-1187	91	29	;	;	PUNCT
hls-1187	91	30	pci	pci	ADJ
hls-1187	91	31	,	,	PUNCT
hls-1187	91	32	percutaneous	percutaneous	ADJ
hls-1187	91	33	coronary	coronary	ADJ
hls-1187	91	34	intervention	intervention	NOUN
hls-1187	91	35	;	;	PUNCT
hls-1187	91	36	cabg	cabg	VERB
hls-1187	91	37	,	,	PUNCT
hls-1187	91	38	coronary	coronary	ADJ
hls-1187	91	39	artery	artery	NOUN
hls-1187	91	40	bypass	bypass	NOUN
hls-1187	91	41	graft	graft	NOUN
hls-1187	91	42	;	;	PUNCT
hls-1187	91	43	tia	tia	PROPN
hls-1187	91	44	,	,	PUNCT
hls-1187	91	45	transient	transient	VERB
hls-1187	91	46	ischemic	ischemic	ADJ
hls-1187	91	47	attack	attack	NOUN
hls-1187	91	48	;	;	PUNCT
hls-1187	91	49	macce	macce	NOUN
hls-1187	91	50	,	,	PUNCT
hls-1187	91	51	major	major	ADJ
hls-1187	91	52	adverse	adverse	ADJ
hls-1187	91	53	cardiac	cardiac	ADJ
hls-1187	91	54	and	and	CCONJ
hls-1187	91	55	cerebrovascular	cerebrovascular	ADJ
hls-1187	91	56	events	event	NOUN
hls-1187	91	57	.	.	PUNCT
hls-1187	92	1	table	table	NOUN
hls-1187	92	2	3	3	NUM
hls-1187	92	3	.	.	NUM
hls-1187	92	4	unadjusted	unadjuste	VERB
hls-1187	92	5	and	and	CCONJ
hls-1187	92	6	adjusted	adjust	VERB
hls-1187	92	7	cox	cox	PROPN
hls-1187	92	8	proportional	proportional	ADJ
hls-1187	92	9	hazard	hazard	NOUN
hls-1187	92	10	models	model	NOUN
hls-1187	92	11	of	of	ADP
hls-1187	92	12	survival	survival	NOUN
hls-1187	92	13	from	from	ADP
hls-1187	92	14	major	major	ADJ
hls-1187	92	15	adverse	adverse	ADJ
hls-1187	92	16	cardiac	cardiac	ADJ
hls-1187	92	17	and	and	CCONJ
hls-1187	92	18	cerebrovascular	cerebrovascular	ADJ
hls-1187	92	19	events	event	NOUN
hls-1187	92	20	.	.	PUNCT
hls-1187	93	1	unadjusted	unadjuste	VERB
hls-1187	93	2	adjusted	adjusted	ADJ
hls-1187	93	3	predictors	predictor	NOUN
hls-1187	93	4	hazard	hazard	NOUN
hls-1187	93	5	ratio	ratio	NOUN
hls-1187	93	6	95	95	NUM
hls-1187	93	7	%	%	NOUN
hls-1187	93	8	ci	ci	NOUN
hls-1187	94	1	p	p	NOUN
hls-1187	94	2	hazard	hazard	NOUN
hls-1187	94	3	ratio	ratio	NOUN
hls-1187	94	4	95	95	NUM
hls-1187	94	5	%	%	NOUN
hls-1187	94	6	ci	ci	NOUN
hls-1187	94	7	p	p	PROPN
hls-1187	94	8	sex	sex	NOUN
hls-1187	94	9	1.12	1.12	NUM
hls-1187	94	10	0.69	0.69	NUM
hls-1187	94	11	-	-	SYM
hls-1187	94	12	1.81	1.81	NUM
hls-1187	95	1	0.652	0.652	NUM
hls-1187	95	2	2.46	2.46	NUM
hls-1187	95	3	1.08	1.08	NUM
hls-1187	95	4	-	-	SYM
hls-1187	95	5	5.61	5.61	NUM
hls-1187	95	6	0.032	0.032	NUM
hls-1187	95	7	diabetes	diabetes	NOUN
hls-1187	95	8	1.28	1.28	NUM
hls-1187	95	9	0.85	0.85	NUM
hls-1187	95	10	-	-	SYM
hls-1187	95	11	1.94	1.94	NUM
hls-1187	95	12	0.241	0.241	NUM
hls-1187	95	13	5.65	5.65	NUM
hls-1187	95	14	2.14	2.14	NUM
hls-1187	95	15	-	-	SYM
hls-1187	95	16	14.95	14.95	NUM
hls-1187	95	17	0.000	0.000	NUM
hls-1187	95	18	acute	acute	NOUN
hls-1187	95	19	mi	mi	PROPN
hls-1187	95	20	1.51	1.51	NUM
hls-1187	95	21	1.09	1.09	NUM
hls-1187	95	22	-	-	SYM
hls-1187	95	23	2.10	2.10	NUM
hls-1187	95	24	0.014	0.014	NUM
hls-1187	95	25	1.43	1.43	NUM
hls-1187	95	26	1.02	1.02	NUM
hls-1187	95	27	-	-	SYM
hls-1187	95	28	2.00	2.00	NUM
hls-1187	95	29	0.036	0.036	NUM
hls-1187	95	30	arrhythmia	arrhythmia	NOUN
hls-1187	95	31	1.66	1.66	NUM
hls-1187	95	32	1.09	1.09	NUM
hls-1187	95	33	-	-	SYM
hls-1187	95	34	2.53	2.53	NUM
hls-1187	95	35	0.018	0.018	NUM
hls-1187	95	36	1.64	1.64	NUM
hls-1187	95	37	1.07	1.07	NUM
hls-1187	95	38	-	-	SYM
hls-1187	95	39	2.50	2.50	NUM
hls-1187	95	40	0.022	0.022	NUM
hls-1187	95	41	sex*diabetes	sex*diabete	VERB
hls-1187	95	42	0.16	0.16	NUM
hls-1187	95	43	0.05	0.05	NUM
hls-1187	95	44	-	-	SYM
hls-1187	95	45	0.47	0.47	NUM
hls-1187	95	46	0.001	0.001	NUM
hls-1187	95	47	ci	ci	NOUN
hls-1187	95	48	,	,	PUNCT
hls-1187	95	49	confidence	confidence	NOUN
hls-1187	95	50	interval	interval	NOUN
hls-1187	95	51	;	;	PUNCT
hls-1187	95	52	mi	mi	PROPN
hls-1187	95	53	,	,	PUNCT
hls-1187	95	54	myocardial	myocardial	ADJ
hls-1187	95	55	infarction	infarction	NOUN
hls-1187	95	56	;	;	PUNCT
hls-1187	95	57	sex*diabetes	sex*diabete	NOUN
hls-1187	95	58	,	,	PUNCT
hls-1187	95	59	interaction	interaction	NOUN
hls-1187	95	60	between	between	ADP
hls-1187	95	61	sex	sex	NOUN
hls-1187	95	62	and	and	CCONJ
hls-1187	95	63	diabetes	diabetes	NOUN
hls-1187	95	64	.	.	PUNCT
hls-1187	96	1	table	table	NOUN
hls-1187	96	2	4	4	NUM
hls-1187	96	3	.	.	PUNCT
hls-1187	97	1	interaction	interaction	NOUN
hls-1187	97	2	between	between	ADP
hls-1187	97	3	sex	sex	NOUN
hls-1187	97	4	and	and	CCONJ
hls-1187	97	5	diabetes	diabetes	NOUN
hls-1187	97	6	in	in	ADP
hls-1187	97	7	survival	survival	NOUN
hls-1187	97	8	from	from	ADP
hls-1187	97	9	major	major	ADJ
hls-1187	97	10	adverse	adverse	ADJ
hls-1187	97	11	cardiac	cardiac	NOUN
hls-1187	97	12	and	and	CCONJ
hls-1187	97	13	cerebrovascular	cerebrovascular	ADJ
hls-1187	97	14	events	event	NOUN
hls-1187	97	15	after	after	ADP
hls-1187	97	16	controlling	control	VERB
hls-1187	97	17	for	for	ADP
hls-1187	97	18	acute	acute	ADJ
hls-1187	97	19	myocardial	myocardial	ADJ
hls-1187	97	20	infarction	infarction	NOUN
hls-1187	97	21	and	and	CCONJ
hls-1187	97	22	arrhythmia	arrhythmia	NOUN
hls-1187	97	23	.	.	PUNCT
hls-1187	98	1	patients	patient	NOUN
hls-1187	98	2	(	(	PUNCT
hls-1187	98	3	n	n	CCONJ
hls-1187	98	4	)	)	PUNCT
hls-1187	98	5	macce	macce	NOUN
hls-1187	98	6	(	(	PUNCT
hls-1187	98	7	n	n	CCONJ
hls-1187	98	8	)	)	PUNCT
hls-1187	98	9	hazard	hazard	NOUN
hls-1187	98	10	ratio	ratio	NOUN
hls-1187	98	11	(	(	PUNCT
hls-1187	98	12	95	95	NUM
hls-1187	98	13	%	%	NOUN
hls-1187	98	14	ci	ci	NOUN
hls-1187	98	15	)	)	PUNCT
hls-1187	98	16	p	p	NOUN
hls-1187	98	17	diabetes	diabetes	NOUN
hls-1187	98	18	male	male	NOUN
hls-1187	98	19	58	58	NUM
hls-1187	98	20	15	15	NUM
hls-1187	98	21	0.40	0.40	NUM
hls-1187	98	22	(	(	PUNCT
hls-1187	98	23	0.19	0.19	NUM
hls-1187	98	24	-	-	SYM
hls-1187	98	25	0.85	0.85	NUM
hls-1187	98	26	)	)	PUNCT
hls-1187	98	27	0.02	0.02	NUM
hls-1187	98	28	female	female	NOUN
hls-1187	98	29	24	24	NUM
hls-1187	98	30	15	15	NUM
hls-1187	98	31	1.0	1.0	NUM
hls-1187	98	32	(	(	PUNCT
hls-1187	98	33	reference	reference	NOUN
hls-1187	98	34	)	)	PUNCT
hls-1187	98	35	no	no	DET
hls-1187	98	36	diabetes	diabetes	NOUN
hls-1187	98	37	male	male	NOUN
hls-1187	98	38	361	361	NUM
hls-1187	98	39	143	143	NUM
hls-1187	98	40	2.46	2.46	NUM
hls-1187	98	41	(	(	PUNCT
hls-1187	98	42	1.08	1.08	NUM
hls-1187	98	43	-	-	NUM
hls-1187	98	44	5.61	5.61	NUM
hls-1187	98	45	)	)	PUNCT
hls-1187	98	46	0.03	0.03	NUM
hls-1187	98	47	female	female	NOUN
hls-1187	98	48	42	42	NUM
hls-1187	98	49	7	7	NUM
hls-1187	98	50	1.0	1.0	NUM
hls-1187	98	51	(	(	PUNCT
hls-1187	98	52	reference	reference	NOUN
hls-1187	98	53	)	)	PUNCT
hls-1187	98	54	macce	macce	NOUN
hls-1187	98	55	,	,	PUNCT
hls-1187	98	56	major	major	ADJ
hls-1187	98	57	adverse	adverse	ADJ
hls-1187	98	58	cardiac	cardiac	ADJ
hls-1187	98	59	and	and	CCONJ
hls-1187	98	60	cerebrovascular	cerebrovascular	ADJ
hls-1187	98	61	events	event	NOUN
hls-1187	98	62	;	;	PUNCT
hls-1187	98	63	ci	ci	NOUN
hls-1187	98	64	,	,	PUNCT
hls-1187	98	65	confidence	confidence	NOUN
hls-1187	98	66	interval	interval	NOUN
hls-1187	98	67	.	.	PUNCT
hls-1187	99	1	figure	figure	NOUN
hls-1187	99	2	1	1	NUM
hls-1187	99	3	.	.	PUNCT
hls-1187	99	4	survivor	survivor	NOUN
hls-1187	99	5	functions	function	NOUN
hls-1187	99	6	by	by	ADP
hls-1187	99	7	sex	sex	NOUN
hls-1187	99	8	,	,	PUNCT
hls-1187	99	9	adjusted	adjust	VERB
hls-1187	99	10	for	for	ADP
hls-1187	99	11	acute	acute	ADJ
hls-1187	99	12	myocardial	myocardial	ADJ
hls-1187	99	13	infarction	infarction	NOUN
hls-1187	99	14	and	and	CCONJ
hls-1187	99	15	arrhythmia	arrhythmia	NOUN
hls-1187	99	16	.	.	PUNCT
hls-1187	100	1	non	non	PROPN
hls-1187	100	2	co	co	PROPN
hls-1187	100	3	mmerc	mmerc	PROPN
hls-1187	100	4	ial	ial	PROPN
hls-1187	100	5	us	us	PROPN
hls-1187	101	1	e	e	NOUN
hls-1187	101	2	o	o	X
hls-1187	101	3	nly	nly	ADV
hls-1187	101	4	[	[	X
hls-1187	101	5	page	page	NOUN
hls-1187	101	6	60	60	NUM
hls-1187	101	7	]	]	PUNCT
hls-1187	102	1	[	[	X
hls-1187	102	2	healthcare	healthcare	NOUN
hls-1187	102	3	in	in	ADP
hls-1187	102	4	low	low	ADJ
hls-1187	102	5	-	-	PUNCT
hls-1187	102	6	resource	resource	NOUN
hls-1187	102	7	settings	setting	NOUN
hls-1187	102	8	2013	2013	NUM
hls-1187	102	9	;	;	PUNCT
hls-1187	102	10	1	1	NUM
hls-1187	102	11	:	:	PUNCT
hls-1187	102	12	e17	e17	NOUN
hls-1187	102	13	]	]	PUNCT
hls-1187	102	14	similar	similar	ADJ
hls-1187	102	15	between	between	ADP
hls-1187	102	16	sexes	sex	NOUN
hls-1187	102	17	,	,	PUNCT
hls-1187	102	18	despite	despite	SCONJ
hls-1187	102	19	the	the	DET
hls-1187	102	20	differences	difference	NOUN
hls-1187	102	21	in	in	ADP
hls-1187	102	22	baseline	baseline	ADJ
hls-1187	102	23	profiles	profile	NOUN
hls-1187	102	24	.	.	PUNCT
hls-1187	103	1	these	these	DET
hls-1187	103	2	results	result	NOUN
hls-1187	103	3	agree	agree	VERB
hls-1187	103	4	with	with	ADP
hls-1187	103	5	past	past	ADJ
hls-1187	103	6	studies	study	NOUN
hls-1187	103	7	that	that	PRON
hls-1187	103	8	also	also	ADV
hls-1187	103	9	had	have	VERB
hls-1187	103	10	a	a	DET
hls-1187	103	11	retrospective	retrospective	ADJ
hls-1187	103	12	design	design	NOUN
hls-1187	103	13	,	,	PUNCT
hls-1187	103	14	followed	follow	VERB
hls-1187	103	15	patients	patient	NOUN
hls-1187	103	16	3	3	NUM
hls-1187	103	17	years	year	NOUN
hls-1187	103	18	or	or	CCONJ
hls-1187	103	19	longer	long	ADV
hls-1187	103	20	,	,	PUNCT
hls-1187	103	21	and	and	CCONJ
hls-1187	103	22	similarly	similarly	ADV
hls-1187	103	23	enrolled	enrol	VERB
hls-1187	103	24	patients	patient	NOUN
hls-1187	103	25	with	with	ADP
hls-1187	103	26	stable	stable	ADJ
hls-1187	103	27	and	and	CCONJ
hls-1187	103	28	unstable	unstable	ADJ
hls-1187	103	29	angina	angina	NOUN
hls-1187	103	30	and	and	CCONJ
hls-1187	103	31	acute	acute	PROPN
hls-1187	103	32	mi.7,9,18	mi.7,9,18	PROPN
hls-1187	103	33	however	however	ADV
hls-1187	103	34	,	,	PUNCT
hls-1187	103	35	these	these	DET
hls-1187	103	36	studies	study	NOUN
hls-1187	103	37	demonstrated	demonstrate	VERB
hls-1187	103	38	that	that	SCONJ
hls-1187	103	39	after	after	SCONJ
hls-1187	103	40	the	the	DET
hls-1187	103	41	adjustment	adjustment	NOUN
hls-1187	103	42	for	for	ADP
hls-1187	103	43	baseline	baseline	PROPN
hls-1187	103	44	differences	difference	NOUN
hls-1187	103	45	the	the	DET
hls-1187	103	46	rates	rate	NOUN
hls-1187	103	47	of	of	ADP
hls-1187	103	48	major	major	ADJ
hls-1187	103	49	adverse	adverse	ADJ
hls-1187	103	50	cardiac	cardiac	ADJ
hls-1187	103	51	events	event	NOUN
hls-1187	103	52	(	(	PUNCT
hls-1187	103	53	mace	mace	NOUN
hls-1187	103	54	)	)	PUNCT
hls-1187	103	55	were	be	AUX
hls-1187	103	56	no	no	ADV
hls-1187	103	57	longer	long	ADV
hls-1187	103	58	different	different	ADJ
hls-1187	103	59	between	between	ADP
hls-1187	103	60	the	the	DET
hls-1187	103	61	sexes	sex	NOUN
hls-1187	103	62	.	.	PUNCT
hls-1187	104	1	overall	overall	ADJ
hls-1187	104	2	,	,	PUNCT
hls-1187	104	3	compared	compare	VERB
hls-1187	104	4	to	to	ADP
hls-1187	104	5	studies	study	NOUN
hls-1187	104	6	in	in	ADP
hls-1187	104	7	the	the	DET
hls-1187	104	8	early	early	ADJ
hls-1187	104	9	1990s	1990	NOUN
hls-1187	104	10	,	,	PUNCT
hls-1187	104	11	recent	recent	ADJ
hls-1187	104	12	studies	study	NOUN
hls-1187	104	13	have	have	AUX
hls-1187	104	14	mostly	mostly	ADV
hls-1187	104	15	shown	show	VERB
hls-1187	104	16	that	that	SCONJ
hls-1187	104	17	with	with	ADP
hls-1187	104	18	improved	improved	ADJ
hls-1187	104	19	care	care	NOUN
hls-1187	104	20	and	and	CCONJ
hls-1187	104	21	technologies	technology	NOUN
hls-1187	104	22	,	,	PUNCT
hls-1187	104	23	the	the	DET
hls-1187	104	24	gap	gap	NOUN
hls-1187	104	25	between	between	ADP
hls-1187	104	26	men	man	NOUN
hls-1187	104	27	and	and	CCONJ
hls-1187	104	28	women	woman	NOUN
hls-1187	104	29	in	in	ADP
hls-1187	104	30	complication	complication	NOUN
hls-1187	104	31	rates	rate	NOUN
hls-1187	104	32	and	and	CCONJ
hls-1187	104	33	rates	rate	NOUN
hls-1187	104	34	of	of	ADP
hls-1187	104	35	mace	mace	NOUN
hls-1187	104	36	at	at	ADP
hls-1187	104	37	long	long	ADJ
hls-1187	104	38	-	-	PUNCT
hls-1187	104	39	term	term	NOUN
hls-1187	104	40	follow	follow	NOUN
hls-1187	104	41	-	-	PUNCT
hls-1187	104	42	up	up	NOUN
hls-1187	104	43	is	be	AUX
hls-1187	104	44	disappearing.19	disappearing.19	NOUN
hls-1187	104	45	the	the	DET
hls-1187	104	46	evidence	evidence	NOUN
hls-1187	104	47	of	of	ADP
hls-1187	104	48	the	the	DET
hls-1187	104	49	impact	impact	NOUN
hls-1187	104	50	of	of	ADP
hls-1187	104	51	diabetes	diabetes	NOUN
hls-1187	104	52	status	status	NOUN
hls-1187	104	53	on	on	ADP
hls-1187	104	54	sex	sex	NOUN
hls-1187	104	55	differences	difference	NOUN
hls-1187	104	56	in	in	ADP
hls-1187	104	57	pci	pci	ADJ
hls-1187	104	58	outcomes	outcome	NOUN
hls-1187	104	59	is	be	AUX
hls-1187	104	60	still	still	ADV
hls-1187	104	61	contradictory	contradictory	ADJ
hls-1187	104	62	.	.	PUNCT
hls-1187	105	1	in	in	ADP
hls-1187	105	2	our	our	PRON
hls-1187	105	3	sample	sample	NOUN
hls-1187	105	4	of	of	ADP
hls-1187	105	5	patients	patient	NOUN
hls-1187	105	6	,	,	PUNCT
hls-1187	105	7	the	the	DET
hls-1187	105	8	prevalence	prevalence	NOUN
hls-1187	105	9	of	of	ADP
hls-1187	105	10	diabetes	diabetes	NOUN
hls-1187	105	11	was	be	AUX
hls-1187	105	12	almost	almost	ADV
hls-1187	105	13	2.5	2.5	NUM
hls-1187	105	14	times	time	NOUN
hls-1187	105	15	higher	high	ADJ
hls-1187	105	16	among	among	ADP
hls-1187	105	17	women	woman	NOUN
hls-1187	105	18	than	than	ADP
hls-1187	105	19	men	man	NOUN
hls-1187	105	20	(	(	PUNCT
hls-1187	105	21	36	36	NUM
hls-1187	105	22	and	and	CCONJ
hls-1187	105	23	14	14	NUM
hls-1187	105	24	%	%	NOUN
hls-1187	105	25	,	,	PUNCT
hls-1187	105	26	respectively	respectively	ADV
hls-1187	105	27	)	)	PUNCT
hls-1187	105	28	.	.	PUNCT
hls-1187	106	1	after	after	ADP
hls-1187	106	2	adjusting	adjust	VERB
hls-1187	106	3	for	for	ADP
hls-1187	106	4	acute	acute	PROPN
hls-1187	106	5	mi	mi	PROPN
hls-1187	106	6	and	and	CCONJ
hls-1187	106	7	arrhythmia	arrhythmia	NOUN
hls-1187	106	8	,	,	PUNCT
hls-1187	106	9	we	we	PRON
hls-1187	106	10	found	find	VERB
hls-1187	106	11	that	that	SCONJ
hls-1187	106	12	women	woman	NOUN
hls-1187	106	13	with	with	ADP
hls-1187	106	14	diabetes	diabetes	NOUN
hls-1187	106	15	had	have	VERB
hls-1187	106	16	a	a	DET
hls-1187	106	17	higher	high	ADJ
hls-1187	106	18	risk	risk	NOUN
hls-1187	106	19	of	of	ADP
hls-1187	106	20	macce	macce	NOUN
hls-1187	106	21	than	than	ADP
hls-1187	106	22	men	man	NOUN
hls-1187	106	23	.	.	PUNCT
hls-1187	107	1	in	in	ADP
hls-1187	107	2	contrast	contrast	NOUN
hls-1187	107	3	,	,	PUNCT
hls-1187	107	4	a	a	DET
hls-1187	107	5	recent	recent	ADJ
hls-1187	107	6	study	study	NOUN
hls-1187	107	7	that	that	PRON
hls-1187	107	8	enrolled	enrol	VERB
hls-1187	107	9	only	only	ADJ
hls-1187	107	10	patients	patient	NOUN
hls-1187	107	11	with	with	ADP
hls-1187	107	12	diabetes	diabetes	NOUN
hls-1187	107	13	in	in	ADP
hls-1187	107	14	japan	japan	PROPN
hls-1187	107	15	found	find	VERB
hls-1187	107	16	that	that	SCONJ
hls-1187	107	17	at	at	ADP
hls-1187	107	18	4year	4year	NUM
hls-1187	107	19	follow	follow	NOUN
hls-1187	107	20	-	-	PUNCT
hls-1187	107	21	up	up	NOUN
hls-1187	107	22	after	after	ADP
hls-1187	107	23	pci	pci	ADJ
hls-1187	107	24	,	,	PUNCT
hls-1187	107	25	the	the	DET
hls-1187	107	26	cumulative	cumulative	ADJ
hls-1187	107	27	incidence	incidence	NOUN
hls-1187	107	28	of	of	ADP
hls-1187	107	29	mace	mace	NOUN
hls-1187	107	30	was	be	AUX
hls-1187	107	31	similar	similar	ADJ
hls-1187	107	32	between	between	ADP
hls-1187	107	33	the	the	DET
hls-1187	107	34	sexes	sex	NOUN
hls-1187	107	35	,	,	PUNCT
hls-1187	107	36	despite	despite	SCONJ
hls-1187	107	37	the	the	DET
hls-1187	107	38	fact	fact	NOUN
hls-1187	107	39	that	that	SCONJ
hls-1187	107	40	women	woman	NOUN
hls-1187	107	41	had	have	AUX
hls-1187	107	42	a	a	DET
hls-1187	107	43	worse	bad	ADJ
hls-1187	107	44	baseline	baseline	NOUN
hls-1187	107	45	profile.20	profile.20	NOUN
hls-1187	107	46	similar	similar	ADJ
hls-1187	107	47	to	to	ADP
hls-1187	107	48	our	our	PRON
hls-1187	107	49	study	study	NOUN
hls-1187	107	50	,	,	PUNCT
hls-1187	107	51	a	a	DET
hls-1187	107	52	significant	significant	ADJ
hls-1187	107	53	interaction	interaction	NOUN
hls-1187	107	54	was	be	AUX
hls-1187	107	55	observed	observe	VERB
hls-1187	107	56	by	by	ADP
hls-1187	107	57	mehilli	mehilli	PROPN
hls-1187	107	58	et	et	PROPN
hls-1187	107	59	al	al	PROPN
hls-1187	107	60	.	.	PROPN
hls-1187	107	61	,	,	PUNCT
hls-1187	107	62	who	who	PRON
hls-1187	107	63	evaluated	evaluate	VERB
hls-1187	107	64	the	the	DET
hls-1187	107	65	impact	impact	NOUN
hls-1187	107	66	of	of	ADP
hls-1187	107	67	sex	sex	NOUN
hls-1187	107	68	on	on	ADP
hls-1187	107	69	mortality	mortality	NOUN
hls-1187	107	70	after	after	ADP
hls-1187	107	71	pci	pci	ADJ
hls-1187	107	72	in	in	ADP
hls-1187	107	73	a	a	DET
hls-1187	107	74	cohort	cohort	NOUN
hls-1187	107	75	of	of	ADP
hls-1187	107	76	patients	patient	NOUN
hls-1187	107	77	with	with	ADP
hls-1187	107	78	stable	stable	ADJ
hls-1187	107	79	and	and	CCONJ
hls-1187	107	80	unstable	unstable	ADJ
hls-1187	107	81	angina.12	angina.12	NOUN
hls-1187	107	82	they	they	PRON
hls-1187	107	83	reported	report	VERB
hls-1187	107	84	that	that	SCONJ
hls-1187	107	85	diabetic	diabetic	ADJ
hls-1187	107	86	women	woman	NOUN
hls-1187	107	87	had	have	VERB
hls-1187	107	88	almost	almost	ADV
hls-1187	107	89	twice	twice	DET
hls-1187	107	90	the	the	DET
hls-1187	107	91	mortality	mortality	NOUN
hls-1187	107	92	hazard	hazard	NOUN
hls-1187	107	93	in	in	ADP
hls-1187	107	94	comparison	comparison	NOUN
hls-1187	107	95	to	to	ADP
hls-1187	107	96	diabetic	diabetic	ADJ
hls-1187	107	97	men	man	NOUN
hls-1187	107	98	,	,	PUNCT
hls-1187	107	99	whereas	whereas	SCONJ
hls-1187	107	100	no	no	DET
hls-1187	107	101	significant	significant	ADJ
hls-1187	107	102	difference	difference	NOUN
hls-1187	107	103	was	be	AUX
hls-1187	107	104	observed	observe	VERB
hls-1187	107	105	in	in	ADP
hls-1187	107	106	mortality	mortality	NOUN
hls-1187	107	107	among	among	ADP
hls-1187	107	108	the	the	DET
hls-1187	107	109	non	non	ADJ
hls-1187	107	110	-	-	ADJ
hls-1187	107	111	diabetic	diabetic	ADJ
hls-1187	107	112	population	population	NOUN
hls-1187	107	113	.	.	PUNCT
hls-1187	108	1	further	further	ADJ
hls-1187	108	2	analysis	analysis	NOUN
hls-1187	108	3	of	of	ADP
hls-1187	108	4	our	our	PRON
hls-1187	108	5	data	datum	NOUN
hls-1187	108	6	revealed	reveal	VERB
hls-1187	108	7	that	that	SCONJ
hls-1187	108	8	among	among	ADP
hls-1187	108	9	men	man	NOUN
hls-1187	108	10	,	,	PUNCT
hls-1187	108	11	diabetes	diabetes	NOUN
hls-1187	108	12	status	status	NOUN
hls-1187	108	13	did	do	AUX
hls-1187	108	14	not	not	PART
hls-1187	108	15	significantly	significantly	ADV
hls-1187	108	16	affect	affect	VERB
hls-1187	108	17	the	the	DET
hls-1187	108	18	risk	risk	NOUN
hls-1187	108	19	of	of	ADP
hls-1187	108	20	developing	develop	VERB
hls-1187	108	21	macce	macce	NOUN
hls-1187	108	22	.	.	PUNCT
hls-1187	109	1	among	among	ADP
hls-1187	109	2	women	woman	NOUN
hls-1187	109	3	,	,	PUNCT
hls-1187	109	4	diabetes	diabetes	NOUN
hls-1187	109	5	was	be	AUX
hls-1187	109	6	a	a	DET
hls-1187	109	7	significant	significant	ADJ
hls-1187	109	8	predictor	predictor	NOUN
hls-1187	109	9	of	of	ADP
hls-1187	109	10	macce	macce	NOUN
hls-1187	109	11	after	after	ADP
hls-1187	109	12	adjusting	adjust	VERB
hls-1187	109	13	for	for	ADP
hls-1187	109	14	acute	acute	PROPN
hls-1187	109	15	mi	mi	PROPN
hls-1187	109	16	and	and	CCONJ
hls-1187	109	17	arrhythmia	arrhythmia	NOUN
hls-1187	109	18	(	(	PUNCT
hls-1187	109	19	data	datum	NOUN
hls-1187	109	20	not	not	PART
hls-1187	109	21	shown	show	VERB
hls-1187	109	22	)	)	PUNCT
hls-1187	109	23	.	.	PUNCT
hls-1187	110	1	our	our	PRON
hls-1187	110	2	finding	finding	NOUN
hls-1187	110	3	is	be	AUX
hls-1187	110	4	supported	support	VERB
hls-1187	110	5	by	by	ADP
hls-1187	110	6	a	a	DET
hls-1187	110	7	recent	recent	ADJ
hls-1187	110	8	meta	meta	ADJ
hls-1187	110	9	-	-	PUNCT
hls-1187	110	10	analysis	analysis	NOUN
hls-1187	110	11	of	of	ADP
hls-1187	110	12	37	37	NUM
hls-1187	110	13	studies	study	NOUN
hls-1187	110	14	that	that	PRON
hls-1187	110	15	evaluated	evaluate	VERB
hls-1187	110	16	the	the	DET
hls-1187	110	17	risk	risk	NOUN
hls-1187	110	18	of	of	ADP
hls-1187	110	19	fatal	fatal	ADJ
hls-1187	110	20	coronary	coronary	ADJ
hls-1187	110	21	events	event	NOUN
hls-1187	110	22	among	among	ADP
hls-1187	110	23	a	a	DET
hls-1187	110	24	diabetic	diabetic	ADJ
hls-1187	110	25	population.21	population.21	NOUN
hls-1187	110	26	it	it	PRON
hls-1187	110	27	demonstrated	demonstrate	VERB
hls-1187	110	28	that	that	SCONJ
hls-1187	110	29	the	the	DET
hls-1187	110	30	rate	rate	NOUN
hls-1187	110	31	of	of	ADP
hls-1187	110	32	adverse	adverse	ADJ
hls-1187	110	33	outcomes	outcome	NOUN
hls-1187	110	34	was	be	AUX
hls-1187	110	35	higher	high	ADJ
hls-1187	110	36	among	among	ADP
hls-1187	110	37	diabetic	diabetic	NOUN
hls-1187	110	38	than	than	ADP
hls-1187	110	39	nondiabetic	nondiabetic	ADJ
hls-1187	110	40	patients	patient	NOUN
hls-1187	110	41	,	,	PUNCT
hls-1187	110	42	but	but	CCONJ
hls-1187	110	43	the	the	DET
hls-1187	110	44	difference	difference	NOUN
hls-1187	110	45	was	be	AUX
hls-1187	110	46	more	more	ADV
hls-1187	110	47	pronounced	pronounced	ADJ
hls-1187	110	48	among	among	ADP
hls-1187	110	49	women	woman	NOUN
hls-1187	110	50	than	than	ADP
hls-1187	110	51	men	man	NOUN
hls-1187	110	52	.	.	PUNCT
hls-1187	111	1	the	the	DET
hls-1187	111	2	study	study	NOUN
hls-1187	111	3	concluded	conclude	VERB
hls-1187	111	4	that	that	SCONJ
hls-1187	111	5	the	the	DET
hls-1187	111	6	relative	relative	ADJ
hls-1187	111	7	risk	risk	NOUN
hls-1187	111	8	for	for	ADP
hls-1187	111	9	fatal	fatal	ADJ
hls-1187	111	10	cad	cad	NOUN
hls-1187	111	11	associated	associate	VERB
hls-1187	111	12	with	with	ADP
hls-1187	111	13	diabetes	diabetes	NOUN
hls-1187	111	14	is	be	AUX
hls-1187	111	15	overall	overall	ADJ
hls-1187	111	16	50	50	NUM
hls-1187	111	17	%	%	NOUN
hls-1187	111	18	higher	high	ADJ
hls-1187	111	19	in	in	ADP
hls-1187	111	20	women	woman	NOUN
hls-1187	111	21	than	than	ADP
hls-1187	111	22	in	in	ADP
hls-1187	111	23	men	man	NOUN
hls-1187	111	24	,	,	PUNCT
hls-1187	111	25	most	most	ADV
hls-1187	111	26	likely	likely	ADJ
hls-1187	111	27	due	due	ADP
hls-1187	111	28	to	to	ADP
hls-1187	111	29	differences	difference	NOUN
hls-1187	111	30	in	in	ADP
hls-1187	111	31	baseline	baseline	ADJ
hls-1187	111	32	risk	risk	NOUN
hls-1187	111	33	profiles	profile	NOUN
hls-1187	111	34	and	and	CCONJ
hls-1187	111	35	disparities	disparity	NOUN
hls-1187	111	36	in	in	ADP
hls-1187	111	37	treatment	treatment	NOUN
hls-1187	111	38	approaches	approach	NOUN
hls-1187	111	39	.	.	PUNCT
hls-1187	112	1	in	in	ADP
hls-1187	112	2	our	our	PRON
hls-1187	112	3	study	study	NOUN
hls-1187	112	4	,	,	PUNCT
hls-1187	112	5	we	we	PRON
hls-1187	112	6	did	do	AUX
hls-1187	112	7	not	not	PART
hls-1187	112	8	evaluate	evaluate	VERB
hls-1187	112	9	the	the	DET
hls-1187	112	10	severity	severity	NOUN
hls-1187	112	11	of	of	ADP
hls-1187	112	12	diabetes	diabetes	NOUN
hls-1187	112	13	(	(	PUNCT
hls-1187	112	14	insulin	insulin	NOUN
hls-1187	112	15	dependent	dependent	ADJ
hls-1187	112	16	or	or	CCONJ
hls-1187	112	17	not	not	PART
hls-1187	112	18	;	;	PUNCT
hls-1187	112	19	effectively	effectively	ADV
hls-1187	112	20	managed	manage	VERB
hls-1187	112	21	or	or	CCONJ
hls-1187	112	22	not	not	PART
hls-1187	112	23	)	)	PUNCT
hls-1187	112	24	that	that	PRON
hls-1187	112	25	might	might	AUX
hls-1187	112	26	explain	explain	VERB
hls-1187	112	27	the	the	DET
hls-1187	112	28	observed	observed	ADJ
hls-1187	112	29	variability	variability	NOUN
hls-1187	112	30	in	in	ADP
hls-1187	112	31	the	the	DET
hls-1187	112	32	impact	impact	NOUN
hls-1187	112	33	of	of	ADP
hls-1187	112	34	diabetes	diabetes	NOUN
hls-1187	112	35	on	on	ADP
hls-1187	112	36	the	the	DET
hls-1187	112	37	outcomes	outcome	NOUN
hls-1187	112	38	by	by	ADP
hls-1187	112	39	sex	sex	NOUN
hls-1187	112	40	.	.	PUNCT
hls-1187	113	1	a	a	DET
hls-1187	113	2	study	study	NOUN
hls-1187	113	3	that	that	PRON
hls-1187	113	4	evaluated	evaluate	VERB
hls-1187	113	5	the	the	DET
hls-1187	113	6	effectiveness	effectiveness	NOUN
hls-1187	113	7	of	of	ADP
hls-1187	113	8	drug	drug	NOUN
hls-1187	113	9	-	-	PUNCT
hls-1187	113	10	eluting	elute	VERB
hls-1187	113	11	stents	stent	NOUN
hls-1187	113	12	in	in	ADP
hls-1187	113	13	acute	acute	ADJ
hls-1187	113	14	coronary	coronary	ADJ
hls-1187	113	15	syndrome	syndrome	NOUN
hls-1187	113	16	patients	patient	NOUN
hls-1187	113	17	with	with	ADP
hls-1187	113	18	diabetes	diabetes	NOUN
hls-1187	113	19	reported	report	VERB
hls-1187	113	20	a	a	DET
hls-1187	113	21	higher	high	ADJ
hls-1187	113	22	prevalence	prevalence	NOUN
hls-1187	113	23	of	of	ADP
hls-1187	113	24	insulindependent	insulindependent	NOUN
hls-1187	113	25	diabetes	diabetes	NOUN
hls-1187	113	26	among	among	ADP
hls-1187	113	27	women	woman	NOUN
hls-1187	113	28	compared	compare	VERB
hls-1187	113	29	to	to	PART
hls-1187	113	30	men.22	men.22	VERB
hls-1187	113	31	the	the	DET
hls-1187	113	32	sex	sex	NOUN
hls-1187	113	33	differences	difference	NOUN
hls-1187	113	34	in	in	ADP
hls-1187	113	35	our	our	PRON
hls-1187	113	36	study	study	NOUN
hls-1187	113	37	may	may	AUX
hls-1187	113	38	also	also	ADV
hls-1187	113	39	be	be	AUX
hls-1187	113	40	explained	explain	VERB
hls-1187	113	41	by	by	ADP
hls-1187	113	42	unequal	unequal	ADJ
hls-1187	113	43	access	access	NOUN
hls-1187	113	44	to	to	ADP
hls-1187	113	45	or	or	CCONJ
hls-1187	113	46	utilization	utilization	NOUN
hls-1187	113	47	of	of	ADP
hls-1187	113	48	health	health	NOUN
hls-1187	113	49	care	care	NOUN
hls-1187	113	50	services	service	NOUN
hls-1187	113	51	in	in	ADP
hls-1187	113	52	armenia	armenia	PROPN
hls-1187	113	53	.	.	PUNCT
hls-1187	114	1	the	the	DET
hls-1187	114	2	2005	2005	NUM
hls-1187	114	3	armenian	armenian	ADJ
hls-1187	114	4	demographic	demographic	ADJ
hls-1187	114	5	and	and	CCONJ
hls-1187	114	6	health	health	NOUN
hls-1187	114	7	survey	survey	NOUN
hls-1187	114	8	found	find	VERB
hls-1187	114	9	that	that	SCONJ
hls-1187	114	10	although	although	SCONJ
hls-1187	114	11	a	a	DET
hls-1187	114	12	higher	high	ADJ
hls-1187	114	13	proportion	proportion	NOUN
hls-1187	114	14	of	of	ADP
hls-1187	114	15	women	woman	NOUN
hls-1187	114	16	reported	report	VERB
hls-1187	114	17	having	have	VERB
hls-1187	114	18	health	health	NOUN
hls-1187	114	19	problems	problem	NOUN
hls-1187	114	20	than	than	ADP
hls-1187	114	21	men	man	NOUN
hls-1187	114	22	(	(	PUNCT
hls-1187	114	23	13.8	13.8	NUM
hls-1187	114	24	vs	vs	ADP
hls-1187	114	25	11.2	11.2	NUM
hls-1187	114	26	%	%	NOUN
hls-1187	114	27	)	)	PUNCT
hls-1187	114	28	,	,	PUNCT
hls-1187	114	29	men	man	NOUN
hls-1187	114	30	had	have	VERB
hls-1187	114	31	overall	overall	ADJ
hls-1187	114	32	higher	high	ADJ
hls-1187	114	33	hospitalization	hospitalization	NOUN
hls-1187	114	34	rates	rate	NOUN
hls-1187	114	35	than	than	ADP
hls-1187	114	36	women	woman	NOUN
hls-1187	114	37	(	(	PUNCT
hls-1187	114	38	2.6	2.6	NUM
hls-1187	114	39	vs	vs	ADP
hls-1187	114	40	2.3%).13	2.3%).13	NUM
hls-1187	114	41	the	the	DET
hls-1187	114	42	limitations	limitation	NOUN
hls-1187	114	43	of	of	ADP
hls-1187	114	44	the	the	DET
hls-1187	114	45	study	study	NOUN
hls-1187	114	46	merit	merit	NOUN
hls-1187	114	47	discussion	discussion	NOUN
hls-1187	114	48	.	.	PUNCT
hls-1187	115	1	in	in	ADP
hls-1187	115	2	the	the	DET
hls-1187	115	3	studied	studied	ADJ
hls-1187	115	4	sample	sample	NOUN
hls-1187	115	5	,	,	PUNCT
hls-1187	115	6	the	the	DET
hls-1187	115	7	male	male	ADJ
hls-1187	115	8	female	female	ADJ
hls-1187	115	9	ratio	ratio	NOUN
hls-1187	115	10	was	be	AUX
hls-1187	115	11	almost	almost	ADV
hls-1187	115	12	six	six	NUM
hls-1187	115	13	to	to	PART
hls-1187	115	14	one	one	NUM
hls-1187	115	15	(	(	PUNCT
hls-1187	115	16	419	419	NUM
hls-1187	115	17	to	to	ADP
hls-1187	115	18	66	66	NUM
hls-1187	115	19	)	)	PUNCT
hls-1187	115	20	,	,	PUNCT
hls-1187	115	21	thus	thus	ADV
hls-1187	115	22	limiting	limit	VERB
hls-1187	115	23	the	the	DET
hls-1187	115	24	number	number	NOUN
hls-1187	115	25	of	of	ADP
hls-1187	115	26	independent	independent	ADJ
hls-1187	115	27	predictors	predictor	NOUN
hls-1187	115	28	that	that	PRON
hls-1187	115	29	could	could	AUX
hls-1187	115	30	have	have	AUX
hls-1187	115	31	been	be	AUX
hls-1187	115	32	studied	study	VERB
hls-1187	115	33	and	and	CCONJ
hls-1187	115	34	potentially	potentially	ADV
hls-1187	115	35	their	their	PRON
hls-1187	115	36	precision	precision	NOUN
hls-1187	115	37	.	.	PUNCT
hls-1187	116	1	another	another	DET
hls-1187	116	2	important	important	ADJ
hls-1187	116	3	limitation	limitation	NOUN
hls-1187	116	4	of	of	ADP
hls-1187	116	5	our	our	PRON
hls-1187	116	6	study	study	NOUN
hls-1187	116	7	was	be	AUX
hls-1187	116	8	that	that	SCONJ
hls-1187	116	9	the	the	DET
hls-1187	116	10	follow	follow	VERB
hls-1187	116	11	-	-	PUNCT
hls-1187	116	12	up	up	ADP
hls-1187	116	13	data	datum	NOUN
hls-1187	116	14	about	about	ADP
hls-1187	116	15	macce	macce	NOUN
hls-1187	116	16	were	be	AUX
hls-1187	116	17	collected	collect	VERB
hls-1187	116	18	retrospectively	retrospectively	ADV
hls-1187	116	19	through	through	ADP
hls-1187	116	20	telephone	telephone	NOUN
hls-1187	116	21	interviews	interview	NOUN
hls-1187	116	22	,	,	PUNCT
hls-1187	116	23	which	which	PRON
hls-1187	116	24	could	could	AUX
hls-1187	116	25	introduce	introduce	VERB
hls-1187	116	26	recall	recall	NOUN
hls-1187	116	27	and	and	CCONJ
hls-1187	116	28	report	report	NOUN
hls-1187	116	29	biases	bias	NOUN
hls-1187	116	30	.	.	PUNCT
hls-1187	117	1	to	to	PART
hls-1187	117	2	minimize	minimize	VERB
hls-1187	117	3	that	that	DET
hls-1187	117	4	bias	bias	NOUN
hls-1187	117	5	,	,	PUNCT
hls-1187	117	6	we	we	PRON
hls-1187	117	7	verified	verify	VERB
hls-1187	117	8	self	self	NOUN
hls-1187	117	9	-	-	PUNCT
hls-1187	117	10	reported	report	VERB
hls-1187	117	11	outcomes	outcome	NOUN
hls-1187	117	12	with	with	ADP
hls-1187	117	13	the	the	DET
hls-1187	117	14	nmmc	nmmc	PROPN
hls-1187	117	15	medical	medical	ADJ
hls-1187	117	16	records	record	NOUN
hls-1187	117	17	where	where	SCONJ
hls-1187	117	18	possible	possible	ADJ
hls-1187	117	19	.	.	PUNCT
hls-1187	118	1	another	another	DET
hls-1187	118	2	source	source	NOUN
hls-1187	118	3	of	of	ADP
hls-1187	118	4	potential	potential	ADJ
hls-1187	118	5	bias	bias	NOUN
hls-1187	118	6	came	come	VERB
hls-1187	118	7	from	from	ADP
hls-1187	118	8	inaccuracies	inaccuracy	NOUN
hls-1187	118	9	in	in	ADP
hls-1187	118	10	medical	medical	ADJ
hls-1187	118	11	records	record	NOUN
hls-1187	118	12	where	where	SCONJ
hls-1187	118	13	,	,	PUNCT
hls-1187	118	14	for	for	ADP
hls-1187	118	15	example	example	NOUN
hls-1187	118	16	,	,	PUNCT
hls-1187	118	17	heart	heart	NOUN
hls-1187	118	18	failure	failure	NOUN
hls-1187	118	19	status	status	NOUN
hls-1187	118	20	and	and	CCONJ
hls-1187	118	21	blood	blood	NOUN
hls-1187	118	22	lipid	lipid	NOUN
hls-1187	118	23	levels	level	NOUN
hls-1187	118	24	were	be	AUX
hls-1187	118	25	not	not	PART
hls-1187	118	26	consistently	consistently	ADV
hls-1187	118	27	reported	report	VERB
hls-1187	118	28	and	and	CCONJ
hls-1187	118	29	were	be	AUX
hls-1187	118	30	excluded	exclude	VERB
hls-1187	118	31	from	from	ADP
hls-1187	118	32	the	the	DET
hls-1187	118	33	analyses	analysis	NOUN
hls-1187	118	34	.	.	PUNCT
hls-1187	119	1	about	about	ADV
hls-1187	119	2	one	one	NUM
hls-1187	119	3	-	-	PUNCT
hls-1187	119	4	third	third	NOUN
hls-1187	119	5	of	of	ADP
hls-1187	119	6	the	the	DET
hls-1187	119	7	patients	patient	NOUN
hls-1187	119	8	from	from	ADP
hls-1187	119	9	the	the	DET
hls-1187	119	10	original	original	ADJ
hls-1187	119	11	sample	sample	NOUN
hls-1187	119	12	were	be	AUX
hls-1187	119	13	unreachable	unreachable	ADJ
hls-1187	119	14	,	,	PUNCT
hls-1187	119	15	either	either	CCONJ
hls-1187	119	16	because	because	SCONJ
hls-1187	119	17	of	of	ADP
hls-1187	119	18	inaccurate	inaccurate	ADJ
hls-1187	119	19	contact	contact	NOUN
hls-1187	119	20	information	information	NOUN
hls-1187	119	21	or	or	CCONJ
hls-1187	119	22	absence	absence	NOUN
hls-1187	119	23	from	from	ADP
hls-1187	119	24	the	the	DET
hls-1187	119	25	country	country	NOUN
hls-1187	119	26	.	.	PUNCT
hls-1187	120	1	the	the	DET
hls-1187	120	2	comparison	comparison	NOUN
hls-1187	120	3	of	of	ADP
hls-1187	120	4	these	these	DET
hls-1187	120	5	non	non	NOUN
hls-1187	120	6	-	-	NOUN
hls-1187	120	7	responders	responder	NOUN
hls-1187	120	8	with	with	ADP
hls-1187	120	9	the	the	DET
hls-1187	120	10	final	final	ADJ
hls-1187	120	11	study	study	NOUN
hls-1187	120	12	population	population	NOUN
hls-1187	120	13	using	use	VERB
hls-1187	120	14	nmmc	nmmc	PROPN
hls-1187	120	15	patient	patient	PROPN
hls-1187	120	16	registry	registry	NOUN
hls-1187	120	17	information	information	NOUN
hls-1187	120	18	indicated	indicate	VERB
hls-1187	120	19	that	that	SCONJ
hls-1187	120	20	nonresponders	nonresponder	NOUN
hls-1187	120	21	were	be	AUX
hls-1187	120	22	on	on	ADP
hls-1187	120	23	average	average	ADJ
hls-1187	120	24	2	2	NUM
hls-1187	120	25	years	year	NOUN
hls-1187	120	26	younger	young	ADJ
hls-1187	120	27	(	(	PUNCT
hls-1187	120	28	p<0.05	p<0.05	NOUN
hls-1187	120	29	)	)	PUNCT
hls-1187	120	30	than	than	ADP
hls-1187	120	31	the	the	DET
hls-1187	120	32	enrolled	enrol	VERB
hls-1187	120	33	patients	patient	NOUN
hls-1187	120	34	,	,	PUNCT
hls-1187	120	35	and	and	CCONJ
hls-1187	120	36	the	the	DET
hls-1187	120	37	difference	difference	NOUN
hls-1187	120	38	was	be	AUX
hls-1187	120	39	mainly	mainly	ADV
hls-1187	120	40	attributed	attribute	VERB
hls-1187	120	41	to	to	ADP
hls-1187	120	42	the	the	DET
hls-1187	120	43	difference	difference	NOUN
hls-1187	120	44	among	among	ADP
hls-1187	120	45	the	the	DET
hls-1187	120	46	male	male	ADJ
hls-1187	120	47	population	population	NOUN
hls-1187	120	48	.	.	PUNCT
hls-1187	121	1	thus	thus	ADV
hls-1187	121	2	,	,	PUNCT
hls-1187	121	3	the	the	DET
hls-1187	121	4	non	non	ADJ
hls-1187	121	5	-	-	ADJ
hls-1187	121	6	response	response	ADJ
hls-1187	121	7	bias	bias	NOUN
hls-1187	121	8	suggests	suggest	VERB
hls-1187	121	9	that	that	SCONJ
hls-1187	121	10	our	our	PRON
hls-1187	121	11	detected	detect	VERB
hls-1187	121	12	differences	difference	NOUN
hls-1187	121	13	would	would	AUX
hls-1187	121	14	probably	probably	ADV
hls-1187	121	15	be	be	AUX
hls-1187	121	16	of	of	ADP
hls-1187	121	17	a	a	DET
hls-1187	121	18	larger	large	ADJ
hls-1187	121	19	magnitude	magnitude	NOUN
hls-1187	121	20	if	if	SCONJ
hls-1187	121	21	the	the	DET
hls-1187	121	22	total	total	ADJ
hls-1187	121	23	sample	sample	NOUN
hls-1187	121	24	had	have	AUX
hls-1187	121	25	been	be	AUX
hls-1187	121	26	included	include	VERB
hls-1187	121	27	.	.	PUNCT
hls-1187	122	1	conclusions	conclusion	NOUN
hls-1187	122	2	in	in	ADP
hls-1187	122	3	conclusion	conclusion	NOUN
hls-1187	122	4	,	,	PUNCT
hls-1187	122	5	we	we	PRON
hls-1187	122	6	found	find	VERB
hls-1187	122	7	that	that	SCONJ
hls-1187	122	8	in	in	ADP
hls-1187	122	9	armenia	armenia	PROPN
hls-1187	122	10	,	,	PUNCT
hls-1187	122	11	women	woman	NOUN
hls-1187	122	12	with	with	ADP
hls-1187	122	13	cad	cad	PROPN
hls-1187	122	14	differed	differ	VERB
hls-1187	122	15	from	from	ADP
hls-1187	122	16	men	man	NOUN
hls-1187	122	17	in	in	ADP
hls-1187	122	18	several	several	ADJ
hls-1187	122	19	baseline	baseline	ADJ
hls-1187	122	20	risk	risk	NOUN
hls-1187	122	21	factors	factor	NOUN
hls-1187	122	22	and	and	CCONJ
hls-1187	122	23	comorbidities	comorbiditie	NOUN
hls-1187	122	24	.	.	PUNCT
hls-1187	123	1	women	woman	NOUN
hls-1187	123	2	were	be	AUX
hls-1187	123	3	older	old	ADJ
hls-1187	123	4	than	than	ADP
hls-1187	123	5	men	man	NOUN
hls-1187	123	6	and	and	CCONJ
hls-1187	123	7	had	have	VERB
hls-1187	123	8	higher	high	ADJ
hls-1187	123	9	prevalence	prevalence	NOUN
hls-1187	123	10	of	of	ADP
hls-1187	123	11	hypertension	hypertension	NOUN
hls-1187	123	12	,	,	PUNCT
hls-1187	123	13	obesity	obesity	NOUN
hls-1187	123	14	,	,	PUNCT
hls-1187	123	15	and	and	CCONJ
hls-1187	123	16	diabetes	diabetes	NOUN
hls-1187	123	17	.	.	PUNCT
hls-1187	124	1	a	a	DET
hls-1187	124	2	significantly	significantly	ADV
hls-1187	124	3	higher	high	ADJ
hls-1187	124	4	proportion	proportion	NOUN
hls-1187	124	5	of	of	ADP
hls-1187	124	6	men	man	NOUN
hls-1187	124	7	smoked	smoke	VERB
hls-1187	124	8	.	.	PUNCT
hls-1187	125	1	the	the	DET
hls-1187	125	2	differences	difference	NOUN
hls-1187	125	3	in	in	ADP
hls-1187	125	4	the	the	DET
hls-1187	125	5	long	long	ADJ
hls-1187	125	6	-	-	PUNCT
hls-1187	125	7	term	term	NOUN
hls-1187	125	8	outcomes	outcome	NOUN
hls-1187	125	9	of	of	ADP
hls-1187	125	10	pci	pci	PROPN
hls-1187	125	11	between	between	ADP
hls-1187	125	12	men	man	NOUN
hls-1187	125	13	and	and	CCONJ
hls-1187	125	14	women	woman	NOUN
hls-1187	125	15	were	be	AUX
hls-1187	125	16	dependent	dependent	ADJ
hls-1187	125	17	on	on	ADP
hls-1187	125	18	the	the	DET
hls-1187	125	19	diabetes	diabetes	NOUN
hls-1187	125	20	status	status	NOUN
hls-1187	125	21	.	.	PUNCT
hls-1187	126	1	future	future	ADJ
hls-1187	126	2	studies	study	NOUN
hls-1187	126	3	should	should	AUX
hls-1187	126	4	investigate	investigate	VERB
hls-1187	126	5	the	the	DET
hls-1187	126	6	nature	nature	NOUN
hls-1187	126	7	,	,	PUNCT
hls-1187	126	8	extent	extent	NOUN
hls-1187	126	9	,	,	PUNCT
hls-1187	126	10	and	and	CCONJ
hls-1187	126	11	causal	causal	ADJ
hls-1187	126	12	mechanism	mechanism	NOUN
hls-1187	126	13	of	of	ADP
hls-1187	126	14	the	the	DET
hls-1187	126	15	excess	excess	ADJ
hls-1187	126	16	risk	risk	NOUN
hls-1187	126	17	of	of	ADP
hls-1187	126	18	diabetes	diabetes	NOUN
hls-1187	126	19	on	on	ADP
hls-1187	126	20	pci	pci	ADJ
hls-1187	126	21	outcomes	outcome	NOUN
hls-1187	126	22	,	,	PUNCT
hls-1187	126	23	and	and	CCONJ
hls-1187	126	24	targeted	target	VERB
hls-1187	126	25	strategies	strategy	NOUN
hls-1187	126	26	should	should	AUX
hls-1187	126	27	be	be	AUX
hls-1187	126	28	developed	develop	VERB
hls-1187	126	29	to	to	PART
hls-1187	126	30	decrease	decrease	VERB
hls-1187	126	31	this	this	DET
hls-1187	126	32	risk	risk	NOUN
hls-1187	126	33	and	and	CCONJ
hls-1187	126	34	improve	improve	VERB
hls-1187	126	35	patient	patient	ADJ
hls-1187	126	36	outcomes	outcome	NOUN
hls-1187	126	37	.	.	PUNCT
hls-1187	127	1	references	reference	NOUN
hls-1187	127	2	1	1	NUM
hls-1187	127	3	.	.	PUNCT
hls-1187	127	4	roger	roger	PROPN
hls-1187	127	5	vl	vl	PROPN
hls-1187	127	6	,	,	PUNCT
hls-1187	127	7	go	go	VERB
hls-1187	127	8	as	as	ADP
hls-1187	127	9	,	,	PUNCT
hls-1187	127	10	lloyd	lloyd	PROPN
hls-1187	127	11	-	-	PUNCT
hls-1187	127	12	jones	jones	PROPN
hls-1187	127	13	dm	dm	PROPN
hls-1187	127	14	,	,	PUNCT
hls-1187	127	15	et	et	PROPN
hls-1187	127	16	al	al	PROPN
hls-1187	127	17	.	.	PUNCT
hls-1187	127	18	heart	heart	NOUN
hls-1187	127	19	disease	disease	NOUN
hls-1187	127	20	and	and	CCONJ
hls-1187	127	21	stroke	stroke	NOUN
hls-1187	127	22	statistics-2011	statistics-2011	ADJ
hls-1187	127	23	update	update	NOUN
hls-1187	127	24	:	:	PUNCT
hls-1187	127	25	a	a	DET
hls-1187	127	26	report	report	NOUN
hls-1187	127	27	from	from	ADP
hls-1187	127	28	the	the	DET
hls-1187	127	29	american	american	PROPN
hls-1187	127	30	heart	heart	PROPN
hls-1187	127	31	association	association	PROPN
hls-1187	127	32	.	.	PUNCT
hls-1187	128	1	circulation	circulation	NOUN
hls-1187	128	2	2011;123	2011;123	NUM
hls-1187	128	3	:	:	PUNCT
hls-1187	128	4	e18	e18	PROPN
hls-1187	128	5	-	-	PUNCT
hls-1187	128	6	e209	e209	PROPN
hls-1187	128	7	.	.	PUNCT
hls-1187	129	1	2	2	NUM
hls-1187	129	2	.	.	NUM
hls-1187	129	3	duvernoy	duvernoy	VERB
hls-1187	129	4	cs	cs	PROPN
hls-1187	129	5	,	,	PUNCT
hls-1187	129	6	smith	smith	PROPN
hls-1187	129	7	de	de	PROPN
hls-1187	129	8	,	,	PUNCT
hls-1187	129	9	manohar	manohar	PROPN
hls-1187	129	10	p	p	PROPN
hls-1187	129	11	,	,	PUNCT
hls-1187	129	12	et	et	PROPN
hls-1187	129	13	al	al	PROPN
hls-1187	129	14	.	.	PUNCT
hls-1187	130	1	gender	gender	NOUN
hls-1187	130	2	differences	difference	NOUN
hls-1187	130	3	in	in	ADP
hls-1187	130	4	adverse	adverse	ADJ
hls-1187	130	5	outcomes	outcome	NOUN
hls-1187	130	6	after	after	ADP
hls-1187	130	7	contemporary	contemporary	ADJ
hls-1187	130	8	percutaneous	percutaneous	ADJ
hls-1187	130	9	coronary	coronary	ADJ
hls-1187	130	10	intervention	intervention	NOUN
hls-1187	130	11	:	:	PUNCT
hls-1187	130	12	an	an	DET
hls-1187	130	13	analysis	analysis	NOUN
hls-1187	130	14	from	from	ADP
hls-1187	130	15	the	the	DET
hls-1187	130	16	blue	blue	PROPN
hls-1187	130	17	cross	cross	NOUN
hls-1187	130	18	blue	blue	ADJ
hls-1187	130	19	shield	shield	NOUN
hls-1187	130	20	of	of	ADP
hls-1187	130	21	michigan	michigan	PROPN
hls-1187	130	22	cardiovascular	cardiovascular	ADJ
hls-1187	130	23	consortium	consortium	NOUN
hls-1187	130	24	(	(	PUNCT
hls-1187	130	25	bmc2	bmc2	PROPN
hls-1187	130	26	)	)	PUNCT
hls-1187	130	27	percutaneous	percutaneous	ADJ
hls-1187	130	28	coronary	coronary	ADJ
hls-1187	130	29	intervention	intervention	NOUN
hls-1187	130	30	registry	registry	PROPN
hls-1187	130	31	.	.	PUNCT
hls-1187	131	1	am	be	AUX
hls-1187	131	2	heart	heart	NOUN
hls-1187	131	3	j	j	PROPN
hls-1187	131	4	2010159:677	2010159:677	NUM
hls-1187	131	5	-	-	PUNCT
hls-1187	131	6	83	83	NUM
hls-1187	131	7	.	.	PUNCT
hls-1187	132	1	3	3	X
hls-1187	132	2	.	.	X
hls-1187	132	3	shu	shu	PROPN
hls-1187	132	4	w	w	PROPN
hls-1187	132	5	,	,	PUNCT
hls-1187	132	6	lei	lei	PROPN
hls-1187	132	7	w	w	PROPN
hls-1187	132	8	,	,	PUNCT
hls-1187	132	9	peng	peng	PROPN
hls-1187	132	10	s.	s.	PROPN
hls-1187	132	11	recent	recent	ADJ
hls-1187	132	12	development	development	NOUN
hls-1187	132	13	of	of	ADP
hls-1187	132	14	ischaemic	ischaemic	ADJ
hls-1187	132	15	heart	heart	NOUN
hls-1187	132	16	disease	disease	NOUN
hls-1187	132	17	in	in	ADP
hls-1187	132	18	sex	sex	NOUN
hls-1187	132	19	difference	difference	NOUN
hls-1187	132	20	.	.	PUNCT
hls-1187	133	1	postgrad	postgrad	PROPN
hls-1187	133	2	med	med	PROPN
hls-1187	133	3	j	j	PROPN
hls-1187	133	4	2007;83:240	2007;83:240	NUM
hls-1187	133	5	-	-	SYM
hls-1187	133	6	3	3	NUM
hls-1187	133	7	.	.	NOUN
hls-1187	133	8	4	4	NUM
hls-1187	133	9	.	.	X
hls-1187	133	10	lansky	lansky	PROPN
hls-1187	133	11	aj	aj	PROPN
hls-1187	133	12	,	,	PUNCT
hls-1187	133	13	hochman	hochman	PROPN
hls-1187	133	14	js	js	PROPN
hls-1187	133	15	,	,	PUNCT
hls-1187	133	16	ward	ward	PROPN
hls-1187	133	17	pa	pa	PROPN
hls-1187	133	18	,	,	PUNCT
hls-1187	133	19	et	et	PROPN
hls-1187	133	20	al	al	PROPN
hls-1187	133	21	.	.	PROPN
hls-1187	134	1	percutaneous	percutaneous	ADJ
hls-1187	134	2	coronary	coronary	ADJ
hls-1187	134	3	intervention	intervention	NOUN
hls-1187	134	4	and	and	CCONJ
hls-1187	134	5	adjunctive	adjunctive	ADJ
hls-1187	134	6	pharmacotherapy	pharmacotherapy	NOUN
hls-1187	134	7	in	in	ADP
hls-1187	134	8	women	woman	NOUN
hls-1187	134	9	:	:	PUNCT
hls-1187	134	10	a	a	DET
hls-1187	134	11	statement	statement	NOUN
hls-1187	134	12	for	for	ADP
hls-1187	134	13	healthcare	healthcare	NOUN
hls-1187	134	14	professionals	professional	NOUN
hls-1187	134	15	from	from	ADP
hls-1187	134	16	the	the	DET
hls-1187	134	17	american	american	PROPN
hls-1187	134	18	heart	heart	PROPN
hls-1187	134	19	association	association	PROPN
hls-1187	134	20	.	.	PUNCT
hls-1187	135	1	circulation	circulation	NOUN
hls-1187	135	2	2005;111:940	2005;111:940	NUM
hls-1187	135	3	-	-	SYM
hls-1187	135	4	53	53	NUM
hls-1187	135	5	.	.	NOUN
hls-1187	135	6	5	5	NUM
hls-1187	135	7	.	.	X
hls-1187	135	8	blomkalns	blomkalns	PROPN
hls-1187	135	9	al	al	PROPN
hls-1187	135	10	,	,	PUNCT
hls-1187	135	11	chen	chen	PROPN
hls-1187	135	12	ay	ay	PROPN
hls-1187	135	13	,	,	PUNCT
hls-1187	135	14	hochman	hochman	PROPN
hls-1187	135	15	js	js	PROPN
hls-1187	135	16	,	,	PUNCT
hls-1187	135	17	et	et	PROPN
hls-1187	135	18	al	al	PROPN
hls-1187	135	19	.	.	PUNCT
hls-1187	136	1	gender	gender	NOUN
hls-1187	136	2	disparities	disparity	NOUN
hls-1187	136	3	in	in	ADP
hls-1187	136	4	the	the	DET
hls-1187	136	5	diagnosis	diagnosis	NOUN
hls-1187	136	6	and	and	CCONJ
hls-1187	136	7	treatment	treatment	NOUN
hls-1187	136	8	of	of	ADP
hls-1187	136	9	non	non	ADJ
hls-1187	136	10	-	-	ADJ
hls-1187	136	11	st	st	ADJ
hls-1187	136	12	-	-	PUNCT
hls-1187	136	13	segment	segment	NOUN
hls-1187	136	14	elevation	elevation	NOUN
hls-1187	136	15	acute	acute	NOUN
hls-1187	136	16	coronary	coronary	ADJ
hls-1187	136	17	syndromes	syndrome	NOUN
hls-1187	136	18	:	:	PUNCT
hls-1187	136	19	large	large	ADJ
hls-1187	136	20	-	-	PUNCT
hls-1187	136	21	scale	scale	NOUN
hls-1187	136	22	observations	observation	NOUN
hls-1187	136	23	from	from	ADP
hls-1187	136	24	the	the	DET
hls-1187	136	25	crusade	crusade	NOUN
hls-1187	136	26	(	(	PUNCT
hls-1187	136	27	can	can	AUX
hls-1187	136	28	rapid	rapid	VERB
hls-1187	136	29	risk	risk	NOUN
hls-1187	136	30	stratification	stratification	NOUN
hls-1187	136	31	of	of	ADP
hls-1187	136	32	unstable	unstable	ADJ
hls-1187	136	33	angina	angina	NOUN
hls-1187	136	34	patients	patient	NOUN
hls-1187	136	35	suppress	suppress	VERB
hls-1187	136	36	adverse	adverse	ADJ
hls-1187	136	37	outcomes	outcome	NOUN
hls-1187	136	38	with	with	ADP
hls-1187	136	39	early	early	ADJ
hls-1187	136	40	implementation	implementation	NOUN
hls-1187	136	41	of	of	ADP
hls-1187	136	42	the	the	DET
hls-1187	136	43	american	american	PROPN
hls-1187	136	44	college	college	PROPN
hls-1187	136	45	of	of	ADP
hls-1187	136	46	cardiology/	cardiology/	PROPN
hls-1187	136	47	american	american	PROPN
hls-1187	136	48	heart	heart	PROPN
hls-1187	136	49	association	association	PROPN
hls-1187	136	50	guidelines	guideline	NOUN
hls-1187	136	51	)	)	PUNCT
hls-1187	136	52	national	national	ADJ
hls-1187	136	53	quality	quality	NOUN
hls-1187	136	54	improvement	improvement	NOUN
hls-1187	136	55	initiative	initiative	NOUN
hls-1187	136	56	.	.	PUNCT
hls-1187	137	1	j	j	PROPN
hls-1187	137	2	am	be	AUX
hls-1187	137	3	coll	coll	PROPN
hls-1187	137	4	cardiol	cardiol	NOUN
hls-1187	137	5	2005;45:832	2005;45:832	NOUN
hls-1187	137	6	-	-	SYM
hls-1187	137	7	7	7	NUM
hls-1187	137	8	.	.	NOUN
hls-1187	137	9	6	6	NUM
hls-1187	137	10	.	.	X
hls-1187	137	11	kovacic	kovacic	PROPN
hls-1187	137	12	jc	jc	PROPN
hls-1187	137	13	,	,	PUNCT
hls-1187	137	14	mehran	mehran	PROPN
hls-1187	137	15	r	r	PROPN
hls-1187	137	16	,	,	PUNCT
hls-1187	137	17	karajgikar	karajgikar	ADJ
hls-1187	137	18	r	r	NOUN
hls-1187	137	19	,	,	PUNCT
hls-1187	137	20	et	et	PROPN
hls-1187	137	21	al	al	PROPN
hls-1187	137	22	.	.	PROPN
hls-1187	137	23	female	female	ADJ
hls-1187	137	24	gender	gender	NOUN
hls-1187	137	25	and	and	CCONJ
hls-1187	137	26	mortality	mortality	NOUN
hls-1187	137	27	after	after	ADP
hls-1187	137	28	percutaneous	percutaneous	ADJ
hls-1187	137	29	coronary	coronary	ADJ
hls-1187	137	30	intervention	intervention	NOUN
hls-1187	137	31	:	:	PUNCT
hls-1187	137	32	results	result	VERB
hls-1187	137	33	from	from	ADP
hls-1187	137	34	a	a	DET
hls-1187	137	35	large	large	ADJ
hls-1187	137	36	registry	registry	NOUN
hls-1187	137	37	.	.	PUNCT
hls-1187	138	1	catheter	catheter	NOUN
hls-1187	138	2	cardio	cardio	NOUN
hls-1187	138	3	inte	inte	NOUN
hls-1187	138	4	2011;80:514	2011;80:514	PROPN
hls-1187	138	5	-	-	SYM
hls-1187	138	6	21	21	NUM
hls-1187	138	7	.	.	PUNCT
hls-1187	139	1	7	7	X
hls-1187	139	2	.	.	X
hls-1187	140	1	onuma	onuma	PROPN
hls-1187	140	2	y	y	PROPN
hls-1187	140	3	,	,	PUNCT
hls-1187	140	4	kukreja	kukreja	NOUN
hls-1187	140	5	n	n	CCONJ
hls-1187	140	6	,	,	PUNCT
hls-1187	140	7	daemen	daemen	PROPN
hls-1187	140	8	j	j	PROPN
hls-1187	140	9	,	,	PUNCT
hls-1187	140	10	et	et	PROPN
hls-1187	140	11	al	al	PROPN
hls-1187	140	12	.	.	PROPN
hls-1187	140	13	impact	impact	NOUN
hls-1187	140	14	of	of	ADP
hls-1187	140	15	sex	sex	NOUN
hls-1187	140	16	on	on	ADP
hls-1187	140	17	3	3	NUM
hls-1187	140	18	-	-	PUNCT
hls-1187	140	19	year	year	NOUN
hls-1187	140	20	outcome	outcome	NOUN
hls-1187	140	21	after	after	ADP
hls-1187	140	22	percutaneous	percutaneous	ADJ
hls-1187	140	23	coronary	coronary	ADJ
hls-1187	140	24	intervention	intervention	NOUN
hls-1187	140	25	using	use	VERB
hls-1187	140	26	bare	bare	ADJ
hls-1187	140	27	-	-	PUNCT
hls-1187	140	28	metal	metal	NOUN
hls-1187	140	29	and	and	CCONJ
hls-1187	140	30	drug	drug	NOUN
hls-1187	140	31	-	-	PUNCT
hls-1187	140	32	eluting	elute	VERB
hls-1187	140	33	stents	stent	NOUN
hls-1187	140	34	in	in	ADP
hls-1187	140	35	previously	previously	ADV
hls-1187	140	36	untreated	untreate	VERB
hls-1187	140	37	coronary	coronary	ADJ
hls-1187	140	38	artery	artery	NOUN
hls-1187	140	39	disease	disease	NOUN
hls-1187	140	40	:	:	PUNCT
hls-1187	140	41	insights	insight	NOUN
hls-1187	140	42	from	from	ADP
hls-1187	140	43	the	the	DET
hls-1187	140	44	research	research	NOUN
hls-1187	140	45	(	(	PUNCT
hls-1187	140	46	rapamycineluting	rapamycinelute	VERB
hls-1187	140	47	stent	stent	NOUN
hls-1187	140	48	evaluated	evaluate	VERB
hls-1187	140	49	at	at	ADP
hls-1187	140	50	rotterdam	rotterdam	PROPN
hls-1187	140	51	cardiology	cardiology	NOUN
hls-1187	140	52	hospital	hospital	NOUN
hls-1187	140	53	)	)	PUNCT
hls-1187	140	54	and	and	CCONJ
hls-1187	140	55	t	t	NOUN
hls-1187	140	56	-	-	PUNCT
hls-1187	140	57	search	search	NOUN
hls-1187	140	58	(	(	PUNCT
hls-1187	140	59	taxus	taxus	NOUN
hls-1187	140	60	-	-	PUNCT
hls-1187	140	61	stent	stent	NOUN
hls-1187	140	62	evaluated	evaluate	VERB
hls-1187	140	63	at	at	ADP
hls-1187	140	64	rotterdam	rotterdam	PROPN
hls-1187	140	65	cardiology	cardiology	NOUN
hls-1187	140	66	hospital	hospital	NOUN
hls-1187	140	67	)	)	PUNCT
hls-1187	140	68	registries	registry	NOUN
hls-1187	140	69	.	.	PUNCT
hls-1187	141	1	jacc	jacc	PROPN
hls-1187	141	2	cardiovasc	cardiovasc	PROPN
hls-1187	141	3	interv	interv	VERB
hls-1187	141	4	2009;2:603	2009;2:603	NOUN
hls-1187	141	5	-	-	SYM
hls-1187	141	6	10	10	NUM
hls-1187	141	7	.	.	NOUN
hls-1187	142	1	8	8	NUM
hls-1187	142	2	.	.	PUNCT
hls-1187	143	1	solinas	solinas	PROPN
hls-1187	143	2	e	e	PROPN
hls-1187	143	3	,	,	PUNCT
hls-1187	143	4	nikolsky	nikolsky	ADJ
hls-1187	143	5	e	e	PROPN
hls-1187	143	6	,	,	PUNCT
hls-1187	143	7	lansky	lansky	PROPN
hls-1187	143	8	aj	aj	PROPN
hls-1187	143	9	,	,	PUNCT
hls-1187	143	10	et	et	PROPN
hls-1187	143	11	al	al	PROPN
hls-1187	143	12	.	.	PUNCT
hls-1187	143	13	gender	gender	NOUN
hls-1187	143	14	-	-	PUNCT
hls-1187	143	15	specific	specific	ADJ
hls-1187	143	16	outcomes	outcome	NOUN
hls-1187	143	17	after	after	ADP
hls-1187	143	18	sirolimuseluting	sirolimuselute	VERB
hls-1187	143	19	stent	stent	NOUN
hls-1187	143	20	implantation	implantation	NOUN
hls-1187	143	21	.	.	PUNCT
hls-1187	144	1	j	j	PROPN
hls-1187	144	2	am	be	AUX
hls-1187	144	3	coll	coll	PROPN
hls-1187	144	4	cardiol	cardiol	VERB
hls-1187	144	5	2007;50:2111	2007;50:2111	PROPN
hls-1187	144	6	-	-	SYM
hls-1187	144	7	6	6	NUM
hls-1187	144	8	.	.	NOUN
hls-1187	144	9	9	9	NUM
hls-1187	144	10	.	.	X
hls-1187	145	1	singh	singh	PROPN
hls-1187	145	2	m	m	PROPN
hls-1187	145	3	,	,	PUNCT
hls-1187	145	4	rihal	rihal	ADJ
hls-1187	145	5	cs	cs	PROPN
hls-1187	145	6	,	,	PUNCT
hls-1187	145	7	gersh	gersh	NOUN
hls-1187	145	8	bj	bj	NOUN
hls-1187	145	9	,	,	PUNCT
hls-1187	145	10	et	et	PROPN
hls-1187	145	11	al	al	PROPN
hls-1187	145	12	.	.	PUNCT
hls-1187	146	1	mortality	mortality	NOUN
hls-1187	146	2	differences	difference	NOUN
hls-1187	146	3	between	between	ADP
hls-1187	146	4	men	man	NOUN
hls-1187	146	5	and	and	CCONJ
hls-1187	146	6	women	woman	NOUN
hls-1187	146	7	after	after	ADP
hls-1187	146	8	percutaneous	percutaneous	ADJ
hls-1187	146	9	coronary	coronary	ADJ
hls-1187	146	10	interventions	intervention	NOUN
hls-1187	146	11	.	.	PUNCT
hls-1187	147	1	a	a	DET
hls-1187	147	2	25year	25year	NUM
hls-1187	147	3	,	,	PUNCT
hls-1187	147	4	single	single	ADJ
hls-1187	147	5	-	-	PUNCT
hls-1187	147	6	center	center	NOUN
hls-1187	147	7	experience	experience	NOUN
hls-1187	147	8	.	.	PUNCT
hls-1187	148	1	j	j	PROPN
hls-1187	148	2	am	be	AUX
hls-1187	148	3	coll	coll	PROPN
hls-1187	148	4	cardiol	cardiol	NOUN
hls-1187	148	5	2008;51:2313	2008;51:2313	NUM
hls-1187	148	6	-	-	SYM
hls-1187	148	7	20	20	NUM
hls-1187	148	8	.	.	PUNCT
hls-1187	148	9	10	10	NUM
hls-1187	148	10	.	.	PUNCT
hls-1187	149	1	alfredsson	alfredsson	PROPN
hls-1187	149	2	j	j	PROPN
hls-1187	149	3	,	,	PUNCT
hls-1187	149	4	stenestrand	stenestrand	NOUN
hls-1187	149	5	u	u	PROPN
hls-1187	149	6	,	,	PUNCT
hls-1187	149	7	wallentin	wallentin	PROPN
hls-1187	149	8	l	l	NOUN
hls-1187	149	9	,	,	PUNCT
hls-1187	149	10	et	et	PROPN
hls-1187	149	11	al	al	PROPN
hls-1187	149	12	.	.	PUNCT
hls-1187	149	13	gender	gender	NOUN
hls-1187	149	14	differences	difference	NOUN
hls-1187	149	15	in	in	ADP
hls-1187	149	16	management	management	NOUN
hls-1187	149	17	and	and	CCONJ
hls-1187	149	18	outcome	outcome	NOUN
hls-1187	149	19	in	in	ADP
hls-1187	149	20	non	non	ADJ
hls-1187	149	21	-	-	ADJ
hls-1187	149	22	st	st	ADJ
hls-1187	149	23	-	-	PUNCT
hls-1187	149	24	elevation	elevation	NOUN
hls-1187	149	25	acute	acute	ADJ
hls-1187	149	26	coronary	coronary	ADJ
hls-1187	149	27	syndrome	syndrome	NOUN
hls-1187	149	28	.	.	PUNCT
hls-1187	150	1	heart	heart	NOUN
hls-1187	150	2	2007;93:1357	2007;93:1357	PROPN
hls-1187	150	3	-	-	SYM
hls-1187	150	4	62	62	NUM
hls-1187	150	5	.	.	PUNCT
hls-1187	150	6	11	11	NUM
hls-1187	150	7	.	.	PUNCT
hls-1187	151	1	berger	berger	PROPN
hls-1187	151	2	js	js	PROPN
hls-1187	151	3	,	,	PUNCT
hls-1187	151	4	sanborn	sanborn	PROPN
hls-1187	151	5	ta	ta	PROPN
hls-1187	151	6	,	,	PUNCT
hls-1187	151	7	sherman	sherman	PROPN
hls-1187	151	8	w	w	PROPN
hls-1187	151	9	,	,	PUNCT
hls-1187	151	10	et	et	PROPN
hls-1187	151	11	al	al	PROPN
hls-1187	151	12	.	.	PUNCT
hls-1187	151	13	influence	influence	NOUN
hls-1187	151	14	of	of	ADP
hls-1187	151	15	sex	sex	NOUN
hls-1187	151	16	on	on	ADP
hls-1187	151	17	in	in	ADP
hls-1187	151	18	-	-	PUNCT
hls-1187	151	19	hospital	hospital	NOUN
hls-1187	151	20	outcomes	outcome	NOUN
hls-1187	151	21	and	and	CCONJ
hls-1187	151	22	long	long	ADJ
hls-1187	151	23	-	-	PUNCT
hls-1187	151	24	term	term	NOUN
hls-1187	151	25	survival	survival	NOUN
hls-1187	151	26	after	after	SCONJ
hls-1187	151	27	contemporary	contemporary	ADJ
hls-1187	151	28	article	article	PROPN
hls-1187	151	29	non	non	X
hls-1187	151	30	co	co	PROPN
hls-1187	151	31	mmerc	mmerc	PROPN
hls-1187	151	32	ial	ial	PROPN
hls-1187	151	33	us	us	PROPN
hls-1187	152	1	e	e	NOUN
hls-1187	152	2	o	o	NOUN
hls-1187	152	3	nly	nly	ADV
hls-1187	152	4	[	[	X
hls-1187	152	5	healthcare	healthcare	NOUN
hls-1187	152	6	in	in	ADP
hls-1187	152	7	low	low	ADJ
hls-1187	152	8	-	-	PUNCT
hls-1187	152	9	resource	resource	NOUN
hls-1187	152	10	settings	setting	NOUN
hls-1187	152	11	2013	2013	NUM
hls-1187	152	12	;	;	PUNCT
hls-1187	152	13	1	1	NUM
hls-1187	152	14	:	:	PUNCT
hls-1187	152	15	e17	e17	NOUN
hls-1187	152	16	]	]	PUNCT
hls-1187	153	1	[	[	X
hls-1187	153	2	page	page	NOUN
hls-1187	153	3	61	61	NUM
hls-1187	153	4	]	]	PUNCT
hls-1187	153	5	percutaneous	percutaneous	ADJ
hls-1187	153	6	coronary	coronary	ADJ
hls-1187	153	7	intervention	intervention	NOUN
hls-1187	153	8	.	.	PUNCT
hls-1187	154	1	am	be	AUX
hls-1187	154	2	heart	heart	NOUN
hls-1187	154	3	j	j	PROPN
hls-1187	154	4	2006;151:1026	2006;151:1026	NUM
hls-1187	154	5	-	-	SYM
hls-1187	154	6	31	31	NUM
hls-1187	154	7	.	.	PUNCT
hls-1187	155	1	12	12	NUM
hls-1187	155	2	.	.	PUNCT
hls-1187	156	1	mehilli	mehilli	PROPN
hls-1187	156	2	j	j	PROPN
hls-1187	156	3	,	,	PUNCT
hls-1187	156	4	kastrati	kastrati	PROPN
hls-1187	156	5	a	a	PRON
hls-1187	156	6	,	,	PUNCT
hls-1187	156	7	bollwein	bollwein	NOUN
hls-1187	156	8	h	h	NOUN
hls-1187	156	9	,	,	PUNCT
hls-1187	156	10	et	et	PROPN
hls-1187	156	11	al	al	PROPN
hls-1187	156	12	.	.	PROPN
hls-1187	156	13	gender	gender	NOUN
hls-1187	156	14	and	and	CCONJ
hls-1187	156	15	restenosis	restenosis	NOUN
hls-1187	156	16	after	after	ADP
hls-1187	156	17	coronary	coronary	ADJ
hls-1187	156	18	artery	artery	NOUN
hls-1187	156	19	stenting	stenting	NOUN
hls-1187	156	20	.	.	PUNCT
hls-1187	157	1	eur	eur	PROPN
hls-1187	157	2	heart	heart	NOUN
hls-1187	157	3	j	j	PROPN
hls-1187	157	4	2003;24:1523	2003;24:1523	NUM
hls-1187	157	5	-	-	SYM
hls-1187	157	6	30	30	NUM
hls-1187	157	7	.	.	PUNCT
hls-1187	157	8	13	13	NUM
hls-1187	157	9	.	.	PUNCT
hls-1187	158	1	national	national	ADJ
hls-1187	158	2	statistical	statistical	ADJ
hls-1187	158	3	service	service	NOUN
hls-1187	158	4	,	,	PUNCT
hls-1187	158	5	armenia	armenia	PROPN
hls-1187	158	6	.	.	PUNCT
hls-1187	159	1	armenia	armenia	PROPN
hls-1187	159	2	demographic	demographic	ADJ
hls-1187	159	3	and	and	CCONJ
hls-1187	159	4	health	health	NOUN
hls-1187	159	5	survey	survey	NOUN
hls-1187	159	6	2005	2005	NUM
hls-1187	159	7	.	.	PUNCT
hls-1187	160	1	yerevan	yerevan	PROPN
hls-1187	160	2	:	:	PUNCT
hls-1187	160	3	national	national	ADJ
hls-1187	160	4	statistical	statistical	ADJ
hls-1187	160	5	service	service	NOUN
hls-1187	160	6	of	of	ADP
hls-1187	160	7	armenia	armenia	PROPN
hls-1187	160	8	ed	ed	PROPN
hls-1187	160	9	.	.	PUNCT
hls-1187	160	10	;	;	PUNCT
hls-1187	160	11	2006	2006	NUM
hls-1187	160	12	.	.	PUNCT
hls-1187	160	13	available	available	ADJ
hls-1187	160	14	from	from	ADP
hls-1187	160	15	:	:	PUNCT
hls-1187	160	16	http://www.measuredhs.com/pubs/pdf/fr18	http://www.measuredhs.com/pubs/pdf/fr18	PROPN
hls-1187	160	17	4	4	NUM
hls-1187	160	18	/	/	SYM
hls-1187	160	19	fr184.pdf	fr184.pdf	PROPN
hls-1187	160	20	14	14	NUM
hls-1187	160	21	.	.	PUNCT
hls-1187	161	1	republic	republic	NOUN
hls-1187	161	2	of	of	ADP
hls-1187	161	3	armenia	armenia	PROPN
hls-1187	161	4	,	,	PUNCT
hls-1187	161	5	ministry	ministry	PROPN
hls-1187	161	6	of	of	ADP
hls-1187	161	7	health	health	PROPN
hls-1187	161	8	.	.	PUNCT
hls-1187	162	1	health	health	NOUN
hls-1187	162	2	and	and	CCONJ
hls-1187	162	3	health	health	NOUN
hls-1187	162	4	care	care	NOUN
hls-1187	162	5	of	of	ADP
hls-1187	162	6	armenia	armenia	PROPN
hls-1187	162	7	2009	2009	NUM
hls-1187	162	8	.	.	PUNCT
hls-1187	163	1	official	official	ADJ
hls-1187	163	2	annual	annual	ADJ
hls-1187	163	3	statistical	statistical	ADJ
hls-1187	163	4	report	report	NOUN
hls-1187	163	5	.	.	PUNCT
hls-1187	164	1	yerevan	yerevan	PROPN
hls-1187	164	2	:	:	PUNCT
hls-1187	164	3	republic	republic	PROPN
hls-1187	164	4	of	of	ADP
hls-1187	164	5	armenia	armenia	PROPN
hls-1187	164	6	,	,	PUNCT
hls-1187	164	7	ministry	ministry	PROPN
hls-1187	164	8	of	of	ADP
hls-1187	164	9	health	health	PROPN
hls-1187	164	10	ed	ed	PROPN
hls-1187	164	11	.	.	PUNCT
hls-1187	164	12	:	:	PUNCT
hls-1187	165	1	2010	2010	NUM
hls-1187	165	2	.	.	PUNCT
hls-1187	166	1	15	15	NUM
hls-1187	166	2	.	.	PUNCT
hls-1187	167	1	abrahamyan	abrahamyan	PROPN
hls-1187	167	2	l	l	PROPN
hls-1187	167	3	,	,	PUNCT
hls-1187	167	4	demirchyan	demirchyan	ADV
hls-1187	167	5	a	a	X
hls-1187	167	6	,	,	PUNCT
hls-1187	167	7	thompson	thompson	PROPN
hls-1187	167	8	me	i	PRON
hls-1187	167	9	,	,	PUNCT
hls-1187	167	10	et	et	PROPN
hls-1187	167	11	al	al	PROPN
hls-1187	167	12	.	.	PUNCT
hls-1187	167	13	determinants	determinant	NOUN
hls-1187	167	14	of	of	ADP
hls-1187	167	15	morbidity	morbidity	NOUN
hls-1187	167	16	and	and	CCONJ
hls-1187	167	17	intensive	intensive	ADJ
hls-1187	167	18	care	care	NOUN
hls-1187	167	19	unit	unit	NOUN
hls-1187	167	20	stay	stay	VERB
hls-1187	167	21	after	after	ADP
hls-1187	167	22	coronary	coronary	ADJ
hls-1187	167	23	surgery	surgery	NOUN
hls-1187	167	24	.	.	PUNCT
hls-1187	168	1	asian	asian	PROPN
hls-1187	168	2	cardiovasc	cardiovasc	PROPN
hls-1187	168	3	thorac	thorac	PROPN
hls-1187	168	4	ann	ann	PROPN
hls-1187	168	5	2006;14:114	2006;14:114	NUM
hls-1187	168	6	-	-	SYM
hls-1187	168	7	8	8	NUM
hls-1187	168	8	.	.	PUNCT
hls-1187	168	9	16	16	NUM
hls-1187	168	10	.	.	PUNCT
hls-1187	169	1	akhter	akhter	PROPN
hls-1187	169	2	n	n	PROPN
hls-1187	169	3	,	,	PUNCT
hls-1187	169	4	milford	milford	NOUN
hls-1187	169	5	-	-	PUNCT
hls-1187	169	6	beland	beland	PROPN
hls-1187	169	7	s	s	PROPN
hls-1187	169	8	,	,	PUNCT
hls-1187	169	9	roe	roe	PROPN
hls-1187	169	10	mt	mt	PROPN
hls-1187	169	11	,	,	PUNCT
hls-1187	169	12	et	et	PROPN
hls-1187	169	13	al	al	PROPN
hls-1187	169	14	.	.	PUNCT
hls-1187	170	1	gender	gender	NOUN
hls-1187	170	2	differences	difference	NOUN
hls-1187	170	3	among	among	ADP
hls-1187	170	4	patients	patient	NOUN
hls-1187	170	5	with	with	ADP
hls-1187	170	6	acute	acute	ADJ
hls-1187	170	7	coronary	coronary	ADJ
hls-1187	170	8	syndromes	syndrome	NOUN
hls-1187	170	9	undergoing	undergo	VERB
hls-1187	170	10	percutaneous	percutaneous	ADJ
hls-1187	170	11	coronary	coronary	ADJ
hls-1187	170	12	intervention	intervention	NOUN
hls-1187	170	13	in	in	ADP
hls-1187	170	14	the	the	DET
hls-1187	170	15	american	american	PROPN
hls-1187	170	16	college	college	PROPN
hls-1187	170	17	of	of	ADP
hls-1187	170	18	cardiology	cardiology	NOUN
hls-1187	170	19	-	-	PUNCT
hls-1187	170	20	national	national	ADJ
hls-1187	170	21	cardiovascular	cardiovascular	ADJ
hls-1187	170	22	data	datum	NOUN
hls-1187	170	23	registry	registry	NOUN
hls-1187	170	24	(	(	PUNCT
hls-1187	170	25	acc	acc	NOUN
hls-1187	170	26	-	-	NOUN
hls-1187	170	27	ncdr	ncdr	NOUN
hls-1187	170	28	)	)	PUNCT
hls-1187	170	29	.	.	PUNCT
hls-1187	171	1	am	be	AUX
hls-1187	171	2	heart	heart	NOUN
hls-1187	171	3	j	j	PROPN
hls-1187	171	4	2009;157:141	2009;157:141	NUM
hls-1187	171	5	-	-	SYM
hls-1187	171	6	8	8	NUM
hls-1187	171	7	.	.	PUNCT
hls-1187	171	8	17	17	NUM
hls-1187	171	9	.	.	PUNCT
hls-1187	172	1	el	el	PROPN
hls-1187	172	2	-	-	PUNCT
hls-1187	172	3	menyar	menyar	PROPN
hls-1187	172	4	a	a	PRON
hls-1187	172	5	,	,	PUNCT
hls-1187	172	6	zubaid	zubaid	PROPN
hls-1187	172	7	m	m	PROPN
hls-1187	172	8	,	,	PUNCT
hls-1187	172	9	rashed	rashe	VERB
hls-1187	172	10	w	w	PROPN
hls-1187	172	11	,	,	PUNCT
hls-1187	173	1	et	et	PROPN
hls-1187	173	2	al	al	PROPN
hls-1187	173	3	.	.	PROPN
hls-1187	173	4	comparison	comparison	NOUN
hls-1187	173	5	of	of	ADP
hls-1187	173	6	men	man	NOUN
hls-1187	173	7	and	and	CCONJ
hls-1187	173	8	women	woman	NOUN
hls-1187	173	9	with	with	ADP
hls-1187	173	10	acute	acute	ADJ
hls-1187	173	11	coronary	coronary	ADJ
hls-1187	173	12	syndrome	syndrome	NOUN
hls-1187	173	13	in	in	ADP
hls-1187	173	14	six	six	NUM
hls-1187	173	15	middle	middle	ADJ
hls-1187	173	16	eastern	eastern	ADJ
hls-1187	173	17	countries	country	NOUN
hls-1187	173	18	.	.	PUNCT
hls-1187	174	1	am	be	AUX
hls-1187	174	2	j	j	PROPN
hls-1187	174	3	cardiol	cardiol	NOUN
hls-1187	174	4	2009;104:1018	2009;104:1018	NUM
hls-1187	174	5	-	-	SYM
hls-1187	174	6	22	22	NUM
hls-1187	174	7	.	.	PUNCT
hls-1187	175	1	18	18	NUM
hls-1187	175	2	.	.	PUNCT
hls-1187	175	3	d’ascenzo	d’ascenzo	NOUN
hls-1187	175	4	f	f	PROPN
hls-1187	175	5	,	,	PUNCT
hls-1187	175	6	gonella	gonella	PROPN
hls-1187	175	7	a	a	NOUN
hls-1187	175	8	,	,	PUNCT
hls-1187	175	9	quadri	quadri	PROPN
hls-1187	175	10	g	g	PROPN
hls-1187	175	11	,	,	PUNCT
hls-1187	175	12	et	et	PROPN
hls-1187	175	13	al	al	PROPN
hls-1187	175	14	.	.	PROPN
hls-1187	175	15	comparison	comparison	NOUN
hls-1187	175	16	of	of	ADP
hls-1187	175	17	mortality	mortality	NOUN
hls-1187	175	18	rates	rate	NOUN
hls-1187	175	19	in	in	ADP
hls-1187	175	20	women	woman	NOUN
hls-1187	175	21	versus	versus	ADP
hls-1187	175	22	men	man	NOUN
hls-1187	175	23	presenting	present	VERB
hls-1187	175	24	with	with	ADP
hls-1187	175	25	st	st	PROPN
hls-1187	175	26	-	-	PUNCT
hls-1187	175	27	segment	segment	NOUN
hls-1187	175	28	elevation	elevation	NOUN
hls-1187	175	29	myocardial	myocardial	ADJ
hls-1187	175	30	infarction	infarction	NOUN
hls-1187	175	31	.	.	PUNCT
hls-1187	176	1	am	be	AUX
hls-1187	176	2	j	j	PROPN
hls-1187	176	3	cardiol	cardiol	NOUN
hls-1187	176	4	2011;107:651	2011;107:651	NUM
hls-1187	176	5	-	-	SYM
hls-1187	176	6	4	4	NUM
hls-1187	176	7	.	.	NOUN
hls-1187	176	8	19	19	NUM
hls-1187	176	9	.	.	PUNCT
hls-1187	177	1	ge	ge	PROPN
hls-1187	177	2	jb	jb	PROPN
hls-1187	177	3	.	.	PUNCT
hls-1187	178	1	gender	gender	NOUN
hls-1187	178	2	difference	difference	NOUN
hls-1187	178	3	in	in	ADP
hls-1187	178	4	patients	patient	NOUN
hls-1187	178	5	with	with	ADP
hls-1187	178	6	acute	acute	ADJ
hls-1187	178	7	myocardial	myocardial	ADJ
hls-1187	178	8	infarction	infarction	NOUN
hls-1187	178	9	treated	treat	VERB
hls-1187	178	10	by	by	ADP
hls-1187	178	11	primary	primary	ADJ
hls-1187	178	12	percutaneous	percutaneous	ADJ
hls-1187	178	13	coronary	coronary	ADJ
hls-1187	178	14	intervention	intervention	NOUN
hls-1187	178	15	in	in	ADP
hls-1187	178	16	drug	drug	NOUN
hls-1187	178	17	-	-	PUNCT
hls-1187	178	18	eluting	elute	VERB
hls-1187	178	19	stent	stent	NOUN
hls-1187	178	20	era	era	NOUN
hls-1187	178	21	.	.	PUNCT
hls-1187	179	1	chinese	chinese	PROPN
hls-1187	179	2	med	med	ADJ
hls-1187	179	3	jpeking	jpeke	VERB
hls-1187	179	4	2010;123:776	2010;123:776	NUM
hls-1187	179	5	-	-	SYM
hls-1187	179	6	7	7	NUM
hls-1187	179	7	.	.	NOUN
hls-1187	179	8	20	20	NUM
hls-1187	179	9	.	.	PUNCT
hls-1187	180	1	ogita	ogita	PROPN
hls-1187	180	2	m	m	PROPN
hls-1187	180	3	,	,	PUNCT
hls-1187	180	4	miyauchi	miyauchi	PROPN
hls-1187	180	5	k	k	PROPN
hls-1187	180	6	,	,	PUNCT
hls-1187	180	7	dohi	dohi	PROPN
hls-1187	180	8	t	t	PROPN
hls-1187	180	9	,	,	PUNCT
hls-1187	180	10	et	et	PROPN
hls-1187	180	11	al	al	PROPN
hls-1187	180	12	.	.	PROPN
hls-1187	180	13	genderbased	genderbase	VERB
hls-1187	180	14	outcomes	outcome	NOUN
hls-1187	180	15	among	among	ADP
hls-1187	180	16	patients	patient	NOUN
hls-1187	180	17	with	with	ADP
hls-1187	180	18	diabetes	diabetes	NOUN
hls-1187	180	19	mellitus	mellitus	NOUN
hls-1187	180	20	after	after	ADP
hls-1187	180	21	percutaneous	percutaneous	ADJ
hls-1187	180	22	coronary	coronary	ADJ
hls-1187	180	23	intervention	intervention	NOUN
hls-1187	180	24	in	in	ADP
hls-1187	180	25	the	the	DET
hls-1187	180	26	drug	drug	NOUN
hls-1187	180	27	-	-	PUNCT
hls-1187	180	28	eluting	elute	VERB
hls-1187	180	29	stent	stent	NOUN
hls-1187	180	30	era	era	NOUN
hls-1187	180	31	.	.	PUNCT
hls-1187	181	1	int	int	NOUN
hls-1187	181	2	heart	heart	NOUN
hls-1187	181	3	j	j	PROPN
hls-1187	181	4	2011;52:348	2011;52:348	NUM
hls-1187	181	5	-	-	SYM
hls-1187	181	6	52	52	NUM
hls-1187	181	7	.	.	PUNCT
hls-1187	182	1	21	21	NUM
hls-1187	182	2	.	.	PUNCT
hls-1187	183	1	huxley	huxley	PROPN
hls-1187	183	2	r	r	PROPN
hls-1187	183	3	,	,	PUNCT
hls-1187	183	4	barzi	barzi	VERB
hls-1187	183	5	f	f	PROPN
hls-1187	183	6	,	,	PUNCT
hls-1187	183	7	woodward	woodward	PROPN
hls-1187	183	8	m.	m.	NOUN
hls-1187	183	9	excess	excess	ADJ
hls-1187	183	10	risk	risk	NOUN
hls-1187	183	11	of	of	ADP
hls-1187	183	12	fatal	fatal	ADJ
hls-1187	183	13	coronary	coronary	ADJ
hls-1187	183	14	heart	heart	NOUN
hls-1187	183	15	disease	disease	NOUN
hls-1187	183	16	associated	associate	VERB
hls-1187	183	17	with	with	ADP
hls-1187	183	18	diabetes	diabetes	NOUN
hls-1187	183	19	in	in	ADP
hls-1187	183	20	men	man	NOUN
hls-1187	183	21	and	and	CCONJ
hls-1187	183	22	women	woman	NOUN
hls-1187	183	23	:	:	PUNCT
hls-1187	183	24	metaanalysis	metaanalysis	NOUN
hls-1187	183	25	of	of	ADP
hls-1187	183	26	37	37	NUM
hls-1187	183	27	prospective	prospective	ADJ
hls-1187	183	28	cohort	cohort	NOUN
hls-1187	183	29	studies	study	NOUN
hls-1187	183	30	.	.	PUNCT
hls-1187	184	1	brit	brit	PROPN
hls-1187	184	2	med	med	PROPN
hls-1187	184	3	j	j	PROPN
hls-1187	184	4	2006;332:73	2006;332:73	NUM
hls-1187	184	5	-	-	SYM
hls-1187	184	6	8	8	NUM
hls-1187	184	7	.	.	PUNCT
hls-1187	185	1	22	22	NUM
hls-1187	185	2	.	.	PUNCT
hls-1187	186	1	longo	longo	PROPN
hls-1187	186	2	g	g	PROPN
hls-1187	186	3	,	,	PUNCT
hls-1187	186	4	gonella	gonella	NOUN
hls-1187	186	5	a	a	PRON
hls-1187	186	6	,	,	PUNCT
hls-1187	186	7	d’ascenzo	d’ascenzo	PROPN
hls-1187	186	8	f	f	PROPN
hls-1187	186	9	,	,	PUNCT
hls-1187	186	10	et	et	PROPN
hls-1187	186	11	al	al	PROPN
hls-1187	186	12	.	.	PROPN
hls-1187	186	13	percutaneous	percutaneous	ADJ
hls-1187	186	14	drug	drug	NOUN
hls-1187	186	15	-	-	PUNCT
hls-1187	186	16	eluting	elute	VERB
hls-1187	186	17	stent	stent	NOUN
hls-1187	186	18	implantation	implantation	NOUN
hls-1187	186	19	in	in	ADP
hls-1187	186	20	diabetic	diabetic	ADJ
hls-1187	186	21	patients	patient	NOUN
hls-1187	186	22	:	:	PUNCT
hls-1187	186	23	short	short	ADJ
hls-1187	186	24	and	and	CCONJ
hls-1187	186	25	long	long	ADJ
hls-1187	186	26	term	term	NOUN
hls-1187	186	27	outcomes	outcome	NOUN
hls-1187	186	28	from	from	ADP
hls-1187	186	29	an	an	DET
hls-1187	186	30	observational	observational	ADJ
hls-1187	186	31	study	study	NOUN
hls-1187	186	32	.	.	PUNCT
hls-1187	187	1	minerva	minerva	PROPN
hls-1187	187	2	cardioangiol	cardioangiol	PROPN
hls-1187	187	3	2011;59:1	2011;59:1	PROPN
hls-1187	187	4	-	-	PUNCT
hls-1187	187	5	7	7	NUM
hls-1187	187	6	.	.	PUNCT
hls-1187	188	1	article	article	PROPN
hls-1187	188	2	non	non	X
hls-1187	188	3	co	co	PROPN
hls-1187	188	4	mmerc	mmerc	PROPN
hls-1187	188	5	ial	ial	PROPN
hls-1187	188	6	us	us	PROPN
hls-1187	188	7	e	e	NOUN
hls-1187	188	8	o	o	NOUN
hls-1187	188	9	nly	nly	ADV